Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3007368	li-igg	mg/l (mg/l)	3357	3891	0.00%
3007368	li-igg	— (—)	666	713	100.00%	Distribution not available
3007368	li-igg	g/l (mg/l)	36	37	0.00%
3007368	li-igg	mg/l______ (mg/l)	29	30	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Autoimmune diseases excluding thyroid diseases, strict definition

1310

1991

3.63

322.23

1.2

50.07

39.75

mg/l

5.05

1094

1701

Other neurological diseases

945

1774

4.20

320.89

1.2

1.1

43.55

44.29

mg/l

0.09

804

1508

Symptoms and signs involving the skin and subcutaneous tissue

1015

2602

3.75

313.33

1.2

1.1

42.25

42.63

mg/l

0.05

858

2206

Autoimmune diseases excluding thyroid diseases

1343

2047

3.60

307.65

1.2

49.73

39.53

mg/l

5.14

1124

1747

Symptoms and signs involving the nervous and musculoskeletal systems

1309

1739

7.79

307.65

1.2

1.1

38.70

45.65

mg/l

2.89

1104

1486

Optic neuritis

258

141

21.31

307.65

1.2

42.58

35.72

mg/l

1.04

202

114

Other degenerative diseases of the nervous system

965

173

43.15

307.65

1.1

51.49

33.59

mg/l

8.70

799

147

Autoimmune diseases related-to ILD

1196

2740

3.70

307.65

1.1

1.2

48.77

41.40

mg/l

3.94

989

2340

Other symptoms and signs involving the nervous and musculoskeletal systems

985

1280

8.00

307.65

1.2

35.96

42.56

mg/l

3.76

840

1091

MS-disease / Multiple Sclerosis

675

226

37.59

307.65

1.1

1.2

56.36

32.22

mg/l

16.35

558

194

Other demyelinating diseases of the central nervous system

427

114

51.29

307.65

1.2

50.38

35.87

mg/l

2.71

348

Neurological diseases

1200

576

10.65

307.65

1.2

1.1

41.56

35.54

mg/l

1.94

1002

484

Disturbances of skin sensation

772

1073

7.54

307.65

1.2

40.12

40.88

mg/l

0.08

655

900

Postprocedural disorders of nervous system

334

266

13.89

307.65

1.2

1.1

32.68

36.30

mg/l

0.53

279

220

Other and unspecified polyneuropathies, also in other diseases

427

440

10.15

307.65

1.2

1.1

48.08

44.08

mg/l

0.68

378

365

Demyelinating diseases of the central nervous system

806

279

36.39

307.65

1.1

1.2

53.53

33.01

mg/l

13.51

669

239

Headache

985

1795

4.31

307.65

1.2

1.1

37.09

44.43

mg/l

2.42

826

1528

Visual disturbances

848

1695

5.13

307.65

1.2

43.44

41.70

mg/l

0.21

737

1424

Visual disturbances and blindness

880

1796

5.01

307.65

1.2

43.91

41.32

mg/l

0.36

762

1513

Abnormal findings on diagnostic imaging of central nervous system

323

150

25.16

307.65

1.2

41.77

39.19

mg/l

0.29

260

125

Neurological diseases, wide definition

501

116

22.19

307.65

1.1

41.09

30.21

mg/l

2.72

415

Polyneuropathies and other disorders of the peripheral nervous system

494

529

9.76

307.65

1.2

1.1

51.09

43.30

mg/l

1.79

439

437

Disorders of optic nerve and visual pathways

398

322

13.54

307.65

1.2

1.1

45.56

37.02

mg/l

1.13

325

273

ILD medications: immunosuppressive drugs

883

2206

3.68

263.28

1.2

1.1

49.35

43.37

mg/l

1.93

727

1873

Concussion

420

435

7.57

262.16

1.2

1.1

39.80

33.29

mg/l

0.61

342

369

Encephalitis

179

26.82

252.59

1.5

1.1

56.48

39.03

mg/l

1.99

163

Intracranial trauma

452

439

7.02

248.01

1.2

1.1

40.50

33.18

mg/l

0.79

374

372

Other encephalitis

172

27.66

245.30

1.5

1.1

57.86

39.99

mg/l

1.93

156

Diplopia

291

344

8.84

227.97

1.2

1.1

58.67

43.42

mg/l

0.95

246

280

Symptoms and signs involving cognition, perception, emotional state and behaviour

1136

2550

3.01

226.68

1.2

1.1

40.39

44.12

mg/l

0.87

976

2138

Abnormalities of gait and mobility

241

230

10.92

221.35

1.1

50.94

46.38

mg/l

0.35

186

198

Other symptoms and signs involving cognitive functions and awareness

550

1077

4.60

219.46

1.2

1.1

44.48

45.43

mg/l

0.08

467

908

General symptoms and signs

1155

1897

3.08

217.39

1.2

1.1

39.82

45.58

mg/l

2.04

982

1617

Inflammatory diseases of the central nervous system

253

267

10.11

217.18

1.4

1.1

67.57

41.18

mg/l

5.65

226

220

Autoimmune diseases

1196

2054

2.99

214.92

1.2

46.68

39.51

mg/l

3.03

1005

1751

ILD medications

1246

2434

2.79

203.24

1.2

1.1

43.54

42.64

mg/l

0.19

1055

2056

Used for control exclusion in common control thyroid runs

1097

1894

2.95

192.90

1.2

1.1

46.14

39.75

mg/l

2.41

917

1620

Subjective visual disturbances

411

823

5.12

192.72

1.2

1.1

38.05

40.87

mg/l

0.30

364

685

Spirochaetal infections, other/unspecified

224

252

9.39

182.93

1.1

1.2

62.32

39.73

mg/l

3.53

215

208

Malaise and fatigue

569

1177

3.85

174.25

1.2

1.1

38.15

45.72

mg/l

2.70

467

1005

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

687

1894

3.19

163.32

1.2

42.60

44.80

mg/l

0.48

583

1612

Other disorders of optic [2nd] nerve and visual pathways

177

190

9.90

150.04

1.2

1.1

47.93

39.37

mg/l

0.44

151

159

Migraine

655

1684

3.07

141.14

1.2

1.1

32.25

42.42

mg/l

6.43

559

1425

Episodal and paroxysmal disorders

1043

2135

2.50

136.17

1.2

1.1

36.70

45.34

mg/l

5.31

879

1809

Cerebral cysts

165

184

9.52

135.89

1.2

1.1

46.59

40.45

mg/l

0.27

145

149

Epilepsy

374

927

4.09

133.24

1.2

1.1

47.53

44.24

mg/l

0.24

330

794

Other soft tissue disorders, not elsewhere classified

981

2251

2.50

132.96

1.2

1.1

38.18

46.14

mg/l

2.38

838

1875

Use of teriflunomide

31.88

132.21

1.1

54.33

32.68

mg/l

3.94

Dorsalgia

985

2102

2.50

131.01

1.2

1.1

37.84

46.23

mg/l

3.80

848

1764

Dizziness and giddiness

727

2067

2.76

130.45

1.2

1.1

37.25

44.04

mg/l

3.29

628

1752

Papilloedema, unspecified

110

17.44

129.42

1.2

1.1

53.25

40.16

mg/l

0.38

Medical observation and evaluation for suspected diseases and conditions

622

989

3.24

128.29

1.2

1.1

37.34

47.61

mg/l

4.64

561

803

Cerebral palsy and other paralytic syndromes

215

351

6.35

126.11

1.3

1.2

51.65

41.22

mg/l

0.53

193

293

Systemic atrophies primarily affecting the central nervous system

117

14.21

125.59

1.1

37.19

42.51

mg/l

0.43

Benign intracranial hypertension

30.16

123.20

1.2

1.1

50.58

39.74

mg/l

0.24

Other headache syndromes

481

1492

3.26

122.30

1.2

1.1

36.32

41.66

mg/l

1.61

400

1266

Diseases of the eye and adnexa

822

1556

2.67

121.66

1.2

1.1

38.72

44.32

mg/l

2.26

692

1319

L04AA Selective immunosuppressants

339

857

4.05

118.64

1.1

1.2

53.62

40.43

mg/l

4.34

261

732

Nerve, nerve root and plexus disorders

1012

2661

2.30

116.83

1.2

1.1

41.50

44.11

mg/l

0.71

859

2252

Implicit Sepsis, including avohilmo

795

2275

2.52

116.58

1.2

1.1

40.47

43.13

mg/l

0.41

669

1939

Other dorsopathies, not elsewhere classified

963

2112

2.39

115.45

1.2

1.1

36.70

46.17

mg/l

5.43

834

1772

Guillain-Barre syndrome

22.84

115.24

1.3

1.1

76.10

43.99

mg/l

1.88

Condition for Implicit Sepsis (Organ dysfunction codes)

820

2322

2.47

114.35

1.2

1.1

40.30

43.71

mg/l

0.57

686

1983

Abnormal involuntary movements

199

331

6.18

114.34

1.2

1.1

35.21

43.15

mg/l

1.73

172

283

Pain, not elsewhere classified

330

840

3.99

114.01

1.2

1.1

46.38

43.39

mg/l

0.17

273

713

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

312

304

5.20

113.10

1.2

1.1

38.67

52.41

mg/l

3.34

259

260

Low back pain

763

2044

2.54

112.41

1.2

1.1

36.25

45.34

mg/l

4.20

653

1712

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

874

2514

2.37

110.64

1.2

1.1

40.62

43.09

mg/l

0.39

728

2143

Cerebrovascular diseases (FINNGEN)

389

740

3.74

110.07

1.2

46.05

42.12

mg/l

0.57

324

616

ILD medications: prednisolone, methylprednisolone, prednisone

964

2377

2.27

105.71

1.2

1.1

39.13

42.87

mg/l

1.16

836

2009

Second line medication for Crohn's disease

622

2411

2.61

105.57

1.2

1.1

47.49

41.86

mg/l

1.62

520

2054

L04AX Other immunosuppressants

603

2306

2.64

105.33

1.2

1.1

47.53

41.92

mg/l

1.59

502

1967

Pain in limb

817

2197

2.38

103.47

1.2

1.1

36.53

45.37

mg/l

5.03

690

1826

Small fibre neuropathy

15.24

103.36

1.2

1.1

42.95

40.60

mg/l

0.14

Care involving use of rehabilitation procedures

641

2275

2.56

102.59

1.2

1.1

39.70

42.38

mg/l

0.71

530

1935

Implicit Sepsis

690

2059

2.49

99.75

1.2

1.1

40.86

43.18

mg/l

0.30

584

1746

Cerebrovascular diseases

599

1559

2.69

99.32

1.2

1.1

46.63

45.84

mg/l

0.09

508

1322

Paralytic strabismus

132

166

8.28

98.43

1.2

59.62

42.14

mg/l

0.68

102

138

Pain in joint

535

1149

2.89

97.51

1.2

1.1

34.26

48.29

mg/l

9.24

468

950

Infections, IBD-co-morbidities

116

12.68

96.66

1.2

1.0

66.40

32.52

mg/l

0.98

General examination and investigation of persons without complaint and reported diagnosis

550

989

2.91

96.28

1.2

1.1

44.19

47.61

mg/l

0.35

492

803

Convulsions, not elsewhere classified

278

697

4.00

96.16

1.2

1.1

35.26

44.57

mg/l

3.51

229

589

Other special examinations and investigations of persons without complaint or reported diagnosis

559

989

2.89

95.61

1.2

1.1

37.41

47.61

mg/l

4.16

468

803

Anxiety disorders, excluding more controls

772

2113

2.35

95.36

1.2

35.32

47.78

mg/l

8.31

648

1785

Mood disorders, excluding more controls

842

2181

2.29

95.32

1.2

37.68

48.08

mg/l

5.87

719

1842

Dorsopathies

927

2124

2.23

94.60

1.2

1.1

36.36

46.06

mg/l

5.80

794

1784

Other acute disseminated demyelination

28.72

93.39

1.2

1.1

43.81

28.13

mg/l

2.66

Other and unspecified visual disturbances

167

293

5.87

90.98

1.2

1.1

36.40

39.66

mg/l

0.39

147

238

Lower back pain or/and sciatica

983

2964

2.07

89.30

1.2

1.1

37.24

45.52

mg/l

4.76

839

2493

Migraine with aura

332

1003

3.36

88.98

1.2

1.1

33.89

41.66

mg/l

1.91

284

849

Disorders of ocular muscles, binocular movement, accommodation and refraction

549

2161

2.55

88.84

1.2

41.20

40.22

mg/l

0.11

443

1845

Mood [affective] disorders

937

2895

2.09

87.07

1.2

36.75

45.75

mg/l

5.88

796

2452

Depression

898

2861

2.11

87.05

1.2

36.72

45.71

mg/l

5.69

764

2422

Mood disorders

938

2895

2.09

86.98

1.2

36.75

45.74

mg/l

5.87

796

2453

Fever of other and unknown origin

476

1533

2.71

85.19

1.2

1.1

44.53

45.09

mg/l

0.08

407

1302

Anxiety disorders

862

2806

2.12

85.03

1.2

34.94

46.11

mg/l

8.45

726

2376

Neurotic, stress-related and somatoform disorders

856

2803

2.12

84.14

1.2

34.99

46.08

mg/l

8.30

722

2375

Bell's palsy

172

338

5.22

82.75

1.2

1.1

49.21

41.94

mg/l

0.72

148

282

STROKE

510

1311

2.64

81.36

1.2

1.1

42.15

43.66

mg/l

0.23

433

1100

Focal epilepsy, strict definition

247

665

3.78

79.10

1.2

41.20

41.68

mg/l

0.06

216

555

Alzheimer disease, excluding more controls

105

11.43

78.61

1.1

1.0

37.61

45.87

mg/l

0.53

Focal epilepsy, mode (most common among epilepsy diagnosis)

238

630

3.85

78.12

1.2

1.1

41.72

41.71

mg/l

0.00

206

526

Disorders of thyroid, IBD co-morbidities

113

9.40

77.80

1.2

1.1

38.27

29.28

mg/l

0.89

Focal epilepsy

261

739

3.59

77.53

1.2

1.1

40.98

41.04

mg/l

0.01

226

619

Myalgia

290

879

3.35

77.45

1.2

1.1

33.85

41.54

mg/l

3.39

255

717

Other antidepressants

854

2082

2.11

76.74

1.2

1.1

38.51

48.39

mg/l

4.85

714

1793

First line medication for Crohn's disease

970

2656

1.98

74.69

1.2

1.1

41.58

43.27

mg/l

0.31

834

2235

Neuromuscular dysfunction of bladder

139

253

5.65

72.90

1.2

62.74

42.37

mg/l

0.69

114

206

Other intervertebral disc disorders

671

1815

2.22

71.48

1.1

39.26

46.13

mg/l

2.33

579

1525

Any reimbursement code in KELA

592

1246

2.40

71.43

1.2

1.1

41.91

38.56

mg/l

0.84

502

1065

Strabismus

320

1077

3.01

71.30

1.2

1.1

46.02

40.50

mg/l

0.48

259

908

Recurrent or chronic depression

394

992

2.78

69.93

1.2

1.1

38.48

47.49

mg/l

2.75

335

852

Implicit viral Sepsis, including avohilmo

285

914

3.15

68.99

1.2

1.1

38.90

41.16

mg/l

0.39

241

776

Examination and observation for other reasons

456

984

2.63

68.84

1.2

1.1

37.08

47.63

mg/l

3.80

416

799

Migraine without aura

272

858

3.22

68.16

1.1

29.37

41.22

mg/l

6.49

226

734

Oral corticosteroids

906

2757

1.94

67.52

1.2

1.1

38.54

45.24

mg/l

2.99

765

2327

Speech disturbances, not elsewhere classified

126

226

5.72

67.12

1.1

40.62

42.67

mg/l

0.16

109

184

Soft tissue disorders

871

2269

1.98

66.41

1.2

1.1

36.52

46.28

mg/l

6.48

753

1892

Ischaemic Stroke, excluding all haemorrhages

391

1085

2.67

65.57

1.2

1.1

45.53

47.06

mg/l

0.16

330

915

Anxiety (asthma-related co-morbidities)

621

2207

2.16

65.38

1.2

34.21

44.32

mg/l

6.11

525

1858

Opioids

849

2240

1.97

64.13

1.2

1.1

38.08

44.17

mg/l

2.96

703

1903

Certain disorders involving the immune mechanism

222

642

3.52

64.04

1.3

1.1

40.67

41.09

mg/l

0.05

188

546

All anxiety disorders

644

2396

2.10

63.87

1.2

33.81

43.54

mg/l

6.21

544

2032

Persons encountering health services for specific procedures and health care

925

2917

1.88

63.39

1.2

1.1

42.97

42.66

mg/l

0.04

769

2480

Inflammatory bowel disease treatment related agents

964

2890

1.86

62.83

1.2

1.1

39.05

44.79

mg/l

2.41

819

2438

Systemic connective tissue disorders

322

1168

2.79

62.82

1.2

45.42

42.00

mg/l

0.44

271

990

Sciatica+with lumbago

442

1634

2.41

62.79

1.2

1.1

39.05

45.51

mg/l

1.74

377

1371

Spirochaetal infections, other/unspecified, including avohilmo

334

1236

2.74

62.75

1.2

53.46

40.03

mg/l

2.86

318

1029

Lyme disease, including avohilmo

331

1225

2.74

62.18

1.2

53.65

39.89

mg/l

2.93

315

1020

Lyme disease

331

1225

2.74

62.18

1.2

53.65

39.89

mg/l

2.93

315

1020

Other spirochaetal diseases

333

1238

2.72

62.00

1.2

53.61

39.78

mg/l

2.99

317

1029

Any mental disorder

850

2196

1.95

61.95

1.2

36.98

47.88

mg/l

6.62

731

1855

Stroke, excluding SAH

413

1187

2.53

61.82

1.2

1.1

46.14

46.68

mg/l

0.05

348

1006

Extrapyramidal and movement disorders

323

1184

2.76

61.73

1.2

1.1

37.21

43.00

mg/l

1.52

270

1001

Other disorders of eye and adnexa

196

536

3.74

61.60

1.2

1.1

42.67

37.46

mg/l

0.77

174

451

Other spirochaetal diseases, including avohilmo

335

1259

2.69

61.07

1.2

53.46

40.39

mg/l

2.74

319

1049

Pain (limb, back, neck, head abdominally)

539

1169

2.32

60.92

1.2

1.1

38.05

49.32

mg/l

5.42

463

964

Sarcoidosis

165

404

4.17

60.57

1.3

1.1

41.83

41.11

mg/l

0.08

138

336

Stroke, including SAH

431

1275

2.44

59.94

1.2

1.1

46.35

46.53

mg/l

0.02

364

1074

Viral Sepsis

200

575

3.53

58.14

1.3

1.1

40.24

43.03

mg/l

0.36

170

473

Implicit viral Sepsis

199

573

3.52

57.71

1.3

1.1

40.26

43.03

mg/l

0.36

169

473

Tramadol

648

1904

2.06

57.58

1.2

1.1

39.58

43.79

mg/l

1.21

553

1621

Other diseases of spinal cord

9.91

56.41

1.2

1.1

47.82

33.64

mg/l

0.87

Other/unspecified dorsalgia

323

1233

2.61

55.44

1.2

1.1

34.63

45.13

mg/l

3.75

276

1034

Other anxiety disorders

504

2003

2.16

54.66

1.2

1.1

34.31

43.07

mg/l

4.18

426

1696

Other general symptoms and signs

129

6.80

54.18

1.2

1.1

26.86

37.42

mg/l

2.89

106

Lumbar disc prolapse

504

1729

2.17

54.07

1.2

1.1

40.03

45.52

mg/l

1.32

429

1455

Persons encountering health services for examination and investigation

462

989

2.36

53.94

1.2

1.1

39.93

47.61

mg/l

2.35

398

803

Spondylopathies

563

1578

2.12

53.92

1.2

1.1

41.85

46.51

mg/l

1.06

470

1323

Symptoms and signs involving speech and voice

299

1137

2.66

53.30

1.1

34.38

41.66

mg/l

2.43

255

953

Use of glatiramer acetate

10.73

53.24

1.1

49.47

31.45

mg/l

2.57

Depression or dysthymia

483

1169

2.27

53.24

1.2

1.1

38.54

51.23

mg/l

4.14

413

1009

Diagnoses used for exclusion with ILD

225

737

3.09

52.93

1.3

1.2

55.66

42.14

mg/l

0.68

185

621

Codeine

769

2204

1.90

52.91

1.2

1.1

38.16

44.13

mg/l

2.73

636

1874

Depression medications

306

536

2.90

52.85

1.2

1.1

34.56

42.50

mg/l

2.26

247

448

Other disorders of lacrimal gland

339

1382

2.48

52.29

1.2

1.1

37.53

42.49

mg/l

1.22

289

1152

Syncope and collapse

316

1019

2.61

52.27

1.2

1.1

37.63

46.50

mg/l

2.49

262

866

Viral infections of the central nervous system, including avohilmo

124

275

4.64

51.92

1.4

1.1

51.97

40.60

mg/l

1.46

104

227

Dysphagia

217

705

3.11

51.77

1.2

1.1

57.12

43.83

mg/l

0.68

188

588

GASTRO-related operations

666

1694

1.98

51.14

1.2

1.1

36.68

43.00

mg/l

2.67

559

1444

Any gastric operation

666

1694

1.98

51.14

1.2

1.1

36.68

43.00

mg/l

2.67

559

1444

Ocular pain

130

307

4.35

50.23

1.2

1.1

41.75

36.86

mg/l

0.54

113

252

Certain infectious and parasitic diseases

768

2063

1.87

50.13

1.2

1.1

42.62

41.10

mg/l

0.29

660

1714

Hemiplegia

126

6.64

49.97

1.3

1.2

30.58

37.56

mg/l

1.05

103

Migraine with aura and triptan purchases

226

770

2.99

49.85

1.1

32.90

39.89

mg/l

1.40

196

650

Diseases of the musculoskeletal system and connective tissue

462

1032

2.26

49.18

1.2

1.1

36.24

47.39

mg/l

3.97

394

850

Parkinson's disease, excluding more controls

9.43

48.54

1.3

1.1

41.58

42.97

mg/l

0.05

Psychiatric diseases

720

1925

1.88

47.69

1.1

38.17

48.32

mg/l

4.81

605

1634

Parkinson's disease, strict definition, excluding more controls

9.93

47.34

1.3

1.1

42.25

44.94

mg/l

0.10

Disorders of lacrimal system

373

1630

2.27

47.16

1.2

1.1

37.99

42.44

mg/l

1.12

317

1365

Other extrapyramidal and movement disorders in other diseases

223

779

2.90

46.89

1.2

1.1

36.94

41.08

mg/l

0.75

189

660

Other specific joint derangements/joint disorders

669

2226

1.88

46.82

1.2

34.73

43.80

mg/l

5.67

584

1871

Non-invasive ventilation

235

717

2.86

46.64

1.1

1.2

50.87

44.38

mg/l

0.29

187

601

Viral infections of the central nervous system

114

258

4.55

46.59

1.4

1.1

52.80

40.69

mg/l

1.44

211

Parasetamol

607

1568

1.97

45.80

1.1

37.17

47.34

mg/l

4.05

520

1325

Somatoform disorder

185

597

3.15

44.85

1.2

1.1

26.98

42.65

mg/l

11.94

153

502

Abnormalities of breathing

731

2314

1.82

44.81

1.2

34.63

46.38

mg/l

10.79

601

1974

Paraplegia, diplegia of upper limbs

10.55

43.71

1.2

1.1

104.57

40.89

mg/l

0.88

Viral encephalitis, not elsewhere classified/unspecified

10.80

42.58

1.6

1.1

63.01

45.96

mg/l

0.75

Provisional assignment of new diseases of uncertain etiology

450

2227

2.02

42.18

1.2

1.1

41.64

41.98

mg/l

0.02

387

1884

Symptoms and signs involving the circulatory and respiratory systems

807

2326

1.75

42.16

1.2

36.65

46.43

mg/l

3.88

681

1986

Asthma, excluding more controls

579

1542

1.94

42.09

1.2

1.1

37.83

44.87

mg/l

2.27

482

1298

Organic, including symptomatic, mental disorders

305

888

2.43

42.06

1.2

1.1

40.88

47.50

mg/l

1.75

253

757

Pain in throat and chest

683

2242

1.81

41.99

1.2

1.1

37.49

46.51

mg/l

2.64

571

1915

Viral encephalitis, not elsewhere classified/unspecified, including avohilmo

10.56

41.93

1.6

1.1

63.01

45.93

mg/l

0.76

Codes for special purposes

450

2232

2.01

41.90

1.2

1.1

41.64

41.96

mg/l

0.02

387

1889

Status epilepticus

8.07

41.90

1.3

1.1

44.17

44.77

mg/l

0.02

Migraine without aura and triptan purchases

220

814

2.75

41.70

1.1

29.35

40.05

mg/l

4.83

182

688

Cardiovascular diseases

608

1718

1.89

41.41

1.2

35.98

41.66

mg/l

2.00

530

1439

Third [oculomotor] nerve palsy

10.42

41.38

1.1

1.2

50.34

43.33

mg/l

0.26

Implicit bacterial Sepsis, including avohilmo

299

1049

2.39

41.19

1.2

1.1

48.52

44.23

mg/l

0.24

249

888

Visual field defects

197

4.82

41.15

1.2

1.1

46.18

39.72

mg/l

0.56

162

Asthma

584

1581

1.91

41.10

1.2

1.1

37.75

44.89

mg/l

2.38

487

1333

Radiculopathy

131

362

3.66

40.58

1.2

1.1

38.73

45.00

mg/l

0.68

107

300

Cervicalgia

181

612

2.99

40.43

1.1

38.66

43.17

mg/l

0.57

149

503

Sixth [abducent] nerve palsy

7.69

40.10

1.2

1.1

49.25

40.91

mg/l

0.42

Sequelae of cerebrovascular disease

222

705

2.71

40.00

1.1

51.29

45.36

mg/l

0.53

194

596

Spondylosis

353

1259

2.20

39.93

1.2

1.1

39.79

47.17

mg/l

1.65

286

1047

Asthma (mode)

575

1597

1.90

39.82

1.2

1.1

37.80

44.85

mg/l

2.27

475

1349

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

269

1107

2.42

39.60

1.2

1.1

37.11

43.24

mg/l

1.59

233

933

Other systemic involvement of connective tissue (FG)

217

805

2.67

39.16

1.2

1.1

40.47

40.85

mg/l

0.03

184

675

Meningitis

158

5.23

38.56

1.2

1.1

91.67

40.58

mg/l

4.12

125

Fibromyalgia

119

320

3.79

38.52

1.2

1.1

28.90

40.59

mg/l

4.03

100

267

Other reaction to severe stress, and adjustment disorders

362

1739

2.10

37.80

1.2

34.57

41.54

mg/l

3.41

298

1468

Symptoms and signs involving the urinary system

543

2222

1.85

37.77

1.2

1.1

46.54

43.19

mg/l

0.35

462

1884

ILD medications: azathioprine

150

478

3.18

37.22

1.3

1.1

57.96

38.52

mg/l

2.47

127

412

Postviral fatigue syndrome

14.30

37.10

1.2

23.70

29.60

mg/l

0.59

Oedema, not elsewhere classified

213

801

2.62

36.95

1.2

1.1

38.88

45.34

mg/l

1.11

188

672

Malignant neoplasm of brain, including Hilmo

131

5.57

36.87

1.1

1.2

83.08

36.95

mg/l

1.17

113

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

12.20

36.75

1.2

1.0

53.86

30.91

mg/l

1.89

Disorders of vestibular function (Vertigo)

336

1544

2.13

36.63

1.2

1.1

40.59

43.51

mg/l

0.53

287

1301

Codeine or tramadol medication

859

2857

1.64

36.46

1.2

1.1

38.15

44.98

mg/l

3.54

713

2426

Cervical disc disorders

245

1018

2.42

36.40

1.1

38.30

46.50

mg/l

1.24

208

848

Anaemias

209

488

2.77

36.34

1.2

1.1

40.17

42.01

mg/l

0.19

169

406

Symptoms and signs involving the digestive system and abdomen

720

2099

1.73

36.26

1.2

1.1

37.84

46.57

mg/l

5.69

619

1770

Hypothyroidism, strict autoimmune

468

1597

1.93

35.99

1.2

1.1

38.11

38.65

mg/l

0.07

394

1361

Other systemic involvement of connective tissue

223

893

2.52

35.95

1.2

41.18

40.18

mg/l

0.10

190

765

Asthma (only as main-diagnosis), excluding more controls

523

1542

1.88

35.86

1.2

1.1

37.17

44.87

mg/l

2.36

430

1298

Asthma (only as main-diagnosis)

528

1581

1.88

35.81

1.2

1.1

37.13

44.89

mg/l

2.44

434

1333

COPD differential diagnosis

582

1598

1.83

35.78

1.2

1.1

39.08

44.85

mg/l

2.40

495

1350

ILD differential diagnosis

580

1597

1.83

35.35

1.2

1.1

39.11

44.85

mg/l

2.37

494

1349

Migraine, single triptan purchase ok & required. ICD-code if available is included

650

2563

1.73

35.05

1.2

35.70

43.84

mg/l

3.63

551

2175

Triptan medication for migraine, single purchase ok

650

2563

1.73

35.05

1.2

35.70

43.84

mg/l

3.63

551

2175

Benzodiazepine use

766

3145

1.65

34.96

1.2

1.1

36.19

44.95

mg/l

4.73

628

2676

Excluding asthma or asthma-COPD overlap

576

1598

1.81

34.29

1.2

1.1

38.59

44.94

mg/l

2.84

488

1349

Chorioretinal inflammation

6.86

34.24

1.2

1.1

45.88

35.00

mg/l

0.82

Alzheimer’s disease (Late onset), excluding more controls

8.13

34.09

1.1

1.0

44.63

40.62

mg/l

0.22

Cardiovascular diseases (excluding rheumatic etc)

600

1950

1.77

33.99

1.2

37.37

41.75

mg/l

1.30

519

1638

Antihypertensive medication - note that there are other indications

587

1720

1.79

33.98

1.2

1.1

34.45

44.28

mg/l

4.37

500

1443

Other joint disorders

727

2262

1.68

33.84

1.2

36.70

44.40

mg/l

4.09

632

1905

Other disorders of urethra and urinary system

530

2048

1.81

33.74

1.2

1.1

42.12

42.08

mg/l

0.00

438

1725

Diseases of the myoneural junction and muscle

117

340

3.49

33.73

1.2

1.1

46.93

43.11

mg/l

0.24

106

280

Factors influencing health status and contact with health services

189

325

2.94

33.73

1.2

1.1

43.95

52.13

mg/l

0.83

157

273

Hypothyroidism and >3 levothyroxin purchases

230

506

2.57

33.38

1.2

1.1

37.37

41.80

mg/l

0.72

195

420

Hypothyroidism, levothyroxine purchases

230

506

2.57

33.38

1.2

1.1

37.37

41.80

mg/l

0.72

195

420

Hypothyroidism (congenital or acquired)

230

506

2.57

33.30

1.2

1.1

39.00

41.80

mg/l

0.37

197

420

Other disorders of central nervous system

11.70

33.23

1.2

1.1

44.33

28.38

mg/l

0.85

Asthma, unspecified (mode), excluding more controls

390

1414

1.98

33.03

1.2

1.1

37.60

44.88

mg/l

2.01

312

1191

Asthma, unspecified (mode)

394

1448

1.97

32.96

1.2

1.1

37.76

44.85

mg/l

1.97

316

1222

Implicit bacterial Sepsis

257

964

2.30

32.93

1.2

1.1

50.52

44.75

mg/l

0.29

213

814

Diseases of inner ear

369

1792

1.98

32.89

1.2

1.1

39.94

44.46

mg/l

0.97

316

1515

Other and unspecified nerve root and plexus disorders, also in other diseases

184

704

2.64

32.68

1.1

42.46

42.12

mg/l

0.03

148

593

Other and unspecified degenerative diseases of nervous system

9.19

32.61

1.3

1.1

47.49

49.17

mg/l

0.04

Symptoms and signs concerning food and fluid intake

237

3.97

32.35

1.2

1.1

39.11

44.55

mg/l

0.37

194

Other necrotizing vasculopathies (FG)

121

5.40

32.34

1.2

1.1

35.49

45.04

mg/l

0.92

103

Delirium, not induced by alcohol and other psychoactive substances

220

4.08

32.23

1.1

46.03

46.35

mg/l

0.02

182

Other disorders of binocular movement

6.86

32.19

1.2

35.83

41.21

mg/l

0.31

Hard cardiovascular diseases

566

1903

1.77

32.11

1.2

39.66

46.89

mg/l

2.17

483

1613

Cervicobrachial syndrome

182

700

2.63

31.97

1.3

1.1

35.79

43.10

mg/l

1.24

168

581

Malignant neoplasm of brain

6.33

31.93

1.1

81.03

37.82

mg/l

0.77

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

193

4.34

31.91

1.2

79.30

37.83

mg/l

1.25

159

Other pulmonary diagnosis

566

1598

1.78

31.88

1.2

1.1

38.24

44.94

mg/l

3.12

478

1349

Follow-up examination after treatment for conditions other than malignant neoplasms

281

842

2.23

31.83

1.1

40.91

45.20

mg/l

0.24

246

681

Disorders of optic nerve, not elsewhere classified

9.27

31.80

1.2

1.1

36.00

44.86

mg/l

0.49

Abdominal and pelvic pain

698

2099

1.68

31.77

1.2

1.1

38.65

46.57

mg/l

4.07

605

1770

Polyuria

170

636

2.70

31.56

1.3

1.1

41.77

43.81

mg/l

0.31

143

534

Other disorders of nervous system

161

4.63

30.86

1.3

1.1

43.42

41.21

mg/l

0.16

133

Covid-19 confirmed case

277

1301

2.14

30.73

1.2

1.1

47.77

41.72

mg/l

0.33

224

1096

Disorders of eyelid, lacrimal system and orbit

623

2735

1.68

30.72

1.2

1.1

37.46

44.46

mg/l

3.25

531

2319

SLE (Finngen)

6.86

30.71

1.3

1.1

55.60

41.67

mg/l

0.61

Spinal stenosis

271

911

2.20

30.45

1.2

1.1

48.04

48.81

mg/l

0.07

228

767

Special screening examination for infectious and parasitic diseases

220

669

2.42

30.39

1.1

42.45

43.84

mg/l

0.17

203

549

Bacterial Sepsis

284

1105

2.14

30.27

1.2

1.1

52.48

44.27

mg/l

0.48

234

938

Other sleep disorders

107

315

3.44

30.27

1.2

1.1

38.65

44.65

mg/l

0.49

261

Enlarged lymph nodes

128

422

3.07

30.03

1.2

1.1

40.72

43.62

mg/l

0.34

106

358

Selective serotonin reuptake inhibitors

667

2091

1.66

29.87

1.2

1.1

37.15

48.27

mg/l

6.20

564

1802

Dissociative [conversion] disorders

146

4.81

29.83

1.1

26.22

37.29

mg/l

3.30

114

Degenerative diseases of the nervous system

176

479

2.66

29.49

1.1

42.04

47.90

mg/l

0.59

145

413

Primary_lymphoid and hematopoietic malignant neoplasms

166

637

2.63

29.33

1.3

1.1

61.92

42.34

mg/l

1.79

138

539

Trigeminal neuralgia

148

4.69

29.24

1.2

38.42

37.05

mg/l

0.07

126

Other strabismus

209

893

2.36

29.10

1.2

1.1

36.52

40.06

mg/l

0.65

172

758

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

133

4.88

28.95

1.3

1.1

36.46

43.53

mg/l

0.87

113

Azathioprine

150

554

2.74

28.68

1.3

1.1

57.96

42.19

mg/l

1.76

127

473

Persons encountering health services in other circumstances, wide

807

2649

1.57

28.65

1.2

1.1

40.67

44.96

mg/l

0.78

697

2232

Other meningitis

8.07

28.31

1.3

1.1

82.87

33.26

mg/l

1.82

Any dementia, excluding more controls

177

472

2.59

27.87

1.1

38.66

48.73

mg/l

2.13

146

404

Nausea and vomiting

205

867

2.32

27.67

1.2

42.59

43.37

mg/l

0.03

163

720

Persons encountering health services for other counselling and medical advice, not elsewhere classified

779

2649

1.57

27.62

1.2

1.1

41.29

44.96

mg/l

0.61

689

2232

Liquid cancers

196

792

2.36

27.26

1.3

1.1

58.80

41.56

mg/l

1.86

163

677

Neuralgia and neuritis, unspecified

137

4.70

27.15

1.3

1.2

63.35

41.69

mg/l

0.31

109

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

703

3011

1.58

27.01

1.2

1.1

44.34

42.73

mg/l

0.19

577

2562

Transient ischemic attack

278

1078

2.06

26.99

1.2

1.1

42.72

45.64

mg/l

0.41

243

906

Personality disorders, excluding more controls

227

1039

2.20

26.94

1.2

32.46

43.28

mg/l

4.31

192

879

Fasciculation

10.98

26.48

1.1

26.41

41.34

mg/l

0.54

Dermatitis

455

2594

1.72

26.22

1.2

1.1

42.51

43.26

mg/l

0.10

383

2214

Pain in thoracic spine

128

456

2.84

26.21

1.1

33.85

44.18

mg/l

1.71

109

375

Malignant neoplasm of eye, brain and central nervous system

114

5.03

26.12

1.1

1.2

78.66

36.53

mg/l

0.79

Other necrotizing vasculopathies

162

4.27

26.11

1.1

37.10

42.40

mg/l

0.53

141

Brachial plexus disorders

106

341

3.16

26.10

1.2

1.1

36.60

38.56

mg/l

0.18

291

Diseases of the ear and mastoid process

840

2769

1.53

26.08

1.2

38.51

44.89

mg/l

2.84

713

2334

Other mental disorders due to brain damage and dysfunction and to physical disease

234

3.63

25.89

1.2

1.1

36.54

45.00

mg/l

1.62

194

Oxycodone

239

960

2.14

25.88

1.2

1.1

51.96

45.94

mg/l

0.52

196

816

Lesion of lateral popliteal nerve

127

4.75

25.77

1.2

35.67

43.48

mg/l

0.64

104

Nonorganic sleeping disorders, excluding more controls

182

777

2.36

25.69

1.2

34.11

43.86

mg/l

3.89

155

656

Dyspnoea

626

2845

1.59

25.37

1.2

1.1

34.34

44.70

mg/l

8.41

526

2409

Triptan medication for migraine, min. 3 purchases

509

2289

1.67

25.01

1.2

34.47

40.68

mg/l

1.81

433

1926

Other diseases of urinary system

689

2475

1.57

24.83

1.2

1.1

46.83

42.16

mg/l

0.69

581

2106

Disorders of refraction and accommodation

252

1241

2.04

24.63

1.2

1.1

32.53

40.72

mg/l

3.81

198

1054

Irritable bowel syndrome

240

1168

2.07

24.52

1.2

1.1

34.47

41.25

mg/l

2.05

202

975

Abnormal findings on diagnostic imaging of lung

260

1228

2.01

24.51

1.2

1.1

43.58

47.25

mg/l

0.57

229

1037

Other and unspecified dermatitis

385

2193

1.76

24.25

1.2

1.1

44.30

42.55

mg/l

0.22

322

1869

Certain infectious and parasitic diseases, including avohilmo

488

1434

1.71

24.15

1.1

41.66

42.02

mg/l

0.05

412

1188

Other functional intestinal disorders

321

1567

1.87

24.11

1.2

1.1

42.20

42.58

mg/l

0.04

259

1315

Any dementia

179

522

2.38

23.88

1.1

39.96

47.41

mg/l

1.29

148

447

Cervicocranial syndrome

287

3.25

23.82

1.2

1.1

52.94

43.23

mg/l

0.45

240

Heterophoria

293

3.23

23.76

1.2

36.13

37.23

mg/l

0.09

243

Cramp and spasm

149

4.26

23.63

1.1

1.2

38.65

39.02

mg/l

0.03

121

Non-Hodgkin lymphoma, all, including Hilmo

320

3.10

23.51

1.2

1.1

69.29

41.43

mg/l

2.81

272

Finngen Rheumatological endpoints

721

2687

1.53

23.29

1.2

1.1

39.74

42.92

mg/l

0.79

609

2263

Dementia, including avohilmo

218

691

2.16

23.14

1.1

38.11

48.21

mg/l

3.03

181

588

Acute upper respiratory infections of multiple and unspecified sites

569

2615

1.59

23.14

1.1

1.2

42.29

43.28

mg/l

0.09

471

2224

Acute upper respiratory infections

713

2811

1.52

23.07

1.2

39.41

44.00

mg/l

1.35

591

2388

Bacterial infection, other or unspecified

330

1527

1.83

22.94

1.2

1.1

54.77

43.49

mg/l

0.95

278

1305

Other symptoms and signs involving the urinary system

289

3.19

22.91

1.4

1.1

38.98

44.29

mg/l

0.59

230

Other facial nerve disorders

6.05

22.72

1.1

33.82

40.79

mg/l

0.53

Visual impairment including blindness (binocular or monocular)

154

4.09

22.55

1.3

1.1

46.40

38.51

mg/l

0.62

127

Dementia

198

612

2.22

22.52

1.1

37.29

47.46

mg/l

2.89

162

525

Speech and linguistic disorders, excluding more controls

277

3.16

22.43

1.2

1.1

43.87

43.33

mg/l

0.03

225

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

370

2065

1.74

21.94

1.2

1.1

40.20

45.02

mg/l

1.10

307

1740

Exclusions for E4_PCOS_BROAD

162

706

2.32

21.88

1.2

1.1

41.29

38.83

mg/l

0.23

127

593

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

655

3369

1.52

21.82

1.2

1.1

45.75

42.49

mg/l

0.61

562

2838

Arthropathies

682

2265

1.53

21.46

1.2

38.53

44.35

mg/l

2.18

586

1908

Cough

283

1423

1.87

21.26

1.1

31.06

45.78

mg/l

10.75

243

1220

Sleep disorders (combined)

746

2620

1.49

21.21

1.2

1.1

36.76

45.11

mg/l

4.72

611

2251

Abnormalities of heart beat

254

1291

1.92

20.93

1.2

1.1

33.93

45.53

mg/l

4.41

209

1099

Liquid cancers, including Hilmo

220

962

2.03

20.89

1.2

1.1

58.85

41.65

mg/l

2.15

183

827

Shoulder lesions

466

1708

1.64

20.64

1.2

1.1

40.45

46.85

mg/l

1.53

406

1425

Retention of urine

194

741

2.13

20.62

1.2

1.1

56.14

46.55

mg/l

0.40

164

620

Systemic lupus erythematosus

106

4.65

20.41

1.3

1.2

55.60

35.68

mg/l

1.18

Benign neoplasm of meninges

263

3.16

20.36

1.2

1.1

56.23

39.82

mg/l

1.30

222

Acute sinusitis

418

2317

1.65

20.27

1.2

39.08

42.38

mg/l

0.50

343

1962

139

588

2.39

20.20

1.2

40.47

40.09

mg/l

0.03

483

Cluster headache, strict

4.85

20.17

1.2

1.1

28.00

44.99

mg/l

2.52

Cystitis

565

2165

1.56

20.16

1.2

1.1

47.08

42.04

mg/l

0.59

477

1827

Bacterial infection, other or unspecified, including avohilmo

359

1720

1.72

20.03

1.2

1.1

53.85

42.83

mg/l

1.03

303

1463

Autonomic disorders

6.41

19.83

1.1

45.16

31.42

mg/l

0.75

Gastro-oesophageal reflux disease

457

2409

1.61

19.81

1.1

1.2

36.23

44.54

mg/l

3.30

390

2047

Benign neoplasm: Cerebral meninges

237

3.25

19.78

1.2

1.1

55.56

39.86

mg/l

1.12

203

Vocal cord dysfunction

111

370

2.66

19.76

1.2

38.62

44.73

mg/l

0.78

306

Dentofacial anomalies [including malocclusion]

557

2850

1.54

19.59

1.2

37.10

42.60

mg/l

1.60

465

2413

Chronic sinusitis

307

1754

1.76

19.20

1.1

39.90

43.96

mg/l

0.45

255

1478

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

269

1484

1.83

19.10

1.2

37.11

39.44

mg/l

0.45

233

1254

Other disorders of fluid, electrolyte and acid-base balance

183

831

2.09

19.05

1.2

44.19

42.05

mg/l

0.27

148

699

Cluster headache, wide

100

4.59

18.97

1.2

1.1

28.00

44.47

mg/l

2.52

Viral infections characterized by skin and mucous membrane lesions

309

1780

1.74

18.83

1.3

1.1

44.85

40.27

mg/l

0.95

267

1513

Restless leg syndrome

117

475

2.49

18.64

1.2

38.53

40.27

mg/l

0.15

100

404

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

699

3081

1.46

18.63

1.2

39.09

43.62

mg/l

1.69

600

2596

Non-follicular lymphoma

221

3.25

18.56

1.2

1.1

71.47

40.19

mg/l

2.29

177

Alzheimer’s disease (Early onset)

5.45

18.56

1.0

1.1

35.34

44.12

mg/l

0.62

Asthma (diagnoses ohter than nonallergic)

608

3315

1.49

18.48

1.2

1.1

37.46

44.10

mg/l

2.39

503

2811

Undetermined asthma

349

2.74

18.46

1.2

1.1

45.09

43.80

mg/l

0.05

301

Use of amantadine

7.09

18.38

1.0

1.1

49.95

41.34

mg/l

0.33

Gastrointestinal diseases

457

1425

1.61

18.29

1.1

1.2

35.99

44.53

mg/l

3.44

388

1194

Asthma, hospital admission 2, infections

412

2512

1.61

18.27

1.2

1.1

38.17

43.03

mg/l

0.97

336

2133

Asthma-related infections

412

2512

1.61

18.27

1.2

1.1

38.17

43.03

mg/l

0.97

336

2133

Coxibs

183

447

2.16

18.21

1.1

37.27

51.21

mg/l

3.01

149

381

Intracranial injury

402

2330

1.61

18.12

1.2

41.41

43.33

mg/l

0.13

324

1999

Behavioural syndromes associated with physiological disturbances and physical factors

664

3081

1.46

18.10

1.2

36.78

44.70

mg/l

3.32

552

2620

Implicit fungal Sepsis, including avohilmo

185

3.45

18.09

1.3

1.1

41.61

43.59

mg/l

0.10

157

Sleep disorders

646

3038

1.47

18.07

1.2

37.01

44.71

mg/l

3.07

537

2583

Other diseases of intestines

759

2955

1.43

18.05

1.2

1.1

37.77

44.06

mg/l

2.87

646

2497

Disorders of other endocrine glands

321

1862

1.71

18.03

1.1

1.2

38.25

40.26

mg/l

0.36

260

1588

Obesity related asthma

251

1380

1.83

18.02

1.1

37.02

42.38

mg/l

0.89

206

1173

Other shoulder lesions

283

2.93

17.98

1.2

1.1

47.42

42.32

mg/l

0.22

232

Undetermined asthma, excluding more controls

354

2.70

17.98

1.2

1.1

45.09

44.19

mg/l

0.04

303

SLE, strict definition

105

4.40

17.91

1.3

1.1

49.62

36.39

mg/l

0.68

SLE, ICD10

105

4.40

17.91

1.3

1.1

49.62

36.39

mg/l

0.68

Hydrocephalus

158

3.65

17.84

1.1

79.78

37.58

mg/l

1.66

126

Disorders of sclera, cornea, iris and ciliary body

384

2379

1.62

17.83

1.2

42.48

43.07

mg/l

0.07

326

2034

Other and unspecified types of non-Hodgkin lymphoma, hilmo

4.80

17.80

1.2

1.1

70.44

39.92

mg/l

1.76

Other diseases of upper respiratory tract

706

2538

1.45

17.73

1.2

1.1

41.43

45.17

mg/l

0.77

608

2122

Use of pramipexole

137

610

2.26

17.70

1.2

40.27

42.13

mg/l

0.16

116

514

Sleep apnoea

607

2585

1.48

17.64

1.2

42.75

45.06

mg/l

0.42

488

2224

Bronchitis

741

3118

1.43

17.53

1.2

38.43

43.77

mg/l

2.53

609

2651

Temporomandibular joint disorders, including avohilmo

383

2308

1.62

17.42

1.1

1.2

34.23

39.46

mg/l

1.30

321

1940

Other symptoms and signs involving the circulatory and respiratory systems

205

3.27

17.35

1.2

1.1

65.97

49.37

mg/l

0.23

161

Respiratory insufficiency

124

3.98

17.34

1.1

83.28

50.40

mg/l

0.33

105

Diseases of oesophagus, stomach and duodenum

716

2957

1.43

17.17

1.1

1.2

37.35

44.33

mg/l

2.96

609

2494

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

100

4.37

17.14

1.3

1.1

50.05

36.92

mg/l

1.11

Lesion of ulnar nerve

104

416

2.52

17.13

1.2

1.1

39.33

42.72

mg/l

0.29

346

Osteopathies and chondropathies

360

2023

1.63

17.00

1.1

1.2

39.43

42.53

mg/l

0.65

295

1729

Complications of medical and surgical care

478

2829

1.52

16.70

1.1

1.2

39.39

43.56

mg/l

0.42

402

2406

Asthma, including avohilmo

800

3156

1.40

16.56

1.2

1.1

37.13

44.74

mg/l

3.51

659

2689

Atypical facial pain

134

3.80

16.49

1.2

1.1

28.73

38.22

mg/l

1.25

114

337

2046

1.64

16.47

1.2

36.67

40.57

mg/l

0.88

281

1732

Other medical care

271

1304

1.75

16.40

1.2

1.1

57.07

43.81

mg/l

0.82

219

1106

Voice disturbances

183

940

1.96

16.27

1.1

30.91

42.21

mg/l

5.50

156

789

Metabolic disorders

619

2556

1.46

16.27

1.2

44.22

43.80

mg/l

0.06

533

2158

Constipation

557

2563

1.48

16.04

1.1

1.2

43.70

43.18

mg/l

0.06

441

2192

Hyperkinetic disorders, excluding more controls

135

579

2.20

16.02

1.2

36.10

40.88

mg/l

0.75

107

474

Panic disorder

143

677

2.13

15.96

1.2

32.45

41.78

mg/l

3.31

124

571

Dental pulpitis, including avohilmo

673

3032

1.43

15.96

1.1

1.2

38.98

44.01

mg/l

1.80

561

2571

Other disorders of bladder

291

2.78

15.95

1.2

1.1

43.38

47.56

mg/l

0.44

239

Chronic lower respiratory diseases

823

3144

1.38

15.72

1.2

1.1

40.54

43.73

mg/l

0.49

689

2665

Enthesopathies of lower limb, excluding foot

150

727

2.08

15.70

1.2

1.1

41.50

43.52

mg/l

0.13

131

597

Dermatitis and eczema

751

3191

1.40

15.65

1.2

1.1

40.06

44.21

mg/l

1.24

627

2707

Insomnia

626

3057

1.43

15.27

1.2

1.1

36.96

44.50

mg/l

2.88

519

2596

Diffuse large B-cell lymphoma

105

4.07

15.26

1.3

1.2

76.93

34.24

mg/l

2.26

Diffuse large B-cell lymphoma, helper endpoint

105

4.07

15.26

1.3

1.2

76.93

34.24

mg/l

2.26

Diffuse large B-cell lymphoma, including Hilmo

105

4.07

15.26

1.3

1.2

76.93

34.24

mg/l

2.26

All influenza

179

933

1.93

15.26

1.2

1.1

36.91

41.56

mg/l

1.19

160

794

Post-traumatic stress disorder

404

2.46

15.24

1.2

25.64

40.61

mg/l

6.24

334

Fourth [trochlear] nerve palsy

5.76

15.16

1.2

1.1

110.56

42.69

mg/l

0.45

Intestinal infectious diseases

639

3358

1.42

15.15

1.2

43.58

43.26

mg/l

0.03

540

2835

Viral meningitis

138

3.64

15.11

1.3

1.1

50.52

40.28

mg/l

0.71

110

COPD/asthma related infections

665

2342

1.43

15.09

1.2

38.95

43.29

mg/l

1.44

555

1994

COPD/asthma/ILD related infections

665

2342

1.43

15.09

1.2

38.95

43.29

mg/l

1.44

555

1994

Injuries to the neck

193

1036

1.88

15.09

1.2

1.1

45.42

40.98

mg/l

0.17

168

869

Viral meningitis, including avohilmo

144

3.55

14.91

1.3

1.1

49.96

39.92

mg/l

0.71

113

Dental caries

178

880

1.92

14.81

1.2

1.1

45.42

47.37

mg/l

0.18

150

731

Hypo-osmolality and hyponatraemia

405

2.42

14.81

1.2

48.95

40.50

mg/l

0.97

336

Exposure to other specified factors

569

3410

1.44

14.80

1.2

44.92

42.80

mg/l

0.20

479

2882

Chronic diseases of tonsils and adenoids

549

2379

1.46

14.78

1.2

38.13

44.87

mg/l

2.28

482

1989

Other disorders of optic disc

6.34

14.78

1.2

1.1

39.21

35.05

mg/l

0.23

Use of hypnotics and sedatives

697

2850

1.40

14.74

1.2

1.1

38.39

44.18

mg/l

2.28

593

2414

Asthma, hospital admissions , main diagnosis only

555

3359

1.44

14.72

1.2

1.1

37.38

43.88

mg/l

1.88

459

2846

Fall on same level

788

3063

1.37

14.68

1.2

42.25

42.83

mg/l

0.10

666

2593

Benign paroxysmal vertigo

176

925

1.91

14.67

1.2

1.1

45.73

41.96

mg/l

0.41

150

786

Dislocation, sprain and strain of joints and ligaments at neck level

148

734

2.04

14.65

1.2

1.1

31.98

39.97

mg/l

2.15

129

619

Intestinal infectious diseases, including avohilmo, including avohilmo

754

3045

1.38

14.64

1.2

42.71

43.62

mg/l

0.10

651

2568

Unknown and unspecified causes of morbidity

155

3.39

14.64

1.4

1.1

34.72

44.00

mg/l

0.93

131

Genitourinary diseases

386

1226

1.58

14.50

1.1

39.13

46.82

mg/l

2.51

324

1043

577

2342

1.44

14.48

1.2

45.17

43.29

mg/l

0.29

482

1994

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

577

2342

1.44

14.48

1.2

45.17

43.29

mg/l

0.29

482

1994

Systemic lupus erythematosus, unspecified

4.24

14.47

1.2

1.1

51.67

32.05

mg/l

1.03

Persons encountering health services in other circumstances

287

1727

1.65

14.45

1.2

1.1

48.88

41.85

mg/l

0.37

211

1448

Diseases of the respiratory system

409

1318

1.56

14.39

1.2

1.1

38.97

44.70

mg/l

1.78

347

1114

Caries of dentine

159

782

1.97

14.39

1.2

1.1

44.91

48.02

mg/l

0.30

137

651

Other symptoms and signs involving the digestive system and abdomen

111

496

2.25

14.33

1.1

37.87

41.02

mg/l

0.34

417

Alzheimer’s disease (Atypical or mixed), excluding more controls

6.50

14.30

1.0

1.1

38.61

37.48

mg/l

0.05

Functional dyspepsia

189

1026

1.85

14.27

1.1

37.65

42.21

mg/l

0.51

161

866

Cardiac arrhythmias

436

1852

1.51

14.12

1.1

1.2

36.93

41.13

mg/l

1.10

359

1571

Adrenocortical insufficiency

4.06

14.12

1.3

1.1

56.01

35.93

mg/l

0.67

Rotator cuff syndrome

340

1472

1.60

14.07

1.1

40.68

47.56

mg/l

1.67

301

1223

Covid-19 suspected case

183

989

1.86

14.05

1.2

44.64

40.10

mg/l

0.17

170

826

Cluster headache, strict, including avohilmo

185

3.14

14.05

1.3

1.2

29.61

40.82

mg/l

2.24

150

Zoster [herpes zoster]

115

527

2.20

13.97

1.4

1.1

48.05

42.06

mg/l

0.57

443

Infections with a predominantly sexual mode of transmission, including avohilmo

351

2070

1.56

13.74

1.2

36.31

40.49

mg/l

0.87

294

1752

Other specified/unspecified systemic involvement of connective tissue

157

3.30

13.70

1.2

42.00

38.90

mg/l

0.14

132

Disorders of adult personality and behaviour

245

1454

1.70

13.66

1.2

32.42

39.85

mg/l

3.06

206

1232

718

2643

1.38

13.62

1.2

38.95

44.30

mg/l

1.77

595

2261

Disorders of muscles

293

2.62

13.61

1.2

1.1

62.96

42.96

mg/l

0.35

240

Chronic laryngitis and laryngotracheitis

419

2.33

13.60

1.1

35.30

43.87

mg/l

1.03

355

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

306

2.58

13.50

1.2

36.53

40.31

mg/l

0.38

261

Exposure to unspecified factor

680

3367

1.38

13.42

1.1

1.2

44.00

43.12

mg/l

0.09

551

2869

Urinary track infection

434

1441

1.51

13.39

1.2

39.25

37.67

mg/l

0.28

382

1216

Iridocyclitis

160

842

1.91

13.36

1.2

1.1

39.66

41.33

mg/l

0.26

132

712

Rheumatism, unspecified

337

2.48

13.35

1.3

1.2

36.98

40.08

mg/l

0.20

286

Injuries to the head

745

3256

1.36

13.34

1.2

43.42

43.01

mg/l

0.04

617

2765

Falls/tendency to fall

725

2652

1.37

13.29

1.2

40.83

42.60

mg/l

0.39

608

2255

Bipolar affective disorders

153

795

1.94

13.28

1.1

1.2

33.78

41.64

mg/l

2.10

131

661

Endocrine, nutritional and metabolic diseases

573

2032

1.43

13.20

1.1

1.2

41.67

42.22

mg/l

0.08

480

1723

Other external causes of accidental injury

531

1843

1.45

13.15

1.2

1.1

41.09

43.23

mg/l

0.47

435

1573

Influenza and pneumonia

716

3248

1.36

13.09

1.2

1.1

46.33

42.03

mg/l

0.62

608

2743

Vertigo of central origin

6.30

13.01

1.1

44.66

45.84

mg/l

0.03

Unspecified dementia

125

3.39

12.98

1.1

33.78

45.22

mg/l

1.96

104

Other diseases of the respiratory system

109

504

2.18

12.98

1.1

63.80

44.68

mg/l

0.42

418

Other respiratory disorders and diseases

109

504

2.18

12.98

1.1

63.80

44.68

mg/l

0.42

418

Inflammatory diseases of female pelvic organs

454

2122

1.47

12.90

1.1

1.2

33.22

40.05

mg/l

2.62

379

1786

Non-selective monoamine reuptake inhibitors

195

1057

1.78

12.85

1.2

1.1

33.32

44.86

mg/l

4.86

161

920

Somnolence, stupor and coma

3.91

12.82

1.3

1.1

50.45

39.76

mg/l

0.48

Abnormal findings on diagnostic imaging of other body structures

399

2.32

12.80

1.2

44.60

41.11

mg/l

0.26

336

Cluster headache, wide,, including avohilmo

196

2.96

12.75

1.3

1.2

29.61

42.14

mg/l

2.64

160

Transport accidents

325

1739

1.56

12.71

1.1

47.65

42.47

mg/l

0.33

282

1482

Ptosis of eyelid

269

2.63

12.64

1.3

1.1

34.82

44.10

mg/l

1.55

221

Hypermetropia

241

2.73

12.60

1.2

29.35

39.39

mg/l

1.61

197

Other viral diseases, including avohilmo

308

1956

1.57

12.54

1.2

1.1

39.80

39.82

mg/l

0.00

257

1658

Hypertensive diseases (excluding secondary)

369

1405

1.53

12.51

1.2

39.59

42.19

mg/l

0.46

313

1189

Dystonia

156

3.19

12.49

1.2

28.44

38.05

mg/l

1.85

131

Accidents

526

1843

1.43

12.43

1.1

40.46

43.23

mg/l

0.66

429

1573

Diarrhoea and gastroenteritis of presumed infectious origin

478

2988

1.43

12.41

1.2

38.19

42.26

mg/l

1.42

401

2520

Continuous positive airway pressure

108

418

2.16

12.30

1.2

62.54

47.55

mg/l

0.39

100

354

Hypothyreosis and Thyroxine purchase for inclusion criteria

590

2789

1.39

12.27

1.2

1.1

38.90

42.72

mg/l

1.02

497

2359

Hypermobility syndrome

235

2.73

12.15

1.2

1.1

26.64

33.30

mg/l

1.92

196

Nonorganic sleeping disorders

182

1030

1.78

12.10

1.2

34.11

39.80

mg/l

1.82

155

862

Use of anticholinesterases

130

500

2.01

12.09

1.1

36.41

47.83

mg/l

2.40

108

428

N06DA Anticholinesterases

130

500

2.01

12.09

1.1

36.41

47.83

mg/l

2.40

108

428

Hypothyroidism, drug reimbursement

303

2.27

12.05

1.2

1.1

33.90

40.11

mg/l

0.94

254

Generalized anxiety disorder

145

765

1.91

12.02

1.2

29.71

41.65

mg/l

6.56

129

641

Personality disorders

227

1368

1.67

12.01

1.2

32.46

39.84

mg/l

2.59

192

1165

Sleep apnoea, including avohilmo

623

2748

1.37

11.98

1.2

41.38

44.63

mg/l

0.71

507

2371

Other bacterial diseases

571

2727

1.39

11.96

1.2

1.1

53.15

42.81

mg/l

1.52

476

2322

Speech and linguistic disorders

400

2.25

11.92

1.2

1.1

43.53

36.59

mg/l

0.53

332

Disorders of synovium and tendon

325

1801

1.54

11.89

1.2

1.1

37.38

45.21

mg/l

2.43

279

1499

Disorders of psychological development

123

570

2.02

11.86

1.2

1.1

38.70

37.63

mg/l

0.08

107

471

Neoplasms

572

2153

1.40

11.85

1.2

1.1

41.29

40.67

mg/l

0.07

483

1815

Vitamin deficiency, wide

136

3.28

11.79

1.1

1.2

33.05

36.10

mg/l

0.32

110

Vitamin deficiency

136

3.28

11.79

1.1

1.2

33.05

36.10

mg/l

0.32

110

Alzheimer disease

115

393

2.10

11.79

1.1

39.59

48.33

mg/l

1.11

340

Sicca syndrome [Sjögren]

227

2.72

11.78

1.3

1.1

33.59

38.10

mg/l

0.54

195

Temporal arteritis

4.30

11.76

1.1

35.04

37.38

mg/l

0.15

Giant cell arteritis with polymyalgia rheumatica

4.30

11.76

1.1

35.04

38.50

mg/l

0.23

Hypothyroidism, other/unspecified

569

2705

1.39

11.73

1.2

1.1

38.44

43.01

mg/l

1.32

483

2289

Implicit fungal Sepsis

3.73

11.70

1.4

1.1

43.39

42.32

mg/l

0.03

Unspecific neurodegenerative disorder

159

584

1.87

11.69

1.1

38.64

47.69

mg/l

1.79

130

501

Acute bronchitis

252

1540

1.61

11.61

1.1

1.2

45.70

41.29

mg/l

0.20

201

1308

Other diseases of blood and blood-forming organs, wide

138

727

1.91

11.55

1.2

1.1

62.50

41.34

mg/l

0.62

101

621

Deforming dorsopathies

162

898

1.81

11.52

1.2

1.1

36.03

44.05

mg/l

2.01

131

737

Injuries to the wrist and hand

671

3313

1.35

11.51

1.2

41.54

43.19

mg/l

0.19

569

2801

Faecal incontinence

213

2.75

11.48

1.1

40.81

40.71

mg/l

0.01

185

Fungal Sepsis

104

3.61

11.48

1.4

1.1

43.14

44.68

mg/l

0.05

Specific personality disorders

198

1166

1.71

11.46

1.2

32.10

39.39

mg/l

2.38

165

984

Osteoporosis

128

603

1.96

11.42

1.1

1.2

48.11

41.34

mg/l

0.69

516

Irregular menses

383

1956

1.48

11.40

1.2

33.39

39.14

mg/l

2.30

321

1641

Pain and other conditions associated with female genital organs and menstrual cycle

188

907

1.74

11.36

1.1

1.2

30.25

39.34

mg/l

3.25

157

755

Zoster [herpes zoster], including avohilmo

286

1781

1.55

11.32

1.3

1.1

48.36

42.12

mg/l

0.70

240

1503

Abnormal findings on examination of blood, without diagnosis

254

1441

1.60

11.28

1.1

44.40

45.72

mg/l

0.14

211

1231

Infections with a predominantly sexual mode of transmission

262

1665

1.58

11.10

1.2

37.13

38.71

mg/l

0.20

225

1401

Other and unspecified drugs and medicaments

282

2.47

11.05

1.2

37.15

40.68

mg/l

0.31

236

Anterior Iridocyclitis

139

746

1.88

11.03

1.2

1.1

38.75

41.11

mg/l

0.39

114

635

Non-allergic asthma (mode), excluding more controls

107

520

2.05

10.98

1.2

1.1

38.19

45.45

mg/l

0.47

435

Other and unspecified myopathies

214

2.69

10.84

1.2

1.1

52.64

43.61

mg/l

0.32

178

Non-allergic asthma (mode)

107

523

2.04

10.82

1.2

1.1

38.19

45.40

mg/l

0.46

438

Hypopituitarism

279

2.47

10.81

1.2

37.09

42.09

mg/l

0.33

228

Use of fingolimod

8.41

10.77

1.1

54.75

33.13

mg/l

1.28

Giant cell arteritis

3.82

10.77

1.1

34.37

38.67

mg/l

0.33

Intermittent heterotropia

232

2.62

10.76

1.1

38.44

37.20

mg/l

0.07

187

Any death

308

1414

1.53

10.74

1.2

1.1

67.01

43.63

mg/l

1.85

256

1208

Alzheimer’s disease, strict definition

326

2.21

10.70

1.1

41.69

49.86

mg/l

0.76

279

Benign neoplasms

657

2672

1.34

10.69

1.2

1.1

38.29

43.71

mg/l

2.21

569

2235

Other specified/unspecified arthritis

172

994

1.74

10.67

1.1

1.2

51.17

41.90

mg/l

0.33

142

829

Dementia in other diseases classified elsewhere

3.87

10.67

1.2

1.1

41.28

40.99

mg/l

0.01

Diseases of pulp and periapical tissues, including avohilmo

665

2573

1.34

10.63

1.2

38.70

44.93

mg/l

2.57

560

2174

Complications of surgical and medical care, not elsewhere classified

624

3109

1.34

10.57

1.2

40.35

43.57

mg/l

0.37

518

2635

Specific development disorders of speech and language

243

2.53

10.50

1.2

1.1

49.37

37.66

mg/l

0.72

194

Trochanteric bursitis

376

2.22

10.50

1.2

1.1

34.91

41.60

mg/l

0.59

313

Metatarsalgia

277

2.44

10.47

1.2

1.1

41.24

42.38

mg/l

0.08

230

Other and unspecified effects of external causes

211

1295

1.64

10.46

1.2

33.52

40.83

mg/l

2.77

172

1090

Undefined dementia

148

2.94

10.45

1.1

33.78

43.01

mg/l

1.45

119

Hypertension, essential

497

2019

1.39

10.43

1.2

42.99

43.57

mg/l

0.08

421

1720

Other arthritis (FG)

192

1151

1.68

10.42

1.1

1.2

49.98

41.04

mg/l

0.36

159

962

Other viral diseases

225

1401

1.61

10.36

1.2

1.1

41.18

39.59

mg/l

0.20

188

1179

Substance abuse, excluding more controls

309

1722

1.50

10.32

1.2

38.75

47.96

mg/l

3.32

264

1455

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

356

2406

1.45

10.30

1.1

1.2

40.47

42.76

mg/l

0.15

298

2057

Chronic iridocyclitis

154

2.97

10.21

1.2

1.1

35.70

39.49

mg/l

0.35

124

Disorders of lens

340

1423

1.49

10.19

1.2

1.1

43.86

47.92

mg/l

0.60

283

1215

Acetic acid derivatives and related substances

153

430

1.85

10.18

1.2

1.1

38.71

50.73

mg/l

2.20

127

365

Other heart diseases

325

1416

1.50

10.18

1.2

37.83

42.28

mg/l

1.02

273

1190

Other abnormal immunological findings in serum

4.30

10.16

1.1

32.30

40.53

mg/l

0.52

Other skin changes

108

549

1.98

10.10

1.2

1.1

36.01

43.39

mg/l

1.25

467

Alzheimer disease, including avohilmo

130

476

1.90

10.07

1.1

39.67

47.70

mg/l

1.17

108

406

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

233

1464

1.58

9.99

1.1

1.2

32.58

38.85

mg/l

2.58

185

1233

Other disorders of bone

143

800

1.80

9.98

1.1

31.34

40.67

mg/l

3.41

120

682

Injuries to the ankle and foot

509

3201

1.36

9.88

1.2

39.75

42.36

mg/l

0.57

413

2724

Other hearing loss

129

678

1.85

9.86

1.1

1.2

34.89

46.24

mg/l

2.72

114

578

External causes of morbidity and mortality

425

1499

1.42

9.85

1.1

39.64

43.83

mg/l

0.96

350

1277

Disorders of the thyroid gland

591

2873

1.34

9.78

1.2

1.1

39.67

43.06

mg/l

0.83

503

2434

Hyperhidrosis

3.71

9.73

1.1

43.28

36.16

mg/l

0.41

Other and unspecified mononeuropathies of upper limb

3.90

9.71

1.1

32.72

42.69

mg/l

0.86

Abnormal weight loss

269

2.40

9.69

1.2

1.1

40.32

41.33

mg/l

0.04

220

Panhypopituitarism

5.40

9.68

1.2

1.1

31.54

39.70

mg/l

0.60

Acute and subacute iridocyclitis

128

700

1.84

9.64

1.2

1.1

38.71

41.25

mg/l

0.41

108

597

Asthma, hospital admissions 3, pneumonia

197

1211

1.63

9.59

1.2

1.1

40.24

42.79

mg/l

0.24

155

1030

Asthma-related pneumonia or sepsis

197

1211

1.63

9.59

1.2

1.1

40.24

42.79

mg/l

0.24

155

1030

Malnutrition

4.68

9.57

1.1

45.54

40.05

mg/l

0.15

Other diseases of pleura

203

1091

1.62

9.56

1.1

63.80

45.25

mg/l

0.72

164

935

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

187

1144

1.65

9.47

1.1

1.2

40.95

38.15

mg/l

0.29

161

961

Other and unspecified mononeuropathies, also in other diseases

4.17

9.46

1.4

1.1

27.24

44.08

mg/l

1.78

Emotional disorders starting during childhood or adolecense, excluding more controls

166

2.78

9.46

1.1

30.21

40.63

mg/l

1.28

129

Herpesviral [herpes simplex] infections

413

2.10

9.46

1.3

1.1

49.34

39.90

mg/l

1.01

350

Mycoses, including avohilmo

594

3424

1.32

9.42

1.2

1.1

40.18

43.92

mg/l

0.94

499

2898

Urticaria and erythema

259

1710

1.52

9.40

1.1

1.2

41.37

39.45

mg/l

0.25

203

1455

Injuries to the knee and lower leg

757

3178

1.29

9.40

1.2

43.60

42.94

mg/l

0.11

645

2688

Asthma-related pneumonia

196

1211

1.62

9.36

1.2

1.1

40.24

42.79

mg/l

0.24

155

1030

Other enthesopathy of foot (+metatarsalgia)

311

2.27

9.34

1.2

1.1

40.46

42.27

mg/l

0.13

260

Diseases of the skin and subcutaneous tissue

623

2362

1.33

9.34

1.2

1.1

39.92

43.29

mg/l

0.98

519

2019

Memory loss

179

2.70

9.30

1.2

1.1

33.07

45.11

mg/l

2.01

150

Other nutritional deficiencies

454

3036

1.37

9.26

1.1

1.2

43.55

41.95

mg/l

0.27

391

2557

Other bacterial diseases, including avohilmo

628

2986

1.31

9.25

1.2

1.1

51.08

42.04

mg/l

1.39

528

2534

Other diseases of stomach and duodenum

152

2.86

9.22

1.2

1.1

45.26

44.67

mg/l

0.02

129

Other disorders of adrenal gland

148

2.88

9.09

1.3

1.1

56.16

37.23

mg/l

0.66

120

Internal derangement of knee

228

1461

1.55

9.07

1.1

1.2

37.76

43.17

mg/l

1.27

193

1232

Injuries to the thorax

253

1674

1.51

9.07

1.2

1.1

52.45

42.72

mg/l

0.55

212

1429

Diseases of male genital organs

282

938

1.52

9.05

1.2

1.1

45.62

53.65

mg/l

1.28

241

803

Candidiasis, including avohilmo

208

1321

1.58

9.03

1.3

1.2

39.48

40.20

mg/l

0.06

173

1123

Paroxysmal tachycardia

140

661

1.77

9.01

1.1

1.2

36.09

42.50

mg/l

1.10

110

552

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

210

1163

1.58

8.94

1.2

42.21

38.24

mg/l

0.21

169

982

Soft tissue disorders related to use, overuse and pressure

147

858

1.72

8.89

1.2

1.1

38.27

44.69

mg/l

0.86

130

706

Other acute lower respiratory infections

322

2136

1.44

8.87

1.2

46.27

42.22

mg/l

0.24

262

1820

All kidney diseases

622

3196

1.31

8.84

1.2

45.39

42.26

mg/l

0.37

522

2688

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

216

1391

1.56

8.83

1.2

39.25

40.02

mg/l

0.09

177

1178

Polyarteritis nodosa and related conditions

7.37

8.81

1.1

61.80

30.07

mg/l

0.78

Other disorders of ear

539

2620

1.33

8.76

1.2

37.58

44.75

mg/l

2.95

461

2215

Hypertensive diseases

500

2096

1.35

8.62

1.2

43.00

43.35

mg/l

0.04

425

1785

Weight loss

303

2.23

8.61

1.2

1.1

40.63

41.98

mg/l

0.05

249

Complications of procedures, not elsewhere classified

492

2965

1.34

8.61

1.2

40.49

43.82

mg/l

0.30

411

2516

Persistent mood disorders

120

668

1.81

8.58

1.2

37.95

42.74

mg/l

0.75

566

Explicit Sepsis, including avohilmo

221

1301

1.54

8.56

1.2

1.1

64.46

43.34

mg/l

1.25

177

1101

Fitting and adjustment of other devices

156

819

1.68

8.56

1.2

1.1

53.85

44.60

mg/l

0.33

142

691

Hypertension

499

2094

1.35

8.54

1.2

43.06

43.37

mg/l

0.04

424

1784

Other complications of surgical and medical care, not elsewhere classified

324

2.18

8.51

1.3

1.2

38.03

40.26

mg/l

0.23

277

Presence of other functional implants

269

1238

1.49

8.47

1.2

1.1

43.66

48.64

mg/l

0.67

192

1075

Carpal tunnel syndrome

324

1971

1.43

8.46

1.2

1.1

40.30

44.39

mg/l

0.88

278

1673

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

152

911

1.68

8.40

1.2

34.58

36.82

mg/l

0.27

122

780

Emotionally unstable personality disorder

116

645

1.81

8.37

1.1

30.90

38.00

mg/l

2.29

538

Spondyloarthritis

101

537

1.89

8.36

1.1

36.32

38.27

mg/l

0.20

452

Pain associated with micturition

393

2.05

8.34

1.2

1.1

63.98

41.04

mg/l

0.38

320

Unspecified/other endometriosis

472

1.95

8.33

1.1

27.64

37.32

mg/l

3.41

403

Phobic anxiety disorders

112

615

1.83

8.33

1.2

35.42

41.47

mg/l

0.74

518

Explicit Sepsis

215

1273

1.54

8.31

1.2

1.1

64.43

43.38

mg/l

1.20

172

1081

Cerebral aneurysm, nonruptured

226

2.41

8.31

1.1

43.58

41.99

mg/l

0.08

192

Aneurysms, operations, SAH

428

2.00

8.26

1.1

1.2

44.66

43.08

mg/l

0.11

357

Inflammatory disease of uterus

116

648

1.80

8.24

1.1

1.2

30.22

36.31

mg/l

0.88

555

Vestibular neuronitis

258

2.31

8.23

1.2

1.1

32.47

43.89

mg/l

2.23

212

Disorders of choroid and retina

419

2153

1.36

8.15

1.2

1.1

48.51

44.33

mg/l

0.79

338

1842

Pneumonia, organism unspecified

564

2966

1.31

8.11

1.2

1.1

47.79

42.16

mg/l

0.68

468

2508

Benign neoplasm of other and unspecified endocrine glands

418

2.00

8.09

1.1

37.56

41.49

mg/l

0.54

347

Reimbursement for rheumatic diseases

330

2339

1.41

8.07

1.2

44.27

41.38

mg/l

0.40

277

1985

Social phobias

385

2.04

8.04

1.1

1.2

32.84

41.05

mg/l

1.58

321

Benign neoplasm: Pituitary gland, craniopharyngeal duct

170

2.62

8.03

1.2

1.1

34.72

39.91

mg/l

0.64

135

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

625

3238

1.29

8.02

1.2

1.1

48.80

42.04

mg/l

0.97

526

2736

Benign neoplasm of colon, rectum, anus and anal canal

295

1738

1.44

8.02

1.2

47.91

45.87

mg/l

0.22

268

1458

Convergent concomitant strabismus

212

2.43

8.00

1.2

33.24

37.83

mg/l

0.46

174

Myopia

106

583

1.83

7.94

1.2

1.1

35.45

39.05

mg/l

0.65

492

Poisoning by drugs, medicaments and biological substances

178

1126

1.59

7.94

1.2

37.76

39.55

mg/l

0.23

149

956

Other enthesopathies

170

1064

1.60

7.90

1.2

1.1

42.36

44.64

mg/l

0.20

150

882

All pneumoniae

643

3269

1.28

7.86

1.2

1.1

48.54

41.84

mg/l

1.00

543

2763

Pneumonias (Asthma/COPD co-morbidities)

639

3264

1.28

7.86

1.2

1.1

48.61

41.88

mg/l

1.00

539

2759

Use of levodopa decarboxylase inhibitor

302

2.16

7.84

1.2

1.1

49.93

46.74

mg/l

0.10

253

Chronic apical periodontitis

702

3107

1.27

7.82

1.2

1.1

37.82

44.57

mg/l

3.57

594

2627

Tonsillectomy and adenotomy

445

2315

1.34

7.74

1.2

38.69

40.09

mg/l

0.20

384

1958

Senile cataract

280

1171

1.46

7.74

1.2

1.1

43.25

48.99

mg/l

0.96

239

998

Chronic rhinitis, nasopharyngitis and pharyngitis

207

1363

1.52

7.71

1.3

1.1

32.96

41.28

mg/l

4.14

182

1150

Oxicams

115

359

1.83

7.71

1.2

1.1

39.39

52.18

mg/l

1.43

101

304

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

320

2284

1.40

7.71

1.1

1.2

40.51

42.83

mg/l

0.13

268

1948

Other and unspecified mood [affective] disorders

292

2.18

7.68

1.2

36.63

39.59

mg/l

0.27

238

Scleritis and episcleritis

210

2.41

7.68

1.1

1.2

45.26

38.90

mg/l

0.18

179

Psychotic depression

134

2.78

7.64

1.2

1.1

30.92

50.85

mg/l

3.57

117

Astigmatism

223

2.35

7.60

1.2

30.36

37.64

mg/l

0.85

180

Urticaria

213

1418

1.51

7.56

1.2

43.26

39.66

mg/l

0.46

166

1197

Anti-inflammatory and antirheumatic products, non-steroids

157

475

1.67

7.52

1.1

40.69

49.55

mg/l

1.19

127

408

Other arrhythmias

401

2217

1.35

7.51

1.1

1.2

35.74

43.34

mg/l

2.68

330

1896

Poisoning by medicine

164

1032

1.60

7.51

1.2

38.42

39.74

mg/l

0.15

136

872

Paracetamol or NSAID medication

254

1.93

7.50

1.2

1.1

41.33

47.76

mg/l

0.47

221

Septicaemia

201

1203

1.53

7.49

1.2

1.1

64.12

42.84

mg/l

1.13

163

1026

Use of donepezil

305

2.10

7.49

1.1

40.12

44.69

mg/l

0.41

258

Other peripheral vascular diseases

251

2.25

7.42

1.1

1.2

35.01

39.23

mg/l

0.45

210

Disturbance of activity and attention

132

770

1.69

7.41

1.2

36.09

37.58

mg/l

0.18

104

641

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

195

2.43

7.41

1.1

46.48

40.28

mg/l

0.53

166

Impingement syndrome of shoulder

113

647

1.75

7.40

1.2

1.1

43.47

45.58

mg/l

0.11

101

536

Other specified/unspecified dorsopathies

3.38

7.40

1.1

45.33

41.85

mg/l

0.12

Other predominantly sexually transmitted diseases, not elsewhere classified

146

897

1.64

7.39

1.1

1.2

41.84

37.49

mg/l

0.40

129

753

Fracture of rib(s), sternum and thoracic spine

154

959

1.61

7.35

1.1

62.05

43.50

mg/l

0.67

127

815

Myocarditis

137

2.73

7.35

1.5

1.2

37.30

41.40

mg/l

0.35

110

Disorders of vitreous body and globe

246

1600

1.46

7.34

1.1

41.25

43.68

mg/l

0.41

218

1354

Dementia in Alzheimer disease

182

2.35

7.27

1.1

37.84

53.14

mg/l

1.36

154

Disorders of vitreous body

239

1559

1.46

7.26

1.2

1.1

41.63

43.85

mg/l

0.35

213

1321

Injury, poisoning and certain other consequences of external causes

340

1222

1.40

7.26

1.1

38.32

44.60

mg/l

1.50

281

1042

Deviated nasal septum

178

1149

1.55

7.25

1.2

1.1

45.27

47.06

mg/l

0.16

155

967

Diabetic neuropathy

253

2.22

7.18

1.2

1.1

55.42

46.87

mg/l

0.47

214

Other problems related to primary support group, including family circumstances

100

543

1.81

7.16

1.2

1.1

32.80

36.70

mg/l

0.66

460

Heartburn

361

2.01

7.15

1.1

33.51

43.58

mg/l

1.26

306

Asthma/COPD (KELA code 203)

598

3141

1.27

7.15

1.2

1.1

41.18

43.77

mg/l

0.27

504

2662

3.39

7.14

1.2

1.1

45.97

38.57

mg/l

0.31

Supplementary factors related to causes of morbidity and mortality classified elsewhere

196

1303

1.51

7.04

1.2

1.1

35.17

41.12

mg/l

1.72

170

1098

Other and unspecified erythematous conditions

3.12

7.04

1.1

26.80

41.62

mg/l

1.58

Disorders of lipoprotein metabolism and other lipidaemias

430

1967

1.33

7.03

1.1

1.2

44.93

45.34

mg/l

0.05

378

1656

Schizophrenia or delusion, excluding more controls

169

1074

1.56

7.02

1.1

1.2

36.95

45.32

mg/l

2.88

143

909

Retinal detachments and breaks

159

1010

1.58

7.01

1.2

1.1

45.21

43.18

mg/l

0.23

129

866

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

279

1236

1.43

6.99

1.2

41.29

41.68

mg/l

0.04

243

1045

Polymyalgia rheumatica

258

2.18

6.95

1.1

45.90

45.84

mg/l

0.00

220

Propionic acid derivatives

154

475

1.64

6.91

1.1

39.10

49.54

mg/l

1.62

126

408

Protozoal diseases, including avohilmo

3.22

6.87

1.0

1.2

56.88

38.47

mg/l

0.69

Benign neoplasm: Colon

239

1555

1.45

6.86

1.1

1.2

48.37

46.76

mg/l

0.14

221

1303

Allergic asthma (mode)

150

922

1.59

6.84

1.2

1.1

35.48

42.33

mg/l

1.55

133

781

Other viral diseases, not elsewhere classified, including avohilmo

195

1295

1.50

6.84

1.2

35.99

39.45

mg/l

0.84

168

1093

Adverse effects, not elsewhere classified

141

877

1.62

6.82

1.2

33.63

39.29

mg/l

1.35

119

743

Other disorders of eyelid

189

1182

1.51

6.81

1.2

1.1

36.60

44.85

mg/l

2.26

161

990

Persons with potential health hazards related to communicable diseases

288

2053

1.40

6.81

1.2

46.88

39.74

mg/l

0.37

203

1758

Use of rivastigmine

247

2.19

6.77

1.0

1.1

30.96

46.40

mg/l

3.24

206

Appendectomy

418

3030

1.32

6.74

1.2

34.62

43.45

mg/l

5.41

356

2562

Other CVD (FINNGEN)

210

2.15

6.73

1.3

1.2

40.64

43.67

mg/l

0.25

170

Superficial injury of abdomen, lower back and pelvis

108

629

1.73

6.73

1.1

46.07

40.75

mg/l

0.38

525

Other heart diseases, wide

605

2900

1.26

6.72

1.2

37.27

43.68

mg/l

2.75

503

2463

Mycoses

170

1108

1.54

6.72

1.2

39.36

41.18

mg/l

0.20

142

934

Injuries to the abdomen, lower back, lumbar spine and pelvis

228

1555

1.45

6.69

1.1

1.2

41.54

41.69

mg/l

0.01

194

1317

Other specified/unspecified soft tissue disorders

3.00

6.66

1.1

31.16

41.48

mg/l

1.00

Other erythematous conditions

105

2.90

6.65

1.1

26.86

40.80

mg/l

1.75

Allergic asthma (mode), excluding more controls

150

929

1.58

6.64

1.2

1.1

35.48

42.33

mg/l

1.56

133

786

Disorders of skin appendages

335

2470

1.35

6.58

1.2

1.1

42.03

39.84

mg/l

0.25

279

2094

Hypothyroidism, strict autoimmune, 3 medication purchases required

500

2615

1.29

6.53

1.2

1.1

38.88

41.39

mg/l

0.54

418

2210

Cytomegalovirus infection, IBD co-morbidity

3.70

6.50

1.2

1.1

42.13

39.18

mg/l

0.08

Ovarian cyst

237

938

1.45

6.40

1.2

32.76

41.94

mg/l

2.44

201

782

Hypokalaemia

321

2.00

6.40

1.2

41.10

38.23

mg/l

0.23

262

Eosinophilia

4.13

6.39

1.1

42.32

43.27

mg/l

0.03

Suicide or other Intentional self-harm

169

1116

1.52

6.33

1.2

37.91

40.34

mg/l

0.34

143

949

Disturbances of smell and taste

2.92

6.33

1.2

1.1

44.18

39.39

mg/l

0.11

Thyroiditis, ILD-related definition

350

1.95

6.33

1.3

1.1

34.90

34.64

mg/l

0.02

300

Hyperkinetic disorders

135

827

1.60

6.30

1.2

1.1

36.10

37.11

mg/l

0.12

107

686

Injuries to the shoulder and upper arm

489

2951

1.28

6.29

1.1

1.2

40.50

45.14

mg/l

1.23

416

2502

Spondylolisthesis/Spondylolysis

487

1.79

6.24

1.1

36.43

43.43

mg/l

1.23

400

Drug-induced adrenocortical insufficiency

3.73

6.23

1.3

1.1

77.40

38.28

mg/l

0.53

Other septicaemia

172

1076

1.51

6.23

1.2

1.1

62.69

43.09

mg/l

0.86

140

918

Problems related to lifestyle

416

1.86

6.21

1.2

1.1

33.05

41.26

mg/l

1.92

344

Other/unspecified soft tissue disorders related to use, overuse and pressure

3.16

6.18

1.1

31.82

42.61

mg/l

0.90

Bruxism

3.46

6.18

1.3

1.1

23.51

31.68

mg/l

1.74

Episcleritis

181

2.35

6.17

1.1

1.2

42.96

39.50

mg/l

0.07

152

Fibroblastic disorders

570

1.73

6.16

1.1

37.86

44.95

mg/l

0.91

479

Other septicaemia, including avohilmo

176

1104

1.50

6.15

1.2

1.1

63.14

42.81

mg/l

0.93

143

942

Adhesive capsulitis of shoulder

417

1.85

6.15

1.1

1.2

33.99

43.23

mg/l

2.07

341

Disorders of conjunctiva

531

3261

1.26

6.14

1.1

1.2

37.07

42.78

mg/l

2.77

455

2755

Disorders of mineral metabolism

252

2.12

6.13

1.2

38.34

36.52

mg/l

0.16

206

Otalgia

306

2.01

6.12

1.2

27.19

40.32

mg/l

2.87

255

Herpesviral [herpes simplex] infections, including avohilmo

176

1182

1.50

6.10

1.2

47.64

38.51

mg/l

1.18

151

999

Tinnitus

130

817

1.60

6.07

1.2

34.22

42.04

mg/l

1.33

115

695

Raynaud syndrome

356

1.93

6.05

1.1

40.97

38.47

mg/l

0.17

298

Type of accident

176

1185

1.49

6.02

1.2

1.1

34.43

40.93

mg/l

1.86

151

997

Early lumbar disc prolapse, operated

392

1.88

6.01

1.1

40.39

42.87

mg/l

0.26

315

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

178

1203

1.49

5.98

1.2

41.60

41.83

mg/l

0.02

152

1033

Infections of the skin and subcutaneous tissue

364

2728

1.32

5.96

1.2

1.1

44.29

42.54

mg/l

0.29

308

2312

Vertical strabismus

2.88

5.96

1.1

1.2

48.06

41.28

mg/l

0.26

Congenital malformations of the nervous system

2.94

5.93

1.0

1.2

59.36

34.79

mg/l

0.69

Coagulation defects, purpura and other haemorrhagic conditions

119

737

1.62

5.92

1.2

1.1

45.86

40.71

mg/l

0.55

622

Eosinophilic disease (BM)

5.11

5.91

1.1

42.32

36.61

mg/l

0.25

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

285

1308

1.38

5.91

1.1

1.2

35.09

36.27

mg/l

0.20

252

1079

Other specified/unspecified inflammatory spondylopathies

148

2.46

5.87

1.2

1.1

33.44

44.56

mg/l

0.99

120

Haemorrhage from respiratory passages

156

908

1.52

5.86

1.1

43.78

48.89

mg/l

0.58

128

778

Other disorders starting during childhood or adolecense, excluding more controls

164

2.35

5.86

1.3

1.1

27.47

40.84

mg/l

1.85

129

Other disorders of the genitourinary system

318

1.96

5.85

1.0

1.2

35.98

39.38

mg/l

0.35

271

Other and unspecified iron deficiency

178

1207

1.48

5.82

1.1

1.2

43.47

40.52

mg/l

0.37

151

1025

Other noninfective gastroenteritis and colitis

145

944

1.54

5.81

1.2

1.1

41.39

40.51

mg/l

0.06

120

796

Other disorders of white blood cells

155

2.41

5.80

1.2

38.47

40.26

mg/l

0.10

128

Keratitis

211

1485

1.43

5.75

1.2

42.71

42.17

mg/l

0.05

181

1272

Cytomegaloviral disease

3.38

5.74

1.2

42.13

39.36

mg/l

0.07

Acute pharyngitis

120

744

1.61

5.72

1.2

1.1

38.20

39.67

mg/l

0.16

638

Polycystic ovarian syndrome, consortium definition

467

2100

1.28

5.70

1.2

33.95

40.09

mg/l

2.85

395

1763

Rash and other nonspecific skin eruption

274

2.02

5.65

1.1

58.03

40.52

mg/l

0.39

229

Hyperplasia of prostate

152

555

1.55

5.64

1.1

47.17

56.92

mg/l

1.14

122

471

Bleeding

421

2298

1.29

5.60

1.1

1.2

50.25

42.61

mg/l

0.78

360

1951

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

279

2041

1.35

5.57

1.2

43.24

40.55

mg/l

0.36

225

1744

Early onset COPD, excluding more controls

467

1.76

5.57

1.3

1.1

67.06

46.86

mg/l

0.34

406

Pure hypercholesterolaemia

365

1769

1.31

5.55

1.1

1.2

48.32

45.72

mg/l

0.36

325

1493

Abnormal results of function studies

276

2.01

5.55

1.2

1.1

39.17

43.21

mg/l

0.25

230

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

598

3064

1.23

5.53

1.2

1.1

37.05

43.28

mg/l

3.35

486

2607

Obsessive-compulsive disorder

311

1.94

5.53

1.2

1.1

30.75

41.67

mg/l

2.39

258

Agoraphobia

123

2.55

5.47

1.1

31.41

36.52

mg/l

0.44

Cytomegaloviral disease, including avohilmo

3.27

5.47

1.2

1.1

42.13

38.75

mg/l

0.09

Other and unspecified tonsillitis

253

1534

1.37

5.47

1.2

39.80

40.52

mg/l

0.10

211

1302

Acute tubulo-interstitial nephritis

344

2218

1.31

5.45

1.2

1.1

50.32

42.01

mg/l

0.67

296

1858

Protozoal diseases

2.99

5.43

1.0

1.1

61.58

38.06

mg/l

0.87

Other coagulation defects

258

2.03

5.43

1.2

40.83

37.14

mg/l

0.31

216

Glaucoma suspect

159

1072

1.49

5.43

1.2

1.1

41.58

42.35

mg/l

0.07

129

905

Superficial injury of lower leg

167

1139

1.47

5.41

1.1

33.58

40.19

mg/l

2.08

142

965

Polyarthropathies

378

1871

1.30

5.39

1.1

1.2

49.27

44.34

mg/l

0.38

321

1574

Persons encountering health services for specific procedures, not carried out

307

1.94

5.39

1.3

1.1

43.28

38.60

mg/l

0.22

247

Diseases of the digestive system

220

1568

1.40

5.35

1.2

1.1

46.10

41.95

mg/l

0.31

187

1332

Conjunctivitis (acute, non atopic), including avohilmo

604

2970

1.23

5.35

1.2

40.10

44.65

mg/l

1.28

521

2509

Meralgia paraesthetica

2.81

5.32

1.1

1.2

48.01

38.34

mg/l

0.25

Diseases of tongue

168

2.28

5.30

1.2

1.1

36.37

43.18

mg/l

0.43

138

Unspecified fall

278

2040

1.34

5.25

1.2

42.32

41.36

mg/l

0.10

220

1733

Plantar fascial fibromatosis

275

1.97

5.25

1.2

1.1

38.75

44.33

mg/l

0.32

229

Retinal vascular occlusion

255

2.01

5.21

1.2

1.1

51.90

41.47

mg/l

0.70

216

Arthropathies in other diseases classified elsewhere

2.82

5.15

1.3

1.1

53.31

41.33

mg/l

0.42

Oter anti-inflammatory and antirheumatic agents, non-steroids

283

1.73

5.15

1.1

38.53

55.18

mg/l

2.19

236

Parkinson's disease, including avohilmo

348

1.85

5.12

1.3

1.1

42.68

46.49

mg/l

0.23

290

Retinal vascular disorders

257

1.99

5.11

1.2

1.1

51.90

41.94

mg/l

0.66

217

Iron deficiency anaemia

213

1505

1.39

5.10

1.2

42.66

41.01

mg/l

0.21

175

1280

Procreative management

233

1398

1.38

5.10

1.2

1.1

40.97

43.55

mg/l

0.26

207

1167

Renal tubulo-interstitial diseases

490

2884

1.25

5.10

1.2

46.84

41.74

mg/l

0.53

417

2428

Dislocation, sprain and strain of joints and ligaments of knee

396

2816

1.27

5.09

1.2

44.24

43.16

mg/l

0.12

338

2388

Leisure time condition

110

696

1.59

5.08

1.2

1.1

34.79

41.46

mg/l

1.17

583

Dermatographic urticaria

272

1.97

5.07

1.0

1.2

31.65

37.05

mg/l

0.76

230

Other peripheral vertigo

252

2.00

5.02

1.2

1.1

32.86

42.86

mg/l

1.20

212

Other obstetric conditions, not elsewhere classified

283

1337

1.34

5.01

1.1

1.2

35.14

36.36

mg/l

0.20

249

1104

Exclusions for E4_PCOS_CONSORTIUM

467

2331

1.25

4.96

1.1

1.2

35.41

40.03

mg/l

1.50

383

1965

Diseases of middle ear and mastoid

392

2520

1.27

4.96

1.1

1.2

41.43

40.72

mg/l

0.09

326

2140

Ménière disease

240

2.01

4.93

1.2

1.1

33.75

42.51

mg/l

0.97

203

Appendicitis, broad definition

445

3196

1.25

4.93

1.1

1.2

39.70

43.45

mg/l

0.82

374

2710

Diseases of appendix

448

3210

1.25

4.91

1.1

1.2

39.79

43.49

mg/l

0.81

377

2721

Diseases of external ear

192

1372

1.40

4.87

1.1

1.2

39.12

41.80

mg/l

0.56

165

1163

Contact with and exposure to communicable diseases

234

1721

1.36

4.85

1.2

35.72

38.07

mg/l

0.37

158

1478

Misadventures to patients during surgical and medical care

458

1.71

4.84

1.2

31.72

42.03

mg/l

2.48

388

Sequelae of external causes of morbidity and mortality

131

872

1.51

4.83

1.1

1.2

57.97

40.61

mg/l

0.47

740

Glaucoma

231

1442

1.36

4.82

1.2

1.1

47.67

44.71

mg/l

0.29

189

1223

Spondylopathies (FG)

535

1.65

4.81

1.2

1.1

34.72

41.02

mg/l

1.24

449

Agranulocytosis

327

1.85

4.80

1.2

1.1

88.34

40.02

mg/l

0.62

275

Decubitus ulcer and pressure area

119

2.45

4.79

1.2

1.1

143.06

43.14

mg/l

0.61

104

Noninfective enteritis and colitis

274

2073

1.32

4.79

1.1

1.2

42.18

41.07

mg/l

0.12

223

1770

Osteoporosis with pathological fracture (FG)

119

2.45

4.79

1.2

1.1

44.18

37.87

mg/l

0.18

103

Maltreatment syndromes

230

2.02

4.76

1.3

1.2

34.61

41.51

mg/l

0.74

184

Pneumonitis due to solids and liquids

183

2.14

4.74

1.2

1.1

124.90

43.65

mg/l

0.67

148

Sudden idiopathic hearing loss

286

1.90

4.72

1.1

31.80

45.60

mg/l

2.09

244

Behavioural disorders, excluding more controls

2.98

4.71

1.3

1.1

123.24

49.51

mg/l

0.36

Conjunctivitis (acute, non atopic)

180

1275

1.41

4.70

1.1

1.2

39.87

40.88

mg/l

0.13

157

1068

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

373

2282

1.27

4.69

1.1

1.2

37.29

40.68

mg/l

0.77

308

1935

Fall on and from stairs and steps

147

1009

1.46

4.68

1.2

1.1

43.71

41.35

mg/l

0.28

112

854

Pulmonary heart disease

126

838

1.51

4.67

1.2

53.35

41.36

mg/l

0.67

107

707

Pulmonary embolism

126

839

1.51

4.65

1.2

1.1

53.35

41.35

mg/l

0.67

107

708

Car occupant injured in other and unspecified transport accidents

128

856

1.50

4.65

1.2

1.1

51.40

39.68

mg/l

0.34

115

714

Diaphragmatic hernia

158

1102

1.44

4.62

1.1

37.61

43.77

mg/l

0.81

137

932

Missing teeth due to accident, extraction or parodontitis

294

2016

1.30

4.60

1.2

45.14

44.03

mg/l

0.14

251

1715

Ganglion

118

778

1.52

4.58

1.2

33.64

41.39

mg/l

2.09

104

639

Parkinson's disease

332

1.81

4.58

1.3

1.1

41.58

46.35

mg/l

0.29

277

Conjunctivitis

481

3150

1.23

4.57

1.1

1.2

35.76

42.39

mg/l

3.51

416

2661

Volume depletion

213

2.03

4.55

1.2

52.13

37.59

mg/l

0.71

169

Emotional disorders and disorders of social functioning with onset specific to childhood

263

1.92

4.55

1.1

30.85

37.66

mg/l

0.78

218

Vasomotor and allergic rhinitis

241

1767

1.34

4.52

1.2

34.54

41.20

mg/l

2.23

205

1481

Lung diseases due to external agents

319

1.83

4.52

1.2

1.1

99.66

46.08

mg/l

0.66

258

Other disorders involving the immune mechanism, not elsewhere classified

2.67

4.50

1.4

1.2

40.76

37.11

mg/l

0.11

Acute appendicitis, no complications

346

2712

1.27

4.48

1.1

1.2

35.68

42.63

mg/l

3.30

289

2292

Other and unspecified disorders of vitreous body

182

1280

1.39

4.46

1.2

37.62

44.54

mg/l

1.76

163

1087

Focal brain injury

3.42

4.46

1.1

1.0

89.12

37.40

mg/l

—

Calculus of kidney and ureter

141

970

1.46

4.45

1.1

39.30

42.69

mg/l

0.50

118

824

Urolithiasis

147

1020

1.45

4.44

1.1

40.44

43.54

mg/l

0.40

122

868

Spinal instabilities

2.85

4.40

1.1

31.27

43.46

mg/l

0.91

Chondropathies

603

1.58

4.39

1.1

31.44

39.96

mg/l

2.47

508

Obesity and other hyperalimentation

397

2998

1.25

4.36

1.1

1.2

43.88

42.00

mg/l

0.31

347

2528

Selective deficiency of immunoglobulin G [IgG] subclasses

5.69

4.34

1.0

1.1

31.22

33.97

mg/l

0.14

Meniscus derangement

272

1376

1.31

4.33

1.1

1.2

40.92

45.57

mg/l

0.98

236

1157

Other female pelvic inflammatory diseases

582

1.59

4.32

1.1

1.2

30.54

36.78

mg/l

1.23

502

Protein-energy malnutrition of moderate and mild degree

5.64

4.32

1.2

60.35

31.67

mg/l

—

Malignant immunoproliferative diseases

5.63

4.32

1.7

1.1

84.43

64.59

mg/l

0.37

Methotrexate

413

1.70

4.32

1.2

1.1

42.09

41.88

mg/l

0.01

354

Assault by bodily force

354

1.76

4.31

1.3

1.2

35.65

40.86

mg/l

0.52

290

Degenerative macular diseases

239

1.93

4.28

1.2

1.1

51.00

40.13

mg/l

0.87

204

Monoamine oxidase A inhibitors

304

1.82

4.25

1.1

1.2

35.50

44.16

mg/l

1.15

260

Venous thromboembolism

237

1726

1.32

4.22

1.2

1.1

50.39

44.52

mg/l

0.48

208

1453

Obesity

394

2990

1.24

4.21

1.1

1.2

43.91

41.98

mg/l

0.32

344

2520

Sequelae of injuries, of poisoning and of other consequences of external causes

138

957

1.45

4.21

1.1

1.2

55.83

41.30

mg/l

0.47

118

815

Pulmonary heart disease, diseases of pulmonary circulation

130

891

1.46

4.20

1.2

1.1

52.50

41.71

mg/l

0.60

110

752

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

119

803

1.49

4.19

1.2

1.1

39.06

38.97

mg/l

0.01

681

Vascular dementia (subcortical)

3.44

4.19

1.2

1.1

36.44

48.43

mg/l

0.51

Glomerular diseases

580

1.58

4.15

1.2

46.11

43.68

mg/l

0.21

481

Acute appendicitis

415

3127

1.23

4.14

1.1

1.2

40.23

43.52

mg/l

0.64

350

2648

Parkinson's disease, strict definition

314

1.79

4.13

1.3

1.1

42.25

46.79

mg/l

0.25

262

Tuberculosis, IBD comorbidity

128

2.28

4.12

1.3

1.1

40.60

41.27

mg/l

0.03

107

Sensorineural hearing loss

341

1797

1.27

4.12

1.2

41.32

46.04

mg/l

0.91

285

1521

Superficial injury of head

130

894

1.46

4.12

1.2

1.1

39.08

42.55

mg/l

0.39

115

771

Hypotension

366

1.73

4.11

1.3

1.2

44.15

46.38

mg/l

0.15

299

Tuberculosis, wide

129

2.26

4.05

1.3

1.1

40.60

41.52

mg/l

0.04

107

False labour

237

1111

1.33

4.04

1.2

32.11

38.46

mg/l

1.88

196

926

Emotional disorders starting during childhood or adolescence

250

1.88

4.01

1.1

30.21

38.00

mg/l

0.91

207

Excessive attrition of teeth

381

3050

1.24

4.00

1.2

40.92

41.32

mg/l

0.05

318

2578

Excessive, frequent and irregular menstruation

244

986

1.32

3.98

1.1

30.78

41.36

mg/l

4.40

209

822

Flat foot [pes planus] (acquired)

267

1.84

3.98

1.2

40.69

37.68

mg/l

0.17

229

All influenza (not pneumonia)

547

1.58

3.98

1.2

1.1

35.03

41.35

mg/l

1.12

457

DVT of lower extremities and pulmonary embolism

176

1281

1.37

3.97

1.2

1.1

48.82

42.54

mg/l

0.44

152

1086

Diseases of arteries, arterioles and capillaries (FINNGEN)

104

470

1.53

3.97

1.2

41.37

45.00

mg/l

0.40

392

Acute lymphadenitis

232

1.91

3.97

1.3

1.2

35.77

37.97

mg/l

0.21

188

Other CVD

454

1.63

3.96

1.2

1.1

42.61

44.29

mg/l

0.13

375

Endometriosis

211

912

1.35

3.95

1.1

1.2

39.66

42.27

mg/l

0.22

178

763

Superficial injury of wrist and hand

139

978

1.43

3.95

1.2

1.1

48.27

39.82

mg/l

0.25

122

829

Endometriosis of pelvic peritoneum

110

671

1.50

3.95

1.1

1.2

30.70

38.38

mg/l

2.27

562

Otitis externa

134

937

1.44

3.94

1.1

1.2

38.09

40.67

mg/l

0.40

117

795

Diseases of pulp and periapical tissues and dental caries

330

1334

1.27

3.93

1.2

41.73

47.20

mg/l

1.00

270

1136

Presbyopia

247

1.87

3.92

1.1

1.2

34.58

40.16

mg/l

0.59

215

Haemorrhoids and perianal venous thrombosis

157

1121

1.39

3.92

1.1

46.61

43.95

mg/l

0.21

134

931

Autoimmune hepatitis, wide definition

106

2.38

3.91

1.2

37.31

40.92

mg/l

0.26

Alzheimer’s disease (Late onset)

285

1.74

3.90

1.1

46.86

50.57

mg/l

0.21

242

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

2.59

3.90

1.4

1.2

41.58

37.43

mg/l

0.12

Additional codes for the location of defect, injury or illness

185

2.02

3.88

1.1

1.2

36.65

39.71

mg/l

0.23

150

Viral warts, including avohilmo

140

990

1.42

3.88

1.1

43.53

39.76

mg/l

0.37

123

829

Bacterial pneumonia, not elsewhere classified

181

1169

1.36

3.88

1.2

1.1

59.25

42.28

mg/l

0.80

159

1006

Other diseases of arteries and capillaries

248

1.86

3.88

1.2

1.1

38.15

42.25

mg/l

0.29

205

Nutritional anaemias

234

1707

1.31

3.87

1.2

43.04

42.41

mg/l

0.07

193

1452

Other viral diseases, not elsewhere classified

118

806

1.46

3.87

1.3

1.1

35.60

39.20

mg/l

0.62

102

673

Other/unspecified enthesopathies, not elsewhere classified

199

1.97

3.86

1.1

37.97

44.23

mg/l

0.28

164

Congenital malformations, deformations and chromosomal abnormalities

381

2932

1.23

3.86

1.2

37.77

41.39

mg/l

0.82

328

2479

Other inflammation of eyelid

458

1.62

3.85

1.2

1.1

37.33

41.83

mg/l

0.54

382

Other disorders of skin and subcutaneous tissue

373

2548

1.24

3.83

1.2

1.1

48.90

43.13

mg/l

0.45

314

2165

Other disorders of patella

104

697

1.50

3.82

1.1

1.2

36.39

39.99

mg/l

0.33

575

Haemorrhage, not elsewhere classified

2.85

3.79

1.1

43.17

36.51

mg/l

0.40

Open wound of wrist and hand

266

2007

1.28

3.79

1.1

1.2

39.18

43.58

mg/l

1.11

223

1707

Tuberculosis, wide, including avohilmo

133

2.19

3.79

1.3

1.1

40.60

41.65

mg/l

0.05

110

Unspecified mental disorder

243

1879

1.30

3.76

1.1

1.2

34.82

41.92

mg/l

2.74

207

1599

Lung cancer and mesothelioma

285

1.73

3.76

1.0

1.1

57.63

47.52

mg/l

0.72

245

Other metabolic disorders

508

1.58

3.76

1.2

46.44

36.86

mg/l

0.52

431

Specific development disorders of scholastic skills

211

1.92

3.75

1.1

33.34

37.67

mg/l

0.28

170

Melanocytic naevi of trunk

470

1.60

3.73

1.2

1.1

46.49

39.41

mg/l

0.66

399

Unspecified haematuria

171

1021

1.37

3.71

1.2

1.1

58.09

44.20

mg/l

0.60

154

867

Diseases of liver

170

1252

1.36

3.71

1.2

1.1

45.41

42.07

mg/l

0.28

137

1072

Secondary hypertension

213

1.91

3.70

1.1

1.2

42.45

39.59

mg/l

0.16

174

Mouth breathing

202

1526

1.32

3.68

1.2

40.72

44.32

mg/l

0.53

156

1311

Menorrhagia

204

851

1.34

3.68

1.1

38.15

41.76

mg/l

0.32

171

716

Caries of enamel

581

3214

1.18

3.67

1.1

1.2

42.72

43.02

mg/l

0.03

512

2710

Other and unspecified urticaria

123

860

1.44

3.65

1.2

46.21

39.40

mg/l

0.75

729

Tongue abnormality

162

2.05

3.65

1.2

1.1

38.11

38.88

mg/l

0.03

134

Dermatitis due to substances taken internally

169

2.03

3.64

1.2

1.1

38.36

41.02

mg/l

0.12

139

Dermatopolymyositis (FG)

4.47

3.64

1.2

59.55

33.19

mg/l

0.81

Arthrosis

366

1619

1.24

3.63

1.2

42.68

45.54

mg/l

0.41

317

1364

Malignant neoplasm of digestive organs, including Hilmo

912

0.65

3.61

1.2

1.1

47.16

43.68

mg/l

0.29

783

Dental caries, including avohilmo

363

1498

1.24

3.61

1.1

1.2

41.50

46.99

mg/l

1.12

296

1280

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

412

1.63

3.60

1.1

50.80

41.27

mg/l

0.59

353

Secondary and unspecified malignant neoplasm of lymph nodes

233

1.86

3.59

1.2

1.1

51.24

39.48

mg/l

0.50

194

Unspecified urinary incontinence

226

1.87

3.59

1.1

38.79

41.47

mg/l

0.11

186

Other disorders of conjunctiva

382

1.66

3.58

1.1

1.2

45.23

43.25

mg/l

0.14

321

Bacterial pneumonia (organism specified)

204

1403

1.32

3.57

1.2

1.1

58.40

42.52

mg/l

0.84

177

1205

Melanocytic naevi

183

1372

1.34

3.57

1.2

41.22

40.38

mg/l

0.10

153

1160

Neovascular glaucoma

2.46

3.55

1.2

1.1

36.91

37.49

mg/l

0.03

Dental operations

290

1174

1.27

3.55

1.1

1.2

40.69

48.33

mg/l

1.46

236

1007

Conductive and sensorineural hearing loss

367

1980

1.23

3.54

1.1

1.2

40.46

46.61

mg/l

1.46

305

1681

Disorders of synovium and tendon in diseases classified elsewhere

3.08

3.54

1.1

1.0

49.34

42.87

mg/l

—

Other cataract

180

996

1.35

3.52

1.3

1.1

45.46

45.77

mg/l

0.02

149

852

Nontraumatic intracranial haemmorrhage

422

1.62

3.52

1.1

54.58

45.02

mg/l

0.72

352

Other and unspecified anaemias

168

1168

1.35

3.51

1.1

44.55

43.23

mg/l

0.14

124

996

Nail disorders

301

1.74

3.51

1.3

1.1

40.55

41.03

mg/l

0.03

243

Obesity due to excess calories

300

2404

1.25

3.51

1.1

1.2

44.85

39.62

mg/l

1.01

260

2032

Cardiodefibrillation

905

0.60

3.50

1.2

1.1

44.75

45.74

mg/l

0.08

769

Ankylosing spondylitis

250

1.81

3.49

1.2

1.1

35.31

45.41

mg/l

1.26

201

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

317

1.71

3.47

1.1

1.2

40.17

39.35

mg/l

0.02

259

Other retinal disorders

280

1686

1.26

3.46

1.1

50.37

45.38

mg/l

0.71

227

1441

Asthma and allergy

536

1.53

3.44

1.2

1.1

32.92

41.41

mg/l

1.70

448

Thrombocytopenia, unspecified

208

1.89

3.44

1.2

1.1

61.11

41.50

mg/l

1.13

171

Other diseases of gallbladder

100

2.32

3.43

1.2

55.29

36.81

mg/l

0.53

Other diseases of liver

649

1.48

3.42

1.2

1.1

46.04

41.63

mg/l

0.22

554

Other anaemias

169

1178

1.34

3.42

1.1

44.49

43.13

mg/l

0.14

125

1006

Alcohol abuse, main dg, excluding more controls

465

1.58

3.41

1.2

1.1

37.33

46.46

mg/l

1.51

391

Hernia of abdominal wall, postoperative

485

1.56

3.41

1.2

1.1

41.91

43.51

mg/l

0.09

414

Divergent concomitant strabismus

252

1.80

3.41

1.2

36.49

39.72

mg/l

0.26

210

Superficial injury of hip and thigh

465

1.57

3.41

1.1

36.85

42.09

mg/l

0.63

381

Chronic kidney disease

112

750

1.44

3.40

1.1

46.98

45.88

mg/l

0.08

628

Special screening examination for other diseases and disorders

289

1.73

3.38

1.2

1.1

37.44

44.83

mg/l

0.64

228

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

409

3091

1.21

3.38

1.2

38.19

42.07

mg/l

0.89

350

2613

Malignant neoplasm of digestive organs

841

0.64

3.38

1.2

1.1

51.76

43.44

mg/l

0.70

726

Asthma and allergy, excluding more controls

539

1.53

3.37

1.2

1.1

32.92

41.62

mg/l

1.77

448

Sequelae with surgical and medical care as external cause

635

1.49

3.36

1.1

64.82

42.37

mg/l

0.43

538

Other superficial mycoses, including avohilmo

499

1.55

3.36

1.2

1.1

30.30

39.51

mg/l

3.26

417

Recurrent dislocation and subluxation of joint

268

1.76

3.36

1.1

1.2

42.32

40.18

mg/l

0.05

219

Presence of other devices

601

1.49

3.35

1.2

1.1

41.44

45.65

mg/l

0.55

530

Inflammatory diseases of prostate (prostatitis)

336

1.67

3.33

1.1

35.00

50.40

mg/l

4.51

283

Candidiasis

540

1.52

3.32

1.2

1.1

41.93

39.92

mg/l

0.12

460

Fall on same level involving ice and snow

308

2490

1.24

3.32

1.1

1.2

47.65

41.24

mg/l

0.97

253

2124

Other bacterial intestinal infections

564

1.51

3.32

1.2

1.1

84.76

43.08

mg/l

0.92

469

Glaucoma secondary to other eye disorders

2.38

3.32

1.2

1.1

36.91

40.46

mg/l

0.20

Other sexually transmitted chlamydial diseases

368

1.64

3.31

1.1

31.12

38.84

mg/l

1.73

296

Chronic gastritis

102

704

1.45

3.28

1.1

36.24

44.75

mg/l

1.64

592

Localized swelling, mass and lump of skin and subcutaneous tissue

144

1057

1.37

3.26

1.2

1.1

51.99

42.35

mg/l

0.63

126

884

Fenamates

300

1.59

3.25

1.1

39.80

47.92

mg/l

0.98

252

Other disorders of breast

560

1.51

3.23

1.2

1.1

30.81

36.13

mg/l

1.20

475

Injury of muscle and tendon at shoulder and upper arm level

156

1162

1.35

3.22

1.1

1.2

41.71

45.83

mg/l

0.53

135

992

KRA_PSY_EATING, excluding more controls

352

1.64

3.20

1.2

33.19

41.15

mg/l

0.47

290

Other bacterial intestinal infections, including avohilmo

117

833

1.41

3.19

1.1

72.89

42.51

mg/l

0.89

708

Anogenital herpesviral [herpes simplex] infection, including avohilmo

603

1.48

3.18

1.3

1.2

26.75

37.73

mg/l

6.12

501

Other pleural conditions

214

1.83

3.17

1.2

1.1

35.23

44.94

mg/l

1.20

175

Disease of hard tissues of teeth, NOS

261

1080

1.27

3.15

1.1

36.59

47.68

mg/l

3.36

231

900

Bacterial pneumoniae

188

1264

1.31

3.15

1.2

1.1

57.82

42.14

mg/l

0.76

165

1085

Hyperlipidaemia, other/unspecified

149

992

1.35

3.14

1.1

45.58

47.41

mg/l

0.17

121

837

Sequelae of injuries of upper limb

342

1.65

3.14

1.2

43.68

42.68

mg/l

0.05

284

Disorders of breast

288

2046

1.24

3.14

1.2

39.98

39.26

mg/l

0.06

246

1724

Diseases of oral cavity, salivary glands and jaws

266

1087

1.26

3.12

1.1

40.95

47.53

mg/l

1.13

225

905

Malignant melanoma of skin, including Hilmo

366

1.62

3.11

1.2

1.1

84.84

39.64

mg/l

0.69

313

Diseases of salivary glands

175

1334

1.32

3.10

1.2

33.50

41.18

mg/l

2.24

143

1126

Dermatopolymyositis

3.72

3.10

1.2

59.55

33.35

mg/l

0.81

Conduct disorder

2.35

3.09

1.3

1.1

123.24

39.36

mg/l

0.42

Benign neoplasm: Choroid

173

1.92

3.09

1.1

42.32

41.13

mg/l

0.04

144

Fentanyl

194

1.86

3.08

1.2

1.1

50.45

45.52

mg/l

0.16

160

Ischemic heart diseases

398

1970

1.20

3.07

1.2

36.51

46.93

mg/l

4.83

337

1671

Fracture at wrist and hand level

198

1532

1.29

3.07

1.2

45.91

43.22

mg/l

0.29

168

1308

Assault

657

1.45

3.07

1.2

1.1

33.61

40.44

mg/l

1.20

554

Acute generalized exanthematous pustulosis

139

2.03

3.06

1.1

1.2

40.58

40.69

mg/l

0.00

110

Collagenous colitis

299

1.68

3.05

1.1

1.2

34.56

38.98

mg/l

0.56

249

Purpura and other haemorrhagic conditions

455

1.54

3.04

1.2

1.1

48.79

42.35

mg/l

0.45

371

Use of antiglaucoma preparations and miotics

153

1.97

3.04

1.2

1.1

51.77

40.99

mg/l

0.53

126

Other and unspecified injuries of lower leg

308

1.67

3.01

1.1

1.2

58.84

40.57

mg/l

1.00

256

Bacterial intestinal infections, IBD co-morbidities

553

1.49

3.00

1.1

81.52

43.19

mg/l

0.78

457

Benign neoplasm: Colon, unspecified

643

1.45

3.00

1.1

53.80

43.05

mg/l

0.61

545

Striking against or struck by other objects

206

1610

1.28

3.00

1.2

51.13

42.31

mg/l

0.36

166

1377

Autoimmune hyperthyroidism

147

1.98

2.99

1.4

1.1

41.95

36.13

mg/l

0.36

130

Contusion of other and unspecified parts of foot

226

1.78

2.99

1.1

1.2

28.82

38.52

mg/l

1.67

182

Malignant melanoma, including Hilmo

442

1.54

2.96

1.2

1.1

83.02

40.43

mg/l

0.76

383

Ovarian dysfunction

435

1.55

2.95

1.1

34.21

35.59

mg/l

0.17

364

Behavioural disorders

2.30

2.95

1.3

1.1

123.24

33.97

mg/l

0.46

Viral warts

388

1.58

2.93

1.1

44.10

39.48

mg/l

0.24

325

Rheumatoid arthritis

142

936

1.35

2.93

1.1

1.2

42.50

42.77

mg/l

0.02

120

782

Other keratitis

460

1.53

2.92

1.2

1.1

48.09

40.01

mg/l

0.58

384

Disorders in reading

2.41

2.91

1.1

31.77

40.98

mg/l

0.57

Iron deficiency

142

1.99

2.91

1.0

1.1

59.74

37.48

mg/l

0.51

115

All chronic kidney diseases

249

1590

1.25

2.91

1.1

41.54

43.87

mg/l

0.41

218

1337

Anogenital herpesviral [herpes simplex] infection

319

1.64

2.90

1.3

1.2

27.24

36.63

mg/l

3.03

263

Budesonide

517

1.49

2.90

1.1

44.75

41.69

mg/l

0.22

439

Atopic dermatitis

387

2583

1.19

2.89

1.2

33.81

41.28

mg/l

4.31

324

2197

Bacterial, viral and other infectious agents, including avohilmo

374

1.59

2.88

1.1

1.2

43.67

42.02

mg/l

0.09

306

Other and unspecified vascular occlusions

192

1.83

2.87

1.2

1.1

40.82

40.68

mg/l

0.01

166

Generalized epilepsy

150

1.95

2.85

1.1

1.2

29.27

40.38

mg/l

1.13

121

Nummular dermatitis

230

1.75

2.83

1.2

1.1

34.51

45.99

mg/l

1.96

189

Caries of dentine, including avohilmo

392

1675

1.20

2.82

1.1

1.2

40.82

45.65

mg/l

1.04

320

1432

Other and unspecified nonorganic psychotic disorders

129

956

1.35

2.82

1.1

1.2

35.68

41.34

mg/l

1.12

109

813

Aplastic and other anaemias

181

1285

1.29

2.81

1.1

44.52

43.45

mg/l

0.12

136

1096

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

291

1.66

2.81

1.1

1.2

40.85

40.65

mg/l

0.01

239

Other sexually transmitted chlamydial diseases, including avohilmo

596

1.45

2.79

1.1

1.2

32.01

39.52

mg/l

1.88

484

Glomerulonephritis

300

1.64

2.76

1.2

1.1

47.34

43.42

mg/l

0.25

248

Vitreous haemorrhage

300

1.64

2.76

1.1

55.80

46.10

mg/l

0.58

244

Mental and behavioural disorders due to psychoactive substance use

319

2423

1.21

2.74

1.2

38.95

45.24

mg/l

2.06

271

2060

Gonarthrosis

292

1347

1.23

2.73

1.2

41.32

45.87

mg/l

0.89

254

1126

Fracture of lower leg, including ankle

282

2271

1.22

2.73

1.2

50.12

43.62

mg/l

0.90

237

1936

Substance abuse

309

2375

1.21

2.73

1.2

38.75

45.31

mg/l

2.15

264

2017

Other diseases of anus and rectum

131

975

1.34

2.71

1.1

42.94

43.11

mg/l

0.01

110

809

Exposure to other and unspecified man-made environmental factors

2.53

2.71

1.4

1.1

30.53

36.10

mg/l

0.42

Other disorders of the musculoskeletal system and connective tissue

452

1.51

2.71

1.2

1.1

35.94

43.15

mg/l

1.08

377

Other arthrosis

238

1280

1.25

2.69

1.1

1.2

37.84

45.51

mg/l

2.06

205

1073

Coeliac disease

453

1.51

2.69

1.3

1.1

54.12

40.19

mg/l

0.39

382

Mixed and other personality disorders

334

1.60

2.68

1.1

1.2

30.34

38.30

mg/l

1.78

275

Preterm labour and delivery

148

1129

1.31

2.67

1.1

1.2

39.60

38.77

mg/l

0.05

122

952

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

500

1.48

2.65

1.1

1.2

28.28

37.90

mg/l

1.24

421

Childhood asthma (age<16), excluding more controls

519

1.42

2.65

1.3

1.2

45.63

40.67

mg/l

0.26

427

Superficial injury of ankle and foot

571

1.44

2.61

1.1

39.60

37.25

mg/l

0.24

478

Disorders of orbit

127

1.98

2.60

1.3

1.2

38.71

39.84

mg/l

0.06

105

Childhood asthma (age<16)

521

1.41

2.60

1.3

1.2

45.63

40.60

mg/l

0.27

430

Polyarthrosis

468

1.47

2.60

1.1

1.2

35.96

44.10

mg/l

0.63

401

Status post-ami

453

0.58

2.60

1.1

41.73

52.29

mg/l

0.96

379

Other diseases of hard tissues of teeth

259

1087

1.24

2.59

1.1

42.19

47.53

mg/l

0.73

213

905

Other noninflammatory disorders of vulva and perineum

393

1.53

2.58

1.2

33.46

35.92

mg/l

0.18

328

Achilles tendinitis

275

1.64

2.58

1.2

1.1

35.01

44.76

mg/l

0.97

225

Statin medication

420

2011

1.18

2.57

1.2

42.44

43.38

mg/l

0.13

370

1695

Suppurative and unspecified otitis media

250

1806

1.23

2.56

1.2

40.98

40.33

mg/l

0.06

206

1532

Muscle wasting and atrophy, not elsewhere classified

5.57

2.56

1.0

1.1

45.17

48.78

mg/l

—

Myeloid leukaemia

2.52

2.53

1.4

1.1

27.14

43.37

mg/l

1.29

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

357

1.55

2.52

1.2

29.72

37.01

mg/l

0.89

292

Other disorders of penis

300

1.60

2.51

1.2

37.93

50.40

mg/l

2.57

247

Ingrowing nail

194

1.76

2.51

1.3

1.2

48.96

40.11

mg/l

0.42

156

Transplanted organ and tissue status

332

1.57

2.51

1.2

1.1

43.08

45.93

mg/l

0.23

277

Unspecified lump in breast

551

1.44

2.50

1.2

1.1

40.06

36.32

mg/l

0.24

475

Invasive ventilation

209

1.73

2.50

1.3

1.1

51.65

42.71

mg/l

0.55

171

Streptococcal septicaemia

232

1.69

2.48

1.3

1.1

115.82

45.29

mg/l

0.65

192

Fracture of foot, except ankle

146

1125

1.30

2.48

1.2

36.10

39.80

mg/l

0.54

115

955

L04AD Calcineurin inhibitors

397

1.52

2.48

1.2

1.1

48.08

41.84

mg/l

0.46

331

Other contact dermatitis

271

1.63

2.46

1.1

36.22

43.65

mg/l

0.95

231

Acute renal failure

561

1.43

2.46

1.3

1.1

47.25

45.09

mg/l

0.14

466

Other disorders of skin and subcutaneous tissue, not elsewhere classified

438

1.49

2.46

1.1

42.90

43.16

mg/l

0.01

366

GI-bleeding

120

900

1.34

2.46

1.2

1.1

54.22

43.48

mg/l

0.55

104

760

Other diseases of the digestive system

121

909

1.33

2.45

1.2

1.1

50.86

43.38

mg/l

0.37

105

769

Gingivitis and periodontal diseases

540

2425

1.15

2.45

1.2

1.1

39.23

44.10

mg/l

1.19

462

2049

Heart failure, not strict

326

1837

1.19

2.43

1.2

1.1

41.96

45.66

mg/l

0.72

276

1559

Ehlers-Danlos syndrome

2.95

2.43

1.1

23.45

33.20

mg/l

1.02

Sequelae of infectious and parasitic diseases, including avohilmo

226

1.69

2.43

1.2

1.1

40.47

40.41

mg/l

0.00

185

Acute peritonitis

152

1.85

2.42

1.1

127.74

40.73

mg/l

0.51

129

Phlebitis and thrombophlebitis (not including DVT)

104

766

1.36

2.41

1.2

47.40

41.49

mg/l

0.38

647

Complications of internal orthopaedic prosthetic devices, implants and grafts

572

1.42

2.41

1.1

1.2

41.58

42.31

mg/l

0.06

487

Perforation of tympanic membrane

344

1.55

2.40

1.2

1.1

48.70

41.65

mg/l

0.44

287

Substance use, excluding alcohol

118

888

1.33

2.39

1.2

1.1

36.36

42.53

mg/l

1.35

764

Other specified acquired deformities of limbs

6.39

2.38

1.0

21.58

42.06

mg/l

—

Other local infections of skin and subcutaneous tissue

353

1.54

2.37

1.2

1.1

37.76

40.89

mg/l

0.36

289

Retinal detachment with retinal break

337

1.55

2.37

1.2

1.1

39.02

43.39

mg/l

0.48

285

Endocrine disorders, other/unspecified

2.63

2.37

1.2

1.1

47.15

31.71

mg/l

—

FESS (DNB20)

459

1.47

2.35

1.1

45.29

40.36

mg/l

0.28

389

Injury of muscle and tendon at wrist and hand level

492

1.45

2.35

1.2

46.90

42.49

mg/l

0.31

418

Other gastritis (incl. Duodenitis)

651

1.39

2.34

1.2

49.05

44.60

mg/l

0.16

552

Other inflammation of eyelid, including avohilmo

265

2202

1.21

2.33

1.2

1.1

35.68

40.93

mg/l

1.89

210

1852

L04AC Interleukin inhibitors

260

1.62

2.33

1.2

48.01

41.12

mg/l

0.33

213

Disorders of parathyroid gland

512

1.43

2.31

1.1

31.61

40.15

mg/l

2.38

435

Superficial injury of thorax

527

1.43

2.31

1.1

76.57

42.12

mg/l

0.62

437

Lymphoid leukaemia

133

1.89

2.31

1.2

1.1

48.53

40.80

mg/l

0.29

114

Hypoglycaemia, other or unspecified

222

1.67

2.31

1.2

37.39

42.21

mg/l

0.32

181

Allergic rhinitis

200

1597

1.24

2.30

1.2

34.42

40.09

mg/l

1.57

171

1348

Pyogenic arthritis

155

1.81

2.29

1.2

64.89

45.22

mg/l

0.59

124

Medical abortion

362

1664

1.18

2.29

1.1

1.2

39.22

39.31

mg/l

0.01

312

1393

Crohn's disease of small intestine

277

1.60

2.28

1.2

40.11

41.68

mg/l

0.10

229

Streptococcal septicaemia, including avohilmo

238

1.64

2.28

1.3

1.1

115.82

45.41

mg/l

0.65

197

Distal bite

147

1.84

2.28

1.2

45.29

33.09

mg/l

0.43

119

Drug-induced neutropenia

200

1.71

2.28

1.1

144.38

38.74

mg/l

0.70

169

Other and specified injuries of hip and thigh

2.57

2.27

1.2

1.1

35.83

42.34

mg/l

0.23

Malignant melanoma

397

1.49

2.27

1.2

1.1

87.72

40.11

mg/l

0.69

344

Acute laryngitis and tracheitis

587

1.40

2.26

1.2

1.1

31.41

39.77

mg/l

2.01

496

Noninfectious colitis NAS

513

1.43

2.26

1.2

1.1

42.76

40.69

mg/l

0.10

434

Viral and other specified intestinal infections

137

1036

1.29

2.26

1.1

33.71

40.00

mg/l

1.65

114

870

Any event in cancer register

527

2694

1.14

2.25

1.2

1.1

47.00

41.17

mg/l

0.94

443

2275

Endometriosis diagnosis and infertility diagnosis occurring together

547

1.41

2.25

1.2

30.87

34.02

mg/l

0.65

464

Viral and other specified intestinal infections, including avohilmo

183

1414

1.25

2.25

1.2

36.01

41.15

mg/l

1.19

152

1191

Orchitis and epididymitis

255

1.61

2.23

1.1

1.2

48.70

52.90

mg/l

0.21

213

Noninflammatory disorders of female genital tract

241

991

1.22

2.22

1.1

32.47

41.43

mg/l

3.12

210

827

Maternal care for other conditions predominantly related to pregnancy

153

1175

1.27

2.22

1.2

39.45

36.35

mg/l

0.35

122

981

Open wound of head

260

2034

1.20

2.22

1.2

48.56

44.68

mg/l

0.43

210

1735

Endometriosis ASRM stages 1,2

110

830

1.33

2.21

1.1

1.2

30.70

36.78

mg/l

1.81

714

Gastroduodenal ulcer

622

1.38

2.21

1.1

1.2

38.99

45.66

mg/l

1.04

528

Seronegative rheumatoid arthritis

303

1.56

2.21

1.1

47.62

39.44

mg/l

0.42

256

Other (seronegative) rheumatoid arthritis, wide

549

1.41

2.20

1.1

46.66

39.67

mg/l

0.54

467

Biological medication for rheuma

111

840

1.33

2.19

1.2

44.77

40.32

mg/l

0.39

722

Enterocolitis due to Clostridium difficile

272

1.59

2.19

1.2

1.1

114.60

44.76

mg/l

0.74

226

Ethmoidectomy

475

1.44

2.18

1.1

44.92

40.17

mg/l

0.28

403

Postprocedural endocrine and metabolic disorders, not elsewhere classified

467

1.44

2.18

1.3

1.2

33.41

36.34

mg/l

0.43

396

Rosacea

492

1.43

2.18

1.2

1.1

41.78

38.74

mg/l

0.13

423

Infectious mononucleosis, including avohilmo

451

1.45

2.17

1.1

52.58

37.65

mg/l

1.00

369

Infectious mononucleosis

451

1.45

2.17

1.1

52.58

37.65

mg/l

1.00

369

Amenorrhoea

353

1.51

2.17

1.2

43.29

36.42

mg/l

0.43

297

Medicines for HER+ breast cancer

1162

0.74

2.16

1.2

43.47

41.13

mg/l

0.10

985

Fissure and fistula of anal and rectal regions

116

886

1.31

2.15

1.1

46.15

42.57

mg/l

0.31

739

Respiratory disorders in diseases classified elsewhere

2.81

2.15

1.4

1.1

53.74

36.87

mg/l

—

Pedestrian injured in transport accident

227

1.64

2.14

1.1

31.81

39.82

mg/l

1.07

185

Vasomotor rhinitis (mode)

235

1.62

2.13

1.2

1.1

31.07

41.86

mg/l

1.41

197

Nonsuppurative otitis media, including avohilmo

208

1472

1.22

2.13

1.2

43.82

40.69

mg/l

0.33

181

1245

Superficial injury of shoulder and upper arm

437

1.45

2.11

1.2

1.1

33.60

39.49

mg/l

0.90

365

Otitis externa, unspecified

462

1.43

2.11

1.2

1.1

41.24

39.36

mg/l

0.16

385

Use of memantine

356

1.45

2.11

1.1

38.77

48.98

mg/l

1.33

308

Use of other anti-dementia drugs

356

1.45

2.11

1.1

38.77

48.98

mg/l

1.33

308

Hallux rigidus

347

1.50

2.11

1.0

1.2

46.28

39.63

mg/l

0.31

295

Other and unspecified local infections of skin and subcutaneous tissue

331

1.52

2.11

1.2

1.1

35.60

40.68

mg/l

0.72

270

Smoking dependency

291

1.55

2.11

1.1

39.85

42.34

mg/l

0.17

241

Other bursopathies

315

1.53

2.10

1.1

1.2

57.12

45.35

mg/l

0.48

259

Follicular cysts of skin and subcutaneous tissue

682

1.35

2.10

1.2

37.66

41.88

mg/l

0.42

578

Cerebral atherosclerosis

3.22

2.09

1.3

1.0

49.40

52.05

mg/l

—

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

270

1.57

2.09

1.2

1.1

32.84

38.12

mg/l

0.41

218

Diseases of peritoneum

276

1.56

2.08

1.1

91.95

40.31

mg/l

0.47

232

Other disorders of glucose regulation and pancreatic internal secretion

284

1.56

2.08

1.2

39.90

42.33

mg/l

0.15

234

Other specified and unspecified personality disorders

381

1.48

2.08

1.3

1.2

31.18

39.14

mg/l

0.88

317

Abnormal findings in secretions and smears from cervix uteri vagina vulva

313

1959

1.18

2.08

1.1

1.2

34.56

39.06

mg/l

1.25

264

1659

Necrosis of pulp, including avohilmo

343

2912

1.17

2.07

1.1

1.2

40.14

42.73

mg/l

0.48

280

2473

Dermatophytosis

447

1.44

2.07

1.2

1.1

35.47

43.24

mg/l

1.41

369

Polycystic ovarian syndrome

333

1.51

2.06

1.1

34.23

33.72

mg/l

0.05

276

Malignant neoplasm of pancreas, including Hilmo

191

0.42

2.04

1.4

1.1

77.45

40.55

mg/l

—

165

COPD (mode)

538

1.35

2.04

1.2

1.1

66.80

48.16

mg/l

0.37

466

Recurrent aphthous stomatitis , including avohilmo

541

1.39

2.03

1.1

39.44

39.49

mg/l

0.00

456

Dialysis, with operation codes

391

1.46

2.03

1.4

1.2

47.46

44.98

mg/l

0.13

318

Kela-code for severe mental illness

200

1643

1.22

2.03

1.1

1.2

35.35

41.85

mg/l

2.02

169

1397

Female infertility

183

886

1.24

2.03

1.2

1.1

38.66

41.45

mg/l

0.33

165

735

Mental disorders, not otherwise specified

375

1.47

2.03

1.2

31.89

36.84

mg/l

0.69

312

Mental and behavioural disorders due to tobacco

294

1.54

2.02

1.1

39.85

42.66

mg/l

0.19

244

Obesity, other/unspecified

204

1680

1.22

2.02

1.1

1.2

43.00

39.30

mg/l

0.63

182

1421

DVT of lower extremities

525

1.39

2.01

1.1

41.29

42.82

mg/l

0.12

441

Dislocation, sprain and strain of joints and ligaments of head

155

1.75

2.00

1.1

30.88

44.98

mg/l

1.39

122

Diabetic retinopathy, excluding more controls

104

437

1.33

2.00

1.2

1.1

54.55

47.09

mg/l

0.67

369

Alcohol use disorder, Swedish definition

267

2048

1.19

2.00

1.2

1.1

40.69

45.40

mg/l

1.15

224

1736

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

478

0.61

1.99

1.1

45.61

40.97

mg/l

0.24

416

Explicit bacterial Sepsis

287

1.54

1.99

1.3

1.1

108.99

45.20

mg/l

0.66

239

Sulfonylureas

583

0.68

1.99

1.1

54.48

46.32

mg/l

0.61

492

Rheumatoid arthritis, including avohilmo

165

1332

1.24

1.98

1.1

1.2

40.69

41.67

mg/l

0.11

140

1119

Other disorders of veins

192

1550

1.22

1.97

1.2

1.1

55.32

42.08

mg/l

0.63

166

1302

Hyperparathyroidism

422

1.43

1.97

1.1

30.59

39.64

mg/l

2.51

359

Benign neoplasm: Rectum, anus and anal canal

528

1.39

1.96

1.2

43.33

44.17

mg/l

0.06

448

Other hammer toe(s) (acquired)

365

1.45

1.96

1.2

42.49

43.50

mg/l

0.04

310

Acne conglobata

4.62

1.95

1.2

44.54

42.15

mg/l

—

Viral conjunctivitis, including avohilmo

149

1.76

1.95

1.3

1.1

31.50

39.52

mg/l

0.82

120

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

265

1.55

1.95

1.2

28.55

39.29

mg/l

1.85

216

Other abnormal products of conception

225

1227

1.21

1.93

1.2

34.09

37.14

mg/l

0.75

191

1030

Congenital malformations and deformations of the musculoskeletal system

402

1.44

1.92

1.1

1.2

28.37

38.13

mg/l

0.98

336

Renal failure

168

1159

1.24

1.92

1.2

1.1

43.27

45.03

mg/l

0.20

136

984

Pruritus

396

1.44

1.92

1.2

1.1

45.25

40.73

mg/l

0.19

339

Atrial fibrillation and flutter with reimbursement

432

1.34

1.92

1.1

1.2

69.91

44.74

mg/l

0.53

364

Bacterial, viral and other infectious agents

347

1.48

1.92

1.1

1.2

45.16

42.39

mg/l

0.14

281

Perioral dermatitis

1.97

1.91

1.0

1.2

35.62

33.52

mg/l

0.15

Pneumonia derived septicemia

1.93

1.90

1.1

216.44

40.66

mg/l

0.72

Alzheimer’s disease (Atypical or mixed)

148

1.74

1.90

1.0

1.1

38.61

48.69

mg/l

1.05

121

Congenital obstruction of the pelviureteric junction

3.23

1.89

1.0

39.44

34.90

mg/l

—

Secondary uncertain malignant neoplasm

332

1.48

1.88

1.1

51.59

39.93

mg/l

0.56

278

Benign neoplasm of eye and adnexa

300

1.50

1.87

1.1

41.68

mg/l

0.00

253

Primary open-angle glaucoma, strict

574

1.36

1.86

1.2

1.1

52.40

42.92

mg/l

0.52

493

Malignant neoplasm of breast, HER2-negative

131

1064

0.79

1.86

1.2

39.51

40.97

mg/l

0.09

117

898

Acne, including avohilmo

173

1142

1.23

1.86

1.2

44.49

36.83

mg/l

0.72

144

952

Secondary polycythaemia

2.22

1.84

1.1

1.2

43.64

45.10

mg/l

—

Malignant neoplasm of breast, including Hilmo

136

1090

0.80

1.83

1.2

41.04

40.81

mg/l

0.01

122

920

Malignant neoplasm of breast, HER2-negative, including Hilmo

136

1090

0.80

1.83

1.2

41.04

40.81

mg/l

0.01

122

920

Speech therapy

110

856

1.29

1.83

1.2

37.27

40.41

mg/l

0.43

101

730

Nephropathy related operations

376

1.44

1.82

1.4

1.1

48.91

45.17

mg/l

0.19

308

Cellulitis

111

866

1.28

1.81

1.1

55.47

40.50

mg/l

1.69

730

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

325

2696

1.16

1.81

1.1

1.2

33.12

41.85

mg/l

4.55

281

2274

Pneumococcal septicemia

1.93

1.80

1.1

231.08

42.81

mg/l

0.71

Malignant neoplasm of breast

132

1066

0.80

1.80

1.2

39.47

40.93

mg/l

0.09

118

900

Other disorders starting during childhood or adolescence

260

1.53

1.79

1.3

1.1

27.47

37.18

mg/l

1.24

209

Explicit bacterial Sepsis, including avohilmo

295

1.50

1.79

1.3

1.1

108.99

45.64

mg/l

0.66

245

Torticollis

2.36

1.78

1.4

1.1

41.82

51.64

mg/l

0.25

Otitis media, unspecified

487

1.37

1.77

1.1

29.07

37.68

mg/l

1.89

396

Fracture of lumbar spine and pelvis

614

1.33

1.77

1.1

38.51

42.84

mg/l

0.42

513

Gout

572

1.32

1.75

1.0

1.2

54.80

49.58

mg/l

0.36

484

Female infertility, associated with anovulation

455

1.39

1.75

1.2

1.1

36.96

39.46

mg/l

0.21

386

Infective dermatitis

338

1.45

1.74

1.1

33.16

45.43

mg/l

2.19

280

Atrial fibrillation and flutter

124

632

1.27

1.73

1.2

45.13

44.42

mg/l

0.06

101

528

Other diseases of blood and blood-forming organs

186

1.62

1.72

1.0

1.1

57.26

42.64

mg/l

0.55

152

Disorder of lipoprotein metabolism, unspecified

298

1.48

1.71

1.1

43.49

40.03

mg/l

0.23

245

Lateral epicondylitis

398

1.41

1.70

1.3

1.1

49.99

43.63

mg/l

0.27

324

Type 2 diabetes, wide definition

371

2048

1.14

1.70

1.2

46.18

44.69

mg/l

0.21

311

1744

Fracture of skull and facial bones

109

857

1.27

1.70

1.2

1.1

60.90

43.03

mg/l

0.48

741

Heart failure and coronary heart disease

779

0.76

1.69

1.2

1.1

41.44

48.64

mg/l

1.12

662

Other infestations, including avohilmo

0.00

1.69

0.0

1.1

—

41.89

—

Care involving dialysis

195

1.60

1.68

1.2

48.05

44.37

mg/l

0.16

153

Viral pneumonia

433

1.39

1.68

1.2

1.1

43.45

42.01

mg/l

0.13

360

Disorders of continuity of bone

366

1.43

1.68

1.2

29.65

40.01

mg/l

1.68

315

Benign neoplasm: Rectum

467

1.37

1.67

1.3

1.2

42.65

44.82

mg/l

0.15

393

Congenital malformations of the circulatory system

570

1.33

1.67

1.2

31.28

40.93

mg/l

2.48

476

Pregnancy with abortive outcome

368

1677

1.14

1.67

1.2

39.33

39.22

mg/l

0.01

315

1403

Abnormal findings on antenatal screening of mother

528

1.35

1.66

1.1

1.2

39.24

34.30

mg/l

0.29

440

Vulvovaginal ulceration/inflammation in other diseases

317

1.46

1.66

1.3

1.1

38.53

34.64

mg/l

0.16

270

Colorectal adenocarcinoma

448

0.64

1.65

1.2

1.1

46.06

42.95

mg/l

0.21

390

Female infertility, cervical, vaginal, other or unspecified origin

165

867

1.22

1.64

1.2

35.83

41.34

mg/l

0.92

145

722

Malignant neoplasm of pancreas

147

0.41

1.64

1.5

1.1

84.10

36.48

mg/l

—

126

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

168

1392

1.21

1.64

1.2

40.43

41.25

mg/l

0.07

140

1185

Crohn disease

538

1.34

1.63

1.2

1.1

37.63

39.94

mg/l

0.21

454

Primary open-angle glaucoma

684

1.30

1.63

1.2

1.1

53.31

42.69

mg/l

0.70

584

Inflammatory bowel disease

170

1411

1.21

1.63

1.1

1.2

41.35

40.91

mg/l

0.04

138

1198

Effects of other external causes

120

1.76

1.63

1.0

1.1

28.88

46.94

mg/l

1.87

Other inflammatory liver diseases

197

1.58

1.62

1.2

1.1

38.95

40.65

mg/l

0.13

163

Other diseases of oesophagus

237

1.52

1.62

1.2

1.1

47.00

46.00

mg/l

0.02

194

Early lumbar disc prolapse operation

548

1.34

1.61

1.1

1.2

40.39

39.16

mg/l

0.13

458

286

2213

1.15

1.61

1.2

40.98

46.05

mg/l

1.28

242

1882

Follow-up care involving plastic surgery

1.88

1.60

1.1

40.94

34.96

mg/l

0.36

Stomatitis and related lesions

104

820

1.27

1.60

1.1

38.95

40.17

mg/l

0.12

695

Injuries to the hip and thigh

204

1544

1.19

1.60

1.1

41.00

43.02

mg/l

0.28

174

1314

Failure and rejection of transplanted organs and tissues

2.35

1.59

1.2

1.1

49.00

38.12

mg/l

—

Early syphilis, including avohilmo

2.35

1.59

1.1

1.2

39.64

51.78

mg/l

—

303

2295

1.15

1.59

1.2

40.54

45.57

mg/l

1.33

254

1949

Other hereditary haemolytic anaemias

3.05

1.59

1.3

1.2

25.00

36.25

mg/l

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

210

1765

1.18

1.59

1.2

1.1

39.95

45.10

mg/l

1.15

179

1502

Personal history of medical treatment

2.72

1.58

1.3

1.1

22.46

44.44

mg/l

—

Mixed conductive and sensorineural hearing loss

312

1.45

1.58

1.1

1.2

37.10

42.95

mg/l

0.74

268

Diabetic retinopathy

123

610

1.25

1.58

1.2

1.1

53.58

46.34

mg/l

0.80

517

Other maternal disorders predominantly related to pregnancy

334

1828

1.14

1.58

1.2

35.81

38.92

mg/l

0.66

285

1530

Malignant neoplasm of breast, HER-positive

842

0.78

1.56

1.2

44.13

40.68

mg/l

0.15

710

Malignant melanoma of skin

305

1.45

1.55

1.2

1.1

93.86

38.95

mg/l

0.57

259

Gastric ulcer

423

1.37

1.54

1.1

39.40

45.62

mg/l

0.64

354

Tuberculosis

107

1.78

1.54

1.2

1.1

38.63

41.48

mg/l

0.14

Injury of muscle and tendon at hip and thigh level

356

1.41

1.54

1.0

1.2

49.18

41.50

mg/l

0.50

300

Female genital prolapse

139

628

1.23

1.53

1.1

1.2

32.12

43.33

mg/l

3.22

112

532

Acute suppurative otitis media

182

1426

1.19

1.53

1.2

42.27

40.06

mg/l

0.20

148

1209

Open wound of lower leg

536

1.33

1.52

1.3

1.1

43.29

42.27

mg/l

0.07

446

Malignant neoplasm of breast, ER-positive, including Hilmo

846

0.78

1.52

1.2

44.01

40.67

mg/l

0.14

713

Cholecystitis

365

1.40

1.52

1.2

43.20

42.95

mg/l

0.01

298

Allergic conjunctivitis

337

2857

1.14

1.52

1.1

1.2

33.48

41.85

mg/l

4.45

291

2409

Evidence of alcohol involvement determined by level of intoxication

2.62

1.52

1.6

1.3

52.41

34.72

mg/l

—

Mental and behavioural disorders due to alcohol

251

2064

1.16

1.52

1.2

1.1

39.63

45.84

mg/l

1.71

215

1753

Cholecystectomy

333

2488

1.14

1.51

1.1

1.2

44.31

42.58

mg/l

0.17

285

2107

Nonsuppurative otitis media

146

1043

1.22

1.51

1.2

1.1

44.98

41.65

mg/l

0.25

125

882

Pneumothorax

185

1.57

1.51

1.1

169.54

45.74

mg/l

0.76

155

Prolonged pregnancy

843

0.77

1.51

1.2

1.1

33.83

37.30

mg/l

0.47

707

Glomerular disorders in diseases classified elsewhere

349

1.41

1.51

1.2

1.1

45.86

44.01

mg/l

0.11

284

Gout, FINNGEN

681

1.29

1.50

1.0

1.1

54.80

47.38

mg/l

0.58

573

Scabies, including avohilmo

748

1.27

1.50

1.2

1.1

42.56

39.26

mg/l

0.33

628

LSIL lesion of the cervix uteri, vagina or vulva

713

1.28

1.50

1.1

1.2

33.24

36.00

mg/l

0.39

607

Disorders of tooth development and eruption

578

1.28

1.50

1.2

1.1

55.17

43.42

mg/l

0.28

485

Major coronary heart disease event

366

1934

1.13

1.49

1.1

1.2

34.89

47.36

mg/l

7.17

310

1640

Blepharochalasis

775

1.27

1.49

1.1

39.01

43.96

mg/l

0.56

654

Alcohol use disorder, ICD-based

193

1636

1.18

1.49

1.2

1.1

40.00

44.99

mg/l

0.99

163

1398

Early syphilis

2.46

1.48

1.1

1.2

40.27

53.98

mg/l

—

Sequelae of other external causes

178

1.58

1.48

1.1

1.2

39.69

39.37

mg/l

0.01

145

Crohn's disease NAS

259

1.47

1.48

1.1

1.2

40.97

39.60

mg/l

0.07

216

Colorectal cancer

559

0.70

1.47

1.2

1.1

41.77

42.80

mg/l

0.08

484

Intestinal malabsorption

155

1.62

1.47

1.1

1.2

28.60

42.47

mg/l

2.50

127

Mental and behavioural disorders due to opioids

163

1.60

1.46

1.1

30.89

38.61

mg/l

1.01

132

Other abnormal findings in urine

2.39

1.46

1.2

1.1

41.89

47.73

mg/l

—

Other otitis externa (chronic)

211

1.52

1.46

1.3

1.2

32.82

40.10

mg/l

1.15

175

Benign neoplasm of other and ill-defined parts of digestive system

497

1.33

1.45

1.2

35.88

41.64

mg/l

0.96

422

Degeneration of macula and posterior pole

145

924

1.21

1.44

1.2

1.1

52.75

45.32

mg/l

0.82

120

787

Anomalies of dental arch relationship, including avohilmo

119

873

1.23

1.44

1.2

1.1

35.51

38.91

mg/l

0.39

732

ILD, hospital admission 2, with pulmonary infections

220

1.50

1.43

1.2

1.1

55.88

47.12

mg/l

0.42

186

Diabetic retinopathy, strict definition

442

1.33

1.42

1.1

55.52

44.03

mg/l

0.88

379

Redundant prepuce, phimosis and paraphimosis

734

1.26

1.41

1.2

52.59

49.79

mg/l

0.17

635

Sequelae of infectious and parasitic diseases

221

1.50

1.41

1.2

1.1

39.65

40.66

mg/l

0.05

181

Crohn disease (strict definition, require KELA, min 2 HDR)

254

1.46

1.40

1.1

1.2

38.62

40.70

mg/l

0.12

208

Background retinopathy and retinal vascular changes

2.19

1.40

1.1

54.85

39.38

mg/l

—

Endometriosis ASRM stages 3,4

120

980

1.23

1.40

1.1

1.2

39.87

36.74

mg/l

0.27

107

838

Myocardial infarction, strict

112

976

0.81

1.40

1.1

44.17

50.35

mg/l

0.79

832

Other and unspecified psoriasis

189

1.54

1.40

1.1

40.52

42.52

mg/l

0.05

153

Tibial collateral bursitis [Pellegrini-Stieda]

2.44

1.39

1.6

1.0

29.86

34.28

mg/l

—

Contracture of joint

2.43

1.39

1.1

69.60

36.56

mg/l

—

Peripheral arterial reconstruction

338

0.62

1.39

1.1

61.50

45.77

mg/l

0.92

283

Adenomyosis (Endometriosis of uterus)

483

1.33

1.39

1.2

41.53

39.46

mg/l

0.07

412

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

1.96

1.39

1.0

1.2

35.70

37.66

mg/l

0.09

Galactorrhea

2.22

1.38

1.6

1.1

31.07

27.61

mg/l

—

Complications predominantly related to the puerperium

157

1319

1.19

1.37

1.1

1.2

32.68

36.83

mg/l

0.74

131

1125

Renal tubulo-interstitial disorders in diseases classified elsewhere

2.63

1.37

1.5

1.1

28.50

35.87

mg/l

—

Disorders of plasma-protein metabolism, not elsewhere classified

2.98

1.36

1.4

1.1

122.80

31.25

mg/l

—

Intestinal stricture

113

920

1.23

1.36

1.2

1.1

37.07

42.05

mg/l

0.86

781

Crohn disease (strict definition, require KELA)

256

1.45

1.36

1.1

1.2

38.62

40.71

mg/l

0.12

210

Trigger finger

408

1.35

1.2

1.1

46.88

44.56

mg/l

0.10

342

Paralytic ileus and intestinal obstruction

723

1.26

1.35

1.2

1.1

35.52

44.95

mg/l

2.36

601

Crohn disease (strict definition, all UC cases excluded)

199

1.51

1.35

1.1

1.2

33.65

42.12

mg/l

0.72

160

Allergic contact dermatitis

530

1.31

1.35

1.1

41.47

41.57

mg/l

0.01

453

Schizophrenia or delusion

169

1432

1.18

1.35

1.1

1.2

36.95

42.33

mg/l

1.37

143

1215

Sequelae of other and unspecified infectious and parasitic diseases, including avohilmo

191

1.52

1.34

1.1

42.38

41.62

mg/l

0.03

153

Erysipelas, including avohilmo

328

2154

1.13

1.34

1.2

1.1

53.69

42.69

mg/l

0.87

282

1829

Unspecified acute lower respiratory infection

574

1.29

1.34

1.3

1.1

46.05

41.60

mg/l

0.32

477

Non-small cell lung cancer, including Hilmo

295

1.40

1.34

1.0

1.1

47.37

42.92

mg/l

0.26

257

Event of undetermined intent

257

1.45

1.33

1.3

1.1

33.44

42.18

mg/l

1.00

208

Other benign neoplasms of skin

154

1297

1.19

1.32

1.1

1.2

40.27

41.28

mg/l

0.12

133

1090

Cyst of kidney

168

1.55

1.31

1.2

1.1

57.86

44.16

mg/l

0.66

140

Lactose intolerance

1.74

1.31

1.1

1.2

35.74

30.80

mg/l

0.20

Palmar fascial fibromatosis [Dupuytren]

283

1.42

1.31

1.1

36.35

48.55

mg/l

2.87

234

Other puerperal infections

472

1.32

1.30

1.1

1.2

35.09

34.68

mg/l

0.03

397

Schizophrenia, schizotypal and delusional disorders

169

1437

1.18

1.30

1.1

1.2

36.95

42.31

mg/l

1.36

143

1219

Superficial injury of forearm

420

1.34

1.30

1.2

34.00

39.25

mg/l

0.43

351

Toxic effects of substances chiefly nonmedicinal as to source

446

1.33

1.30

1.1

1.2

27.60

40.10

mg/l

4.47

374

Percutaneous Coronary Intervention

339

1833

1.12

1.30

1.1

1.2

35.05

47.43

mg/l

6.43

285

1556

Nonspecific lymphadenitis

201

1.50

1.29

1.3

1.2

30.56

39.02

mg/l

1.06

168

Other eating disorders

259

1.43

1.29

1.2

1.1

25.22

36.59

mg/l

2.71

213

Schizophrenia

658

0.74

1.28

1.1

1.2

45.87

41.00

mg/l

0.60

560

Presbycusis

207

1.48

1.28

1.2

1.1

49.07

47.33

mg/l

0.07

176

Family history of certain disabilities and chronic diseases leading to disablement

210

1.48

1.28

1.2

1.1

29.88

37.99

mg/l

0.94

173

Secondary thrombocytopenia

2.31

1.27

1.8

1.1

57.63

38.81

mg/l

—

Salpingitis and oophoritis

597

1.28

1.27

1.1

1.2

33.30

39.29

mg/l

1.05

506

Nasal polyp

606

1.27

1.1

57.18

43.81

mg/l

0.48

509

conjunctival haemorrhage

194

1.50

1.26

1.1

38.37

42.28

mg/l

0.26

161

Corneal ulcer

760

1.24

1.3

1.1

33.59

41.03

mg/l

1.72

644

Atopic dermatitis, strict definition with reimbursement

190

1574

1.16

1.24

1.2

1.1

34.78

39.52

mg/l

1.34

158

1330

Hallux valgus (acquired)

135

806

1.20

1.23

1.2

39.61

41.94

mg/l

0.19

119

678

Myeloproliferative diseases (CML excluded)

187

1.50

1.23

1.0

1.1

37.54

41.83

mg/l

0.35

156

Other disorders of kidney and ureter

372

1.35

1.23

1.1

86.56

45.73

mg/l

0.48

307

Early onset COPD

653

1.26

1.23

1.3

1.1

67.06

44.31

mg/l

0.39

555

Other and unspecified injuries of ankle and foot

163

1.54

1.23

1.0

1.2

27.49

37.98

mg/l

1.07

134

Extracorporeal dialysis

163

1.54

1.23

1.2

1.1

53.65

42.41

mg/l

0.50

137

Abnormal serum enzyme levels

105

829

1.22

1.23

1.1

40.39

48.52

mg/l

1.03

703

Artrosis, including avohilmo

445

2207

1.10

1.21

1.2

38.48

45.38

mg/l

2.24

377

1865

Injury of eye and orbit

610

1.27

1.21

1.2

1.1

37.24

42.15

mg/l

0.71

523

Coronary revascularization (ANGIO or CABG)

338

1834

1.12

1.21

1.1

1.2

35.14

47.45

mg/l

6.36

284

1557

Macular pucker

356

1.35

1.21

1.1

50.50

41.36

mg/l

0.72

309

Later onset COPD

423

0.72

1.21

1.0

1.1

41.84

48.93

mg/l

0.49

357

Open wound of forearm

339

1.36

1.21

1.1

41.41

42.07

mg/l

0.03

277

Ankylosing spondylitis, ICD10

322

1.37

1.21

1.2

35.31

41.87

mg/l

0.72

260

Other ill-defined and unspecified causes of mortality

188

1.49

1.21

1.3

1.1

53.53

44.28

mg/l

0.42

149

Atopic dermatitis, strict definition

190

1606

1.16

1.21

1.2

34.47

38.37

mg/l

1.06

158

1361

Dysplasia of cervi uteri

142

840

1.19

1.21

1.1

1.2

33.45

41.54

mg/l

2.07

119

703

Myeloproliferative diseases

205

1.47

1.19

1.1

36.02

41.48

mg/l

0.51

168

Tumor necrosis factor alpha inhibitors

755

1.23

1.19

1.2

44.31

40.33

mg/l

0.31

649

Other appendicitis

289

1.39

1.19

1.2

34.26

43.16

mg/l

1.46

241

Benign neoplasm: Short bones of lower limb

2.33

1.19

1.2

1.1

46.33

37.63

mg/l

—

Iliotibial band syndrome

2.32

1.19

1.0

19.00

31.73

mg/l

—

Ischaemic heart disease, wide definition

309

1693

1.12

1.19

1.2

41.27

46.62

mg/l

1.05

257

1423

Congenital malformations of the musculoskeletal system, not elsewhere classified

1.89

1.18

1.1

1.2

22.08

31.45

mg/l

1.21

Perineal laceration during delivery

894

0.81

1.18

1.1

1.2

33.61

35.29

mg/l

0.17

739

Glucosamine medication

137

920

1.19

1.18

1.1

39.98

45.79

mg/l

0.73

110

791

Colorectal cancer, including Hilmo

615

0.76

1.18

1.2

1.1

37.68

42.11

mg/l

0.53

532

Other condition

551

1.27

1.17

1.2

1.1

33.36

40.05

mg/l

1.23

462

Other respiratory diseases principally affecting the interstitium

419

1.31

1.17

1.1

49.29

44.83

mg/l

0.29

348

Other and unspecified glaucoma

141

1.56

1.17

1.2

1.1

47.23

42.13

mg/l

0.16

118

Excessive vomiting in pregnancy

411

1.32

1.16

1.2

1.1

27.28

35.58

mg/l

2.18

344

Endometriosis of ovary

670

1.24

1.16

1.1

1.2

35.64

39.11

mg/l

0.48

566

Colonic or urogenital fistula

124

1039

1.20

1.16

1.1

1.2

45.98

40.64

mg/l

0.57

104

875

Disorders of gallbladder, biliary tract and pancreas

495

2815

1.09

1.16

1.1

1.2

39.98

43.76

mg/l

0.98

417

2388

Sulfasalazine

127

1067

1.19

1.16

1.1

41.28

42.76

mg/l

0.15

106

901

Ovarian dysfunction, other/unspecified

2.53

1.15

1.2

1.1

40.38

27.78

mg/l

—

Pleural effusion

342

1.35

1.15

1.2

1.1

55.53

45.45

mg/l

0.29

282

Seborrhoeic dermatitis

308

1.37

1.15

1.2

1.1

40.27

47.22

mg/l

0.57

249

Hypertrophic disorders of skin

232

1.43

1.15

1.3

1.2

47.09

37.90

mg/l

0.33

194

Postpartum care and examination

105

541

1.22

1.15

1.2

1.1

32.43

37.95

mg/l

0.71

433

Papulosquamous disorders

177

1530

1.16

1.15

1.1

1.2

43.26

41.70

mg/l

0.15

145

1299

Erysipelas

222

1679

1.14

1.2

1.1

58.43

43.49

mg/l

0.80

186

1424

L02BG Aromatase inhibitors

912

0.80

1.13

1.2

47.96

41.54

mg/l

0.25

776

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

263

2024

1.13

1.2

35.54

38.75

mg/l

0.69

232

1696

Sequelae of injuries of head

175

1.49

1.12

1.0

1.2

126.12

44.28

mg/l

0.47

140

Benign neoplasm: Long bones of lower limb

111

1.63

1.12

1.1

27.44

42.54

mg/l

2.16

Skin changes due to chronic exposure to nonionizing radiation

109

819

1.21

1.12

1.1

41.33

46.14

mg/l

0.53

699

Scoliosis

284

1.38

1.12

1.2

1.1

39.55

43.89

mg/l

0.22

237

Seropositive rheumatoid arthritis

730

1.23

1.12

1.2

42.94

41.89

mg/l

0.07

617

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

478

2763

1.09

1.11

1.2

1.1

44.11

43.73

mg/l

0.03

413

2338

Allergic urticaria

319

1.35

1.11

1.2

42.78

38.35

mg/l

0.16

264

Other congenital malformations

380

1.32

1.10

1.1

1.2

28.25

36.86

mg/l

1.63

317

Periapical abscess

231

2042

1.13

1.09

1.2

40.14

43.42

mg/l

0.55

195

1745

Impacted cerumen

311

1.35

1.09

1.0

1.1

41.54

45.01

mg/l

0.34

257

Pollen allergy

123

1023

1.19

1.09

1.2

32.63

37.47

mg/l

0.99

102

860

Thyroiditis

235

1.41

1.08

1.4

1.2

33.39

36.37

mg/l

0.26

202

Infections of genitourinary tract in pregnancy

443

1.29

1.08

1.1

1.2

33.43

36.82

mg/l

0.29

376

Other/unspecified rheumatoid arthritis

304

1.35

1.06

1.1

46.63

42.45

mg/l

0.20

256

Malignant neoplasm

442

2365

1.09

1.06

1.2

47.66

41.42

mg/l

0.85

367

2008

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

236

1.40

1.06

1.4

1.1

35.09

39.06

mg/l

0.30

198

Loose body in joint

1.93

1.06

1.3

1.1

40.00

44.20

mg/l

—

Malignant neoplasm, wide definition

460

2451

1.09

1.06

1.2

48.46

41.28

mg/l

1.02

387

2081

Dermatophytosis, including avohilmo

339

3007

1.10

1.05

1.1

1.2

40.88

43.63

mg/l

0.49

285

2556

118

894

1.19

1.05

1.1

40.04

45.85

mg/l

0.75

103

764

Open wound of ankle and foot

383

1.31

1.05

1.1

1.2

32.39

39.77

mg/l

1.01

313

Burns and corrosions

552

1.25

1.04

1.1

1.2

36.26

41.26

mg/l

0.73

460

Cholelithiasis, broad definition with cholecystitis

419

2547

1.09

1.04

1.1

1.2

41.27

43.68

mg/l

0.31

349

2172

Other endocrine disorders

187

1.44

1.03

1.1

1.2

39.44

33.93

mg/l

0.33

150

Malignant neoplasm of bronchus and lung

335

1.30

1.03

1.0

1.1

51.66

42.18

mg/l

0.69

291

Emergency coronary revascularization (for ACS)

354

1937

1.10

1.02

1.1

1.2

35.47

47.42

mg/l

6.32

296

1644

Periodontitis

507

2978

1.08

1.02

1.2

44.44

43.77

mg/l

0.08

435

2531

Hypertrophic cardiomyopathy

106

0.47

1.01

1.2

1.1

40.00

43.82

mg/l

—

Other noninfective disorders of lymphatic vessels and lymph nodes

107

0.47

1.01

1.0

1.2

29.80

38.65

mg/l

—

Insulin, fast-acting

165

1435

1.15

1.01

1.1

1.2

44.72

40.86

mg/l

0.48

132

1225

Malignant neoplasm

441

2367

1.09

1.01

1.2

47.90

41.43

mg/l

0.89

367

2008

Obstructed labour due to maternal pelvic abnormality

501

1.26

1.01

1.2

38.36

39.40

mg/l

0.07

424

Polycythaemia vera

1.77

1.00

1.1

43.12

32.55

mg/l

0.80

Other specific arthropathies, wide

1.88

1.00

1.1

53.73

32.75

mg/l

—

Injuries involving multiple body regions

123

1.55

0.99

1.3

1.1

43.54

37.35

mg/l

0.38

Bitten or struck by other mammals

520

1.25

0.99

1.2

1.1

35.51

38.38

mg/l

0.31

443

Blepharospasm

2.19

0.98

1.0

23.60

33.75

mg/l

—

Malignant neoplasm, including Hilmo

458

2452

1.09

0.98

1.2

48.61

41.21

mg/l

1.06

385

2082

Inflammatory disorders of breast

309

1.33

0.98

1.2

1.1

29.91

36.46

mg/l

1.22

260

Dislocation of lens

2.18

0.98

1.8

1.1

50.20

52.21

mg/l

—

Septal defects

235

1.38

0.98

1.1

1.2

24.93

37.01

mg/l

2.99

191

Acne

599

1.23

0.97

1.4

1.1

54.57

36.47

mg/l

0.85

500

Unequal limb length (acquired)

0.00

0.97

0.0

1.3

—

41.11

—

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

116

1.56

0.96

1.1

1.2

28.55

38.84

mg/l

1.08

Chronic periodontitis, including avohilmo

505

2978

1.08

0.96

1.2

44.33

43.80

mg/l

0.06

432

2531

Insulin, combination of fast acting with intermediate-acting or long-acting

269

2195

1.11

0.96

1.1

1.2

50.81

43.88

mg/l

1.17

222

1880

Oligomenorrhoea

157

1.47

0.96

1.3

1.1

37.80

36.19

mg/l

0.11

129

Etanercept

250

1.36

0.95

1.0

1.2

33.83

40.69

mg/l

0.70

208

Chronic pancreatitis

363

1.30

0.95

1.2

1.1

48.82

44.27

mg/l

0.23

298

Persons encountering health services in circumstances related to reproduction

318

1933

1.10

0.95

1.2

40.16

44.19

mg/l

0.81

284

1613

Other salmonella infections, including avohilmo

141

1.49

0.95

1.0

1.1

34.86

39.36

mg/l

0.50

115

Arthropathy in ulcerative colitis

1.90

0.94

1.3

1.1

46.06

34.84

mg/l

—

Malignant neoplasm of respiratory system and intrathoracic organs

396

1.26

0.94

1.0

1.1

58.39

42.51

mg/l

1.37

342

1.62

0.94

1.1

1.2

18.75

32.86

mg/l

—

Pregnancy hypertension

242

1938

1.12

0.94

1.2

36.18

37.74

mg/l

0.26

213

1627

Asthma mixed form (mode)

133

1.51

0.94

1.5

1.1

55.22

40.09

mg/l

0.25

110

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

1.62

0.94

1.1

68.33

37.54

mg/l

0.80

Other diseases of intestine

453

1.26

0.93

1.1

1.2

40.95

45.00

mg/l

0.36

381

Ill-defined and unknown causes of mortality

200

1.40

0.93

1.3

1.1

53.53

44.43

mg/l

0.41

160

All dysplastic lesions of the cervix uteri, vagina or vulva

186

1603

1.13

0.93

1.1

1.2

34.40

37.30

mg/l

0.60

152

1363

Gonarthrosis [arthrosis of knee](FG)

319

1665

1.10

0.93

1.2

42.62

44.90

mg/l

0.35

273

1394

ILD, hospital admissions

356

1.29

0.92

1.2

1.1

52.04

44.92

mg/l

0.46

298

Stenosis and insufficiency of lacrimal passages

243

1.36

0.92

1.4

1.1

32.37

40.64

mg/l

0.73

203

COPD-related respiratory insufficiency

243

1.36

0.92

1.1

113.32

46.79

mg/l

0.51

204

Personal history of other diseases and conditions

568

1.23

0.92

1.1

1.2

33.45

36.94

mg/l

0.36

481

Osteonecrosis

167

1.44

0.92

1.1

34.35

43.39

mg/l

0.87

143

Diseases of arteries, arterioles and capillaries

249

1639

1.11

0.92

1.1

50.44

44.46

mg/l

0.29

202

1408

Phakomatoses, not elsewhere classified

2.16

0.92

1.0

1.1

28.57

33.53

mg/l

—

Other bursitis of knee

2.15

0.91

1.2

1.1

45.50

41.68

mg/l

—

Ulcerative rectosigmoiditis

313

1.31

0.91

1.1

1.2

50.14

42.88

mg/l

0.32

257

ILD, hospital admissions 3, with pneumonia sepsis

184

1.42

0.91

1.2

1.1

52.58

41.02

mg/l

0.49

149

Family history of malignant neoplasm

473

1.25

0.90

1.1

1.2

41.61

39.09

mg/l

0.14

412

Peritonsillar abscess

110

938

1.17

0.90

1.1

1.2

42.39

41.14

mg/l

0.06

796

Suggestive for eosinophilic asthma

270

1.34

0.90

1.2

44.74

43.42

mg/l

0.04

222

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

279

1.33

0.90

1.1

1.2

38.62

40.63

mg/l

0.11

229

Acne vulgaris

473

1.25

0.89

1.3

1.1

57.54

37.26

mg/l

0.75

391

Injury of nerves at lower leg level

2.08

0.89

1.0

21.33

51.38

mg/l

—

Other interstitial pulmonary diseases

358

1.29

0.89

1.2

1.1

52.04

44.92

mg/l

0.46

300

Ulcer of lower limb, not elsewhere classified

367

1.28

0.89

1.2

1.1

101.84

46.33

mg/l

0.62

307

Toxic liver disease

1.92

0.89

1.3

1.1

39.63

30.67

mg/l

—

Actinic keratosis

102

787

1.18

0.88

1.1

42.27

46.05

mg/l

0.35

673

Diverticular disease of intestine

283

1595

1.10

0.88

1.1

39.50

46.80

mg/l

1.92

251

1344

Interstitial lung disease

359

1.28

0.88

1.2

1.1

52.04

44.78

mg/l

0.47

300

Interstitial lung disease endpoints

359

1.28

0.88

1.2

1.1

52.04

44.78

mg/l

0.47

300

LSIL lesion of the cervix uteri

611

1.21

0.87

1.1

1.2

33.24

35.07

mg/l

0.20

518

Foreign body in genitourinary tract

2.02

0.87

1.2

1.1

71.33

37.84

mg/l

—

Insulin, fast-acting or short human

165

1454

1.14

0.87

1.1

1.2

44.72

41.34

mg/l

0.41

132

1239

Adalimumab

431

1.26

0.87

1.2

1.1

43.85

39.06

mg/l

0.32

358

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

440

1.25

0.87

1.1

1.2

36.46

40.85

mg/l

0.58

372

Other viral hepatitis, including avohilmo

281

1.32

0.86

1.2

47.13

42.22

mg/l

0.21

231

Other follicular disorders

325

1.30

0.86

1.3

1.2

42.14

40.58

mg/l

0.09

269

Lichen sclerosus et atrophicus

334

1.29

0.86

1.3

1.2

38.40

38.21

mg/l

0.01

286

Contact with sharp glass

153

1.44

0.85

1.2

1.1

40.65

43.77

mg/l

0.14

122

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

397

1.26

0.85

1.1

41.61

34.38

mg/l

0.35

340

Thyrotoxicosis with diffuse goitre

541

1.22

0.84

1.2

1.1

41.32

39.67

mg/l

0.10

460

Lactose intolerance, other/unspecified

1.60

0.84

1.1

1.2

39.22

30.06

mg/l

0.33

Asthma mixed form (mode), excluding more controls

137

1.46

0.84

1.5

1.1

55.22

40.75

mg/l

0.24

114

Other fall from one level to another

112

964

1.16

0.83

1.2

1.1

41.56

40.67

mg/l

0.06

814

Acute alcohol intoxication

110

946

1.16

0.83

1.2

1.1

36.36

43.49

mg/l

1.61

808

Angina pectoris

198

1172

1.12

0.83

1.1

40.60

49.66

mg/l

2.00

166

997

Hypertrophic scar

214

1.36

0.82

1.3

1.2

47.42

38.69

mg/l

0.28

179

Psoriatic arthropathies

301

1.30

0.82

1.1

1.2

39.97

41.60

mg/l

0.10

248

Adjustment and management of implanted device

354

1.27

0.82

1.1

55.41

44.45

mg/l

0.32

292

Eustachian salpingitis and obstruction

390

1.26

0.82

1.1

1.2

37.40

38.15

mg/l

0.05

325

Cellulitis of external ear

1.89

0.82

1.0

1.1

31.35

49.07

mg/l

—

Polycystic ovarian syndrome, broad definition

690

1.19

0.81

1.2

37.01

36.09

mg/l

0.09

582

Anisometropia and aniseikonia

1.55

0.81

1.1

1.2

27.00

39.56

mg/l

—

Diabetic maculopathy, excluding more controls

373

1.26

0.81

1.2

60.46

41.13

mg/l

1.26

303

Effects of foreign body entering through natural orifice

118

1024

1.15

0.80

1.2

1.1

57.35

42.04

mg/l

0.43

104

864

Complex cardiac defects

0.00

0.79

0.0

1.1

—

39.84

—

Thyrotoxicosis with toxic single thyroid nodule

0.00

0.79

0.0

1.0

—

27.81

—

Melanoma of uvea

0.00

0.79

0.0

1.1

—

54.64

—

Other salmonella infections

1.54

0.78

1.1

35.47

39.87

mg/l

0.38

Antenatal screening

111

718

0.86

0.78

1.2

1.1

39.84

39.46

mg/l

0.02

584

Mental and behavioural disorders due to sedatives or hypnotics

260

1.31

0.78

1.1

1.2

37.36

41.28

mg/l

0.36

211

Ulcerative colitis, NAS

547

1.21

0.77

1.2

1.1

45.72

41.08

mg/l

0.30

467

Thyrotoxicosis

110

953

1.16

0.77

1.2

40.32

40.26

mg/l

0.00

815

Single spontaneous delivery

159

947

0.89

0.77

1.2

36.03

39.49

mg/l

0.59

125

803

Benign neoplasm: Skin of other and unspecified parts of face

287

1.29

0.76

1.1

40.18

40.64

mg/l

0.03

236

Injuries to the elbow and forearm

368

2919

1.08

0.76

1.1

1.2

45.95

42.62

mg/l

0.40

290

2503

Acute alcohol intoxication, ICD10

825

1.17

0.76

1.2

1.1

37.37

41.43

mg/l

0.62

701

Cholelithiasis

395

2501

1.08

0.75

1.1

1.2

41.83

43.68

mg/l

0.21

330

2133

IBD patients in KELA-register

122

1068

1.14

0.75

1.1

1.2

41.39

41.66

mg/l

0.02

101

911

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

458

1.20

0.75

1.0

1.1

58.86

42.43

mg/l

1.58

399

Ulcerative colitis

121

1059

1.14

0.75

1.2

42.94

41.22

mg/l

0.16

102

904

Sequelae of other and unspecified infectious and parasitic diseases

192

1.36

0.75

1.2

1.1

40.44

41.51

mg/l

0.04

154

Valvular operations

370

0.76

0.75

1.1

36.76

45.97

mg/l

0.95

314

In situ neoplasms

158

1407

1.12

0.75

1.1

1.2

40.08

41.75

mg/l

0.19

133

1190

Unspecified maternal hypertension

1.68

0.75

1.0

1.2

29.59

37.15

mg/l

—

Benign neoplasm: Pharynx, unspecified

2.10

0.75

1.2

1.0

43.46

40.92

mg/l

—

Diabetic nephropathy, excluding more controls

321

1.24

0.75

1.2

1.1

55.69

46.73

mg/l

0.51

272

Diabetes, insulin treatment (Kela reimbursement)

449

2861

0.93

0.74

1.1

1.2

46.21

43.95

mg/l

0.39

382

2437

2.09

0.74

1.0

1.3

38.20

38.44

mg/l

—

Hypertensive Renal Disease

1.67

0.74

1.0

1.1

34.67

39.23

mg/l

—

Varicose veins of other sites

201

1.35

0.74

1.1

1.2

33.38

44.02

mg/l

1.15

168

Heart failure, strict

152

1188

0.89

0.74

1.2

1.1

41.34

48.25

mg/l

1.31

126

1010

Artificial joint operation, meniscal resection

394

2339

1.08

0.74

1.1

1.2

42.29

45.89

mg/l

0.74

328

1988

Hereditary retinal dystrophy

1.85

0.73

1.1

35.90

27.86

mg/l

—

Postprocedural musculoskeletal disorders, not elsewhere classified

184

1.36

0.73

1.1

42.06

42.80

mg/l

0.03

158

Crushing injury of wrist and hand

1.85

0.73

1.3

1.1

39.57

49.84

mg/l

—

Seminoma of testis

2.02

0.73

1.0

1.2

60.40

48.14

mg/l

—

5-aminosalicylic acid

101

875

1.16

0.73

1.1

41.55

42.42

mg/l

0.06

746

Gestational [pregnancy-induced] hypertension

156

1389

1.12

0.72

1.2

35.37

36.78

mg/l

0.18

136

1172

ILD, hospital admissions 1, main diag only

317

1.26

0.71

1.1

48.01

45.32

mg/l

0.16

270

Psoriatic and enteropathic arthropathies

389

1.24

0.71

1.1

1.2

40.81

41.96

mg/l

0.08

325

Primary biliary cholangitis (PBC)

1.76

0.71

1.1

28.91

31.90

mg/l

—

Disorders of porphyrin and bilirubin metabolism

1.93

0.71

1.2

27.00

29.56

mg/l

—

Other obstructed labour

309

1.27

0.70

1.1

1.2

29.90

34.94

mg/l

0.82

260

All dysplastic lesions of the vulva

143

1.40

0.70

1.1

1.2

32.09

31.30

mg/l

0.06

119

Alcohol abuse counselling and surveillance

1.71

0.70

1.1

41.77

39.24

mg/l

—

Thyrotoxicosis, other and/or unspecified

776

1.16

0.70

1.2

1.1

38.34

40.40

mg/l

0.19

658

Acquired haemolytic anaemia

1.56

0.70

1.1

60.33

39.09

mg/l

—

Gestational diabetes (for exclusion)

251

1580

1.09

0.69

1.2

37.58

36.67

mg/l

0.13

221

1327

Endometriosis of intestine

1.54

0.69

1.3

1.2

32.17

32.66

mg/l

0.04

Heart failure and antihypertensive medication

466

1.17

0.69

1.2

1.1

40.46

47.79

mg/l

0.66

396

Melanocytic naevi, other sites/unspecified

310

1.26

0.69

1.3

1.1

36.29

40.79

mg/l

0.25

255

All-cause Heart Failure

149

1160

0.89

0.69

1.2

1.1

41.38

48.51

mg/l

1.33

123

986

Melanocytic naevi of eyelid, including canthus

1.86

0.68

1.2

1.1

35.60

31.43

mg/l

—

Myocardial infarction

133

1047

0.89

0.68

1.1

42.09

49.42

mg/l

1.18

111

894

Nonalcoholic fatty liver disease

365

1.24

0.67

1.2

41.13

40.88

mg/l

0.01

309

Cysts of oral region, not elsewhere classified

196

1.33

0.67

1.2

39.07

43.64

mg/l

0.28

161

Corneal degeneration

1.63

0.67

1.0

1.1

40.71

41.32

mg/l

—

Alcoholic liver disease

276

1.27

0.66

1.2

1.1

49.96

45.25

mg/l

0.35

230

Other injuries of lower limb, level unspecified

1.80

0.66

1.0

1.1

49.60

36.93

mg/l

—

Benign leiomyoma with endometriosis

466

1.20

0.66

1.1

1.2

46.19

34.99

mg/l

0.54

409

Certain conditions originating in the perinatal period

373

1.22

0.65

1.1

39.66

35.59

mg/l

0.21

306

severe traumatic brain injury, does not include concussion

614

0.83

0.65

1.2

1.1

88.74

44.01

mg/l

0.59

510

Injury of unspecified body region

242

1.28

0.64

1.0

1.1

31.17

41.87

mg/l

1.60

200

Seminoma of testis, including Hilmo

1.73

0.64

1.0

1.2

60.40

45.11

mg/l

—

Retinal breaks without detachment

468

1.20

0.64

1.2

43.04

40.94

mg/l

0.14

404

Other bursal cyst

1.73

0.64

1.2

31.00

42.51

mg/l

—

Other dialysis

1.50

0.63

1.1

38.43

44.66

mg/l

—

Acute nasopharyngitis (common cold)

465

1.20

0.63

1.1

45.22

42.00

mg/l

0.28

394

Alcohol-induced chronic pancreatitis

181

1.33

0.63

1.2

1.1

41.16

45.92

mg/l

0.43

149

Pediculosis, acariasis and other infestations, including avohilmo

859

1.14

0.63

1.2

1.1

41.46

39.96

mg/l

0.14

723

Intestinal adhesions without obstruction

225

1.29

0.63

1.4

1.1

38.09

46.22

mg/l

0.65

186

Diabetic maculopathy

348

1.22

0.62

1.2

1.1

59.80

43.67

mg/l

0.93

299

Other viral hepatitis

261

1.27

0.62

1.2

45.54

41.81

mg/l

0.14

214

Complications of labour and delivery

331

1710

1.08

0.62

1.1

1.2

36.51

39.59

mg/l

0.64

288

1424

Iron deficiency anaemia secondary to blood loss (chronic)

433

1.20

0.62

1.2

1.1

36.40

41.81

mg/l

0.62

356

Arteriovenous malformation of cerebral vessels

1.67

0.61

1.0

20.60

52.72

mg/l

—

Benign neoplasm: Skin of lip

1.67

0.61

1.0

1.1

32.60

46.03

mg/l

—

Inflammatory bowel disease, strict (require KELA)

122

1087

1.12

0.61

1.1

1.2

41.39

41.29

mg/l

0.01

101

922

Erosion of teeth , including avohilmo

152

1372

1.11

0.61

1.1

1.2

37.01

40.37

mg/l

0.67

131

1169

Other congenital malformations of skin, including avohilmo

325

1.23

0.61

1.2

33.34

39.59

mg/l

0.51

266

Lymphangioma, anys site

0.00

0.60

0.0

1.2

—

35.10

—

Delivery

163

949

0.90

0.60

1.1

1.2

33.36

39.44

mg/l

1.42

130

805

Postmenopausal osteoporosis with pathological fracture

122

1.40

0.60

1.1

52.73

40.18

mg/l

0.20

106

Diabetic nephropathy

403

1.20

0.59

1.2

1.1

55.69

46.87

mg/l

0.52

344

Pre-eclampsia or poor fetal growth

181

1645

1.10

0.59

1.2

35.42

36.38

mg/l

0.12

152

1390

Accessory breast

0.00

0.58

0.0

1.0

—

29.69

—

Bursitis of shoulder

1.51

0.58

1.6

1.1

44.85

41.54

mg/l

—

Alcohol abuse, main dg

631

1.16

0.58

1.2

1.1

37.33

42.70

mg/l

0.74

529

Mucosal proctocolitis

520

1.17

0.58

1.1

43.22

41.56

mg/l

0.09

437

Alcohol dependence

106

941

1.13

0.58

1.3

1.1

37.73

46.57

mg/l

1.92

807

Hypertrophy of breast

716

1.15

0.57

1.2

1.1

41.53

38.60

mg/l

0.10

607

Impetigo

193

1.30

0.57

1.2

29.40

37.93

mg/l

0.95

150

Heart failure and bmi 25plus

612

0.87

0.57

1.1

44.97

47.64

mg/l

0.25

523

Congenital malformations of the respiratory system

1.49

0.57

1.1

36.88

32.35

mg/l

—

Nontoxic goitre/thyroid nodule

947

0.88

0.57

1.2

1.1

46.20

41.14

mg/l

0.35

802

Viral hepatitis, including avohilmo

319

1.23

0.57

1.2

46.19

41.85

mg/l

0.19

265

Insulin, intermediate and long-acting

226

2013

1.08

0.57

1.1

1.2

50.11

44.19

mg/l

0.87

188

1725

Single delivery by caesarean section

100

645

0.88

0.57

1.2

37.68

39.11

mg/l

0.11

543

Intrahepatic Cholestasis of Pregnancy (ICP)

365

1.21

0.56

1.1

42.54

34.10

mg/l

0.36

310

Toxic effect of contact with venomous animals

141

1.35

0.56

1.2

1.1

30.91

39.89

mg/l

1.09

113

Parapsoriasis

1.46

0.56

1.0

1.1

26.50

42.53

mg/l

—

Other disorders of prostate

1.46

0.56

1.3

1.1

42.13

54.40

mg/l

—

Non-small cell lung cancer, squamous, helper endpoint

0.57

0.56

1.0

1.1

57.20

47.28

mg/l

—

Type 1 diabetes

127

1141

1.11

0.56

1.2

46.74

40.31

mg/l

0.69

105

971

Pre-eclampsia

108

963

1.12

0.55

1.2

35.97

37.32

mg/l

0.15

820

Pre-eclampsia or eclampsia

114

1020

1.12

0.55

1.2

35.08

36.99

mg/l

0.24

865

Gout, unspecified

476

1.18

0.55

1.1

57.73

46.35

mg/l

0.73

402

Psoriasis

122

1096

1.11

0.55

1.1

1.2

41.48

40.97

mg/l

0.04

929

Burns and corrosions of external body surface, specified by site

421

1.19

0.55

1.1

1.2

37.10

41.10

mg/l

0.39

346

Primary gonarthrosis, bilateral

169

1291

1.10

0.55

1.1

43.78

46.49

mg/l

0.25

149

1109

Haemorrhage in early pregnancy

155

1371

1.10

0.54

1.2

32.99

36.93

mg/l

0.64

136

1154

Erythema intertrigo

1.50

0.54

1.6

1.1

31.33

45.04

mg/l

—

malignant neoplasm of female genital organs, including Hilmo

480

0.83

0.54

1.2

40.49

40.75

mg/l

0.01

411

Tubulo-interstitial nephritis, not specified as acute or chronic

186

1.29

0.54

1.3

1.2

40.35

38.59

mg/l

0.08

152

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

422

1.19

0.54

1.1

1.2

41.61

35.90

mg/l

0.26

357

Alopecia areata

1.42

0.54

1.0

1.2

31.95

29.96

mg/l

—

Abscess of anal and rectal regions

312

1.22

0.54

1.2

1.1

44.77

45.57

mg/l

0.02

251

Gout, idiopatic and unspecified

608

1.15

0.53

1.1

54.92

46.70

mg/l

0.60

510

Other congenital malformations of female genitalia

1.55

0.53

1.2

35.43

32.88

mg/l

—

Malignant neoplasm of bronchus and lung, including Hilmo

398

1.17

0.53

1.0

1.1

54.40

42.70

mg/l

0.97

346

Contraceptive management

230

1489

1.08

0.53

1.2

39.74

42.94

mg/l

0.42

197

1245

Other congenital malformations, including avohilmo

590

1.15

0.53

1.1

33.00

38.18

mg/l

0.65

500

Kidney transplant status

178

1.30

0.53

1.2

44.76

42.89

mg/l

0.11

144

Mandibular retrognathia

285

1.23

0.53

1.1

1.2

36.68

39.60

mg/l

0.18

240

Other disorders of iris and ciliary body

1.52

0.52

1.3

1.1

29.88

41.95

mg/l

—

Foreign body or object entering through skin

250

1.24

0.52

1.1

1.2

36.57

45.27

mg/l

1.33

204

Eating disorder

497

1.17

0.52

1.2

1.1

33.19

35.81

mg/l

0.13

409

Venous complications and haemorrhoids in the puerperium

1.51

0.52

1.7

1.2

29.50

27.08

mg/l

—

Hypertrophy of breast in women and men

809

1.13

0.51

1.2

1.1

42.26

39.99

mg/l

0.08

684

Spontaneous abortion

245

1527

1.07

0.50

1.2

37.13

39.47

mg/l

0.33

207

1281

Pregnancy, childbirth and the puerperium

113

656

0.90

0.50

1.1

1.2

28.59

38.06

mg/l

3.24

550

Benign lipomatous neoplasm

115

1038

1.11

0.50

1.2

37.87

41.54

mg/l

0.78

879

Pilonidal cyst

408

1.18

0.49

1.3

1.2

54.25

41.40

mg/l

1.24

336

Deep bite

431

1.16

0.49

1.2

33.02

39.13

mg/l

0.66

354

All dysplastic lesions of the cervix uteri

162

1465

1.09

0.49

1.1

1.2

33.62

36.83

mg/l

0.64

132

1239

Helminthiases

1.53

0.48

1.0

1.1

86.86

37.10

mg/l

—

Aortic aneurysm

539

0.85

0.47

1.1

39.95

48.53

mg/l

0.72

458

Cardiac murmurs and other cardiac sounds

341

1.19

0.47

1.3

1.1

30.43

45.30

mg/l

1.61

281

Other and unspecified injuries of abdomen, lower back and pelvis

1.46

0.47

1.3

1.1

25.29

43.57

mg/l

—

Simple and mucopurulent chronic bronchitis

1.41

0.47

1.2

1.1

70.57

35.11

mg/l

—

Lichen planus

355

1.18

0.46

1.1

52.57

41.59

mg/l

0.44

299

Malignant neoplasm of testis

1.43

0.46

1.0

1.2

55.71

43.27

mg/l

—

Use of disulfiram, acamprosate or naltrexone

328

1.19

0.46

1.2

35.86

44.85

mg/l

1.35

268

Atherosclerosis, excluding cerebral and coronary sclerosis

739

0.89

0.46

1.1

47.84

47.07

mg/l

0.06

636

Coxarthrosis [arthrosis of hip](FG)

189

1205

1.08

0.45

1.1

1.2

45.42

45.26

mg/l

0.01

152

1025

Clear cell adenocarcinoma of kidney

103

1.36

0.45

1.4

1.1

57.34

35.84

mg/l

0.99

Carcinoma in situ of skin of scalp and neck

1.40

0.45

1.0

1.1

34.86

47.73

mg/l

—

Schizoid personality disorder

1.38

0.44

1.0

1.1

27.43

35.59

mg/l

—

Myocardial infarction, unclassifiable

372

0.84

0.44

1.1

37.13

49.99

mg/l

1.70

310

Injury of muscle and tendon at lower leg level

535

1.14

0.44

1.1

42.61

43.57

mg/l

0.06

447

Atrophic disorders of skin

573

1.14

0.43

1.3

1.2

33.66

37.95

mg/l

0.42

491

Heart failure,strict

147

1113

0.92

0.43

1.2

1.1

41.35

48.05

mg/l

1.19

122

943

Benign thyroid growths and nodules

101

1034

0.91

0.42

1.2

1.1

45.48

41.11

mg/l

0.35

877

Other and unspecified bullous disorders

1.57

0.42

1.2

1.0

49.20

35.70

mg/l

—

Other abnormal uterine and vaginal bleeding

644

1.10

0.41

1.2

32.84

38.90

mg/l

1.14

545

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

323

1.18

0.41

1.3

1.1

34.21

41.64

mg/l

1.00

263

Acute pancreatitis

623

1.12

0.41

1.2

34.89

43.15

mg/l

1.50

510

Unattended death

0.00

0.40

0.0

1.1

—

40.73

—

Peripheral artery disease

827

0.91

0.40

1.1

71.32

47.14

mg/l

0.53

710

Presence of cardiac and vascular implants and grafts

105

847

0.91

0.40

1.1

41.05

50.26

mg/l

1.55

741

Unstable angina pectoris

104

743

1.10

0.40

1.1

40.68

48.78

mg/l

1.70

639

Urethritis and urethral syndrome

1.34

0.40

1.1

74.53

44.98

mg/l

—

Other congenital malformations of upper alimentary tract

0.00

0.40

0.0

1.1

—

39.92

—

Motorcycle rider injured in other and unspecified transport accidents

241

1.21

0.40

1.0

1.1

51.58

45.92

mg/l

0.18

193

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

596

1.12

0.40

1.1

66.06

41.83

mg/l

1.12

513

Postmenopausal bleeding

428

0.89

0.40

1.2

40.55

45.50

mg/l

0.26

360

Anorexia (incl.atypical)

287

1.19

0.40

1.2

1.1

31.34

36.47

mg/l

0.40

241

Insulin medication

269

2109

1.06

0.39

1.1

1.2

50.81

43.81

mg/l

1.18

222

1800

Malignant neoplasm of cervix uteri

1.31

0.39

1.3

1.1

26.50

29.02

mg/l

—

Congenital malformations of the respiratory system, including avohilmo

1.31

0.39

1.1

1.2

36.88

31.51

mg/l

—

Impacted maxillary molar

357

0.84

0.39

1.1

28.95

36.98

mg/l

1.15

289

Congenital cataract

0.00

0.39

0.0

1.1

—

36.25

—

Eating disorders

569

1.12

0.38

1.2

1.1

35.16

36.30

mg/l

0.05

469

Mental and behabioural disorders of puerperum, not classified elsewhere, excluding more controls

1.39

0.38

1.2

32.88

31.32

mg/l

—

Other/unspecified seropositive rheumatoid arthritis

808

1.10

0.38

1.2

1.1

43.16

40.81

mg/l

0.18

699

Seropositive rheumatoid arthritis, wide

818

1.10

0.38

1.2

1.1

42.94

40.65

mg/l

0.18

707

Polycystic kidney disease

1.31

0.37

1.1

1.2

44.40

43.41

mg/l

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

438

2708

0.96

0.37

1.1

1.2

46.02

43.71

mg/l

0.39

375

2312

Lesion of sciatic nerve

1.31

0.37

1.2

1.1

33.86

40.39

mg/l

—

Poor fetal growth

724

1.11

0.37

1.2

35.77

35.32

mg/l

0.03

618

Malignant neoplasm of stomach, including Hilmo

115

0.69

0.37

1.1

73.00

37.54

mg/l

—

Ascites

161

1.24

0.37

1.1

44.47

45.98

mg/l

0.08

137

Other and unspecified disease of Bartholin gland

1.27

0.36

1.1

38.78

30.09

mg/l

—

Arthropathic psoriasis

384

1.15

0.36

1.1

1.2

45.86

40.56

mg/l

0.24

321

Other diseases of lip and oral mucosa

189

1777

1.06

0.36

1.2

38.80

41.66

mg/l

0.29

167

1505

Granuloma annulare

1.43

0.35

1.2

1.1

29.33

29.56

mg/l

—

Anorexia

1.43

0.35

1.5

1.1

36.17

32.77

mg/l

—

Acute epiglottitis

1.43

0.35

1.0

1.1

34.67

47.11

mg/l

—

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

374

0.85

0.35

1.2

38.37

36.33

mg/l

0.08

308

Acute alcohol intoxication ICD-9

0.63

0.35

1.0

1.1

24.40

45.82

mg/l

—

Acute and transient psychotic disorders

460

1.13

0.35

1.1

1.2

34.04

39.91

mg/l

1.06

385

Other and unspecified injuries of wrist and hand

144

1.25

0.35

1.1

1.2

28.49

37.27

mg/l

0.76

118

Primary biliary cholangitis, wide definition

1.40

0.35

1.2

1.1

28.40

31.66

mg/l

—

Blood alcohol or alcohol intoxication level

1.35

0.34

1.5

1.2

45.81

39.94

mg/l

0.31

Benign neoplasm of middle ear and respiratory system

209

1.20

0.34

1.1

44.51

41.91

mg/l

0.08

171

Hyphaema and other vascular disorders of iris and ciliary body

1.34

0.34

1.3

1.1

23.63

43.81

mg/l

—

Malignant neoplasm of thyroid gland, including Hilmo

228

1.19

0.33

1.2

29.16

35.40

mg/l

0.57

194

Inflammation of lacrimal passages (acute and unspecified)

1.31

0.33

1.7

1.1

65.67

33.82

mg/l

—

Sub-endpoint used in defining T1D endpoints

129

1182

1.07

0.33

1.2

46.75

41.31

mg/l

0.56

107

1002

Nontoxic multinodular goitre

551

0.89

0.33

1.3

1.1

46.26

38.77

mg/l

0.44

475

Leiomyoma of uterus

293

1567

1.05

0.32

1.1

1.2

40.95

39.97

mg/l

0.10

249

1338

Peripheral artery operations in Hilmo

274

0.84

0.32

1.2

1.1

161.34

46.02

mg/l

0.56

231

D07AA Corticosteroids, weak (group I)

701

1.10

0.32

1.2

1.1

38.75

38.74

mg/l

0.00

590

Postpartum haemorrhage due to anatomy

634

0.90

0.32

1.1

1.2

29.82

36.07

mg/l

1.30

533

Maternal care related to the fetus and amniotic cavity and possible delivery problems

252

1404

1.05

0.32

1.1

1.2

33.82

40.01

mg/l

1.70

213

1176

Chronic viral hepatitis

229

1.18

0.32

1.2

50.60

41.28

mg/l

0.31

184

Seropositive rheumatoid arthritis, strict definition

444

0.88

0.32

1.1

45.95

40.49

mg/l

0.26

377

Thoracic aortic aneurysm

391

0.87

0.32

1.1

42.09

47.14

mg/l

0.24

332

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

799

1.09

0.31

1.1

43.22

40.92

mg/l

0.17

692

malignant neoplasm of female genital organs

413

0.88

0.31

1.1

1.2

40.91

38.64

mg/l

0.12

356

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

654

1.10

0.31

1.1

33.56

41.10

mg/l

1.79

546

Non-allergic asthma

276

1.16

0.31

1.3

1.1

49.71

42.75

mg/l

0.12

226

Maternal care for known or suspected malpresentation of fetus

112

858

0.93

0.30

1.2

38.05

37.76

mg/l

0.03

100

725

Hernia

454

2911

1.04

0.30

1.2

1.1

41.37

44.79

mg/l

0.63

392

2476

Family history of other conditions

1.28

0.30

1.3

1.2

38.14

35.45

mg/l

—

Endocarditis

1.31

0.30

1.3

1.1

38.41

49.08

mg/l

0.35

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

391

1.13

0.30

1.1

1.2

42.54

35.56

mg/l

0.28

329

Later onset COPD, excluding more controls

254

1.14

0.30

1.0

1.1

41.84

48.33

mg/l

0.43

218

Dislocation, sprain and strain of joints and ligaments of elbow

259

1.16

0.29

1.1

1.2

54.86

39.10

mg/l

0.39

216

Conduction disorders

719

1.08

0.29

1.1

39.50

44.55

mg/l

0.68

612

Use of biperiden

157

1.21

0.29

1.2

33.54

39.95

mg/l

0.50

130

Puerperal sepsis

439

1.12

0.29

1.1

37.62

37.36

mg/l

0.01

379

Solid cancers, including Hilmo

424

2383

1.04

0.29

1.2

48.17

41.40

mg/l

0.84

354

2022

Malignant neoplasm of testis, including Hilmo

1.23

0.29

1.0

1.2

55.71

44.03

mg/l

—

Lichen simplex chronicus and prurigo

176

1.19

0.28

1.2

1.1

35.00

43.26

mg/l

0.62

143

HSIL lesion of the cervix uteri, vagina or vulva

118

1104

1.07

0.28

1.1

1.2

33.36

37.43

mg/l

0.82

943

Other and unspecified injuries of head

232

1.16

0.28

1.2

1.1

36.28

44.47

mg/l

0.82

190

Injury of muscle and tendon at ankle and foot level

1.32

0.28

1.1

50.00

40.57

mg/l

—

Total colectomy

129

0.77

0.28

1.2

36.30

41.04

mg/l

—

103

Total colectomy operation

129

0.77

0.28

1.2

36.30

41.04

mg/l

—

103

Embedded teeth, including avohilmo

502

0.90

0.28

1.1

28.49

38.21

mg/l

2.56

416

Abnormal spermatozoa

289

1.14

0.28

1.1

60.57

51.20

mg/l

0.33

247

Retained placenta and membranes, without haemorrhage

489

1.11

0.27

1.1

1.2

31.69

38.56

mg/l

1.46

413

Viral hepatitis

299

1.14

0.27

1.2

44.61

41.86

mg/l

0.10

246

Fracture of shoulder and upper arm

138

1299

1.06

0.27

1.1

45.84

40.97

mg/l

0.45

116

1106

Congenital malformations of the urinary system

196

1.18

0.27

1.0

1.2

44.47

39.64

mg/l

0.38

158

Melanocytic naevi of other and unspecified parts of face

204

0.83

0.27

1.2

35.10

40.90

mg/l

0.31

174

Medical treatment for female infertility

121

1275

0.94

0.27

1.1

1.2

31.58

36.56

mg/l

1.04

1068

Injuries to unspecified part of trunk, limb or body region

357

1.12

0.26

1.0

1.1

35.49

40.84

mg/l

0.44

297

Non-small cell lung cancer, squamous

0.70

0.26

1.0

1.1

57.20

38.11

mg/l

—

Diabetes mellitus

547

3068

1.03

0.26

1.2

45.52

42.72

mg/l

0.57

470

2605

Malignant neoplasm of oesophagus, including Hilmo

0.68

0.26

1.0

1.1

43.60

39.76

mg/l

—

Maxillary retrognathism

0.66

0.26

1.6

1.2

26.00

37.31

mg/l

—

Supervision of normal pregnancy

116

705

0.94

0.25

1.2

1.1

34.74

39.70

mg/l

0.66

573

Melanocytic naevi of scalp and neck

1.25

0.25

1.2

1.1

59.78

39.88

mg/l

—

Tooth eruption problems

812

0.93

0.25

1.2

32.06

37.62

mg/l

0.31

681

Foreign body on external eye

588

1.09

0.25

1.2

1.1

77.53

44.90

mg/l

0.48

491

Acute pancreatitis (for exclusion)

646

1.08

0.25

1.2

1.1

34.89

42.90

mg/l

1.43

535

Other complications of labour and delivery, not elsewhere classified

717

0.93

0.25

1.2

34.29

35.86

mg/l

0.13

591

Biguanides

438

2725

0.97

0.25

1.2

46.09

43.05

mg/l

0.60

380

2312

Other malignant neoplasms of skin (=non-melanoma skin cancer)

123

884

0.94

0.24

1.1

46.95

43.01

mg/l

0.35

107

762

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

793

1.07

0.24

1.1

42.64

40.62

mg/l

0.15

669

Dialysis

115

1.22

0.23

1.1

1.2

60.67

45.09

mg/l

—

Premature rupture of membranes

125

940

0.95

0.23

1.2

34.10

37.62

mg/l

0.49

103

795

Evidence of alcohol involvement determined by blood alcohol level

1.32

0.23

1.2

1.1

39.60

mg/l

—

Benign neoplasm: Peripheral nerves and autonomic nervous system

1.32

0.23

1.2

1.1

35.80

44.27

mg/l

—

Bullous pemphigoid

1.32

0.23

1.2

1.1

42.40

44.77

mg/l

—

Malignant neoplasm of head and neck, including Hilmo

237

1.14

0.23

1.2

1.1

146.41

42.09

mg/l

0.69

201

COPD

129

992

1.06

0.23

1.2

1.1

56.96

47.05

mg/l

0.25

103

853

Congenital malformations of the urinary system, including avohilmo

209

1.15

0.22

1.0

1.2

50.33

40.82

mg/l

0.59

169

Thyroiditis, unspecified

1.25

0.22

1.6

1.1

28.94

30.95

mg/l

—

Routine general health check-up of defined subpopulation

1.25

0.22

1.6

1.2

26.80

38.38

mg/l

—

Benign neoplasm: Connective and other soft tissue of head, face and neck

1.22

0.22

1.2

1.1

39.00

47.77

mg/l

—

Type 2 diabetes, strict (exclude DM1)

452

2700

0.97

0.21

1.1

1.2

44.96

42.83

mg/l

0.39

392

2299

Other specified and unspecified disorders of iris and ciliary body

0.00

0.21

0.0

1.0

—

32.25

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

500

1.08

0.21

1.2

1.1

80.63

48.72

mg/l

0.42

426

Prolapse and hernia of ovary and fallopian tube

1.18

0.21

1.0

1.1

36.00

32.27

mg/l

—

Left side

0.00

0.21

0.0

1.2

—

41.96

—

Abnormalities of forces of labour

460

1.09

0.20

1.2

47.87

38.53

mg/l

0.24

391

Complications specific to multiple gestation

0.00

0.20

0.0

1.1

—

26.86

—

Congenital malformations of eye, ear, face and neck

282

0.89

0.20

1.2

22.44

39.04

mg/l

6.04

233

Mental and behavioural disorders due to hallucinogens

0.00

0.20

0.0

1.1

—

39.97

—

Open bite

259

1.12

0.20

1.2

31.41

36.43

mg/l

0.42

209

Cutaneous abscess, furuncle and carbuncle

121

1151

1.05

0.20

1.1

1.2

43.05

40.42

mg/l

0.31

104

973

Other ulcerative colitis

221

1.13

0.20

1.2

40.30

42.48

mg/l

0.09

182

HSIL lesion of the vagina

1.23

0.20

1.0

35.17

30.14

mg/l

—

Contact with heat and hot substances

208

0.86

0.20

1.1

51.38

41.26

mg/l

0.40

168

Oral lichen planus and hypothyroidism or thyroxine medication

1.23

0.20

1.2

1.1

22.17

28.56

mg/l

—

Left hemicolectomy

1.23

0.20

1.2

1.1

24.68

43.44

mg/l

—

Duodenal ulcer

240

1.13

0.20

1.1

39.91

49.28

mg/l

0.97

195

Coxarthrosis, primary

184

1467

1.04

0.20

1.1

45.95

47.18

mg/l

0.08

150

1250

Type 2 diabetes

506

2859

1.02

0.19

1.2

44.71

42.57

mg/l

0.42

435

2429

Conotruncal defects

1.18

0.19

1.0

1.1

25.90

32.54

mg/l

—

Need for immunization against other single viral diseases

1.18

0.19

1.7

1.1

49.00

48.41

mg/l

—

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

704

1.07

0.19

1.1

43.93

40.49

mg/l

0.25

595

Other blood glucose lowering drugs, excl. Insulins

385

0.91

0.19

1.1

1.2

41.30

43.51

mg/l

0.13

322

Maternal care for cervical incompetence

137

1.17

0.19

1.3

1.1

25.20

36.81

mg/l

—

116

Pregnancy examination and test

100

587

1.06

0.18

1.2

1.1

36.70

39.81

mg/l

0.26

468

Postmenopausal atrophic vaginitis

468

1.06

0.18

1.2

38.54

45.32

mg/l

0.44

393

Ulcerative colitis (strict definition, require KELA)

725

1.06

0.18

1.1

43.44

40.62

mg/l

0.20

613

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

134

945

0.96

0.18

1.1

45.59

42.63

mg/l

0.27

114

813

COPD related to multimorbidity

101

810

1.05

0.18

1.2

1.1

61.55

46.81

mg/l

0.30

697

Viral pneumonia (unknown virus, not influenza)

242

1.12

0.18

1.1

43.16

42.65

mg/l

0.03

202

Insulin, fast-acting (human)

621

0.93

0.18

1.1

39.88

40.11

mg/l

0.02

525

Hernia of abdominal wall

168

1745

0.96

0.18

1.2

39.56

43.52

mg/l

0.56

145

1493

Diabetes mellitus in pregnancy

212

1301

1.04

0.18

1.1

1.2

39.80

37.02

mg/l

0.39

185

1080

Foreign body in ear

1.17

0.18

1.0

1.1

45.86

44.32

mg/l

—

Diabetes, varying definitions

541

3070

1.02

0.17

1.1

1.2

45.32

42.72

mg/l

0.52

464

2608

Hypertensive heart and/or renal disease

459

1.07

0.17

1.1

1.2

42.60

42.71

mg/l

0.01

390

Excessive earwax

260

2287

1.03

0.17

1.1

1.2

49.02

43.52

mg/l

0.27

207

1959

Other benign neoplasms of connective and other soft tissue

311

1.09

0.16

1.3

1.1

33.91

41.44

mg/l

0.90

263

Acute posthaemorrhagic anaemia

1.16

0.16

1.1

44.62

38.87

mg/l

—

Combinations of oral blood glucose lowering drugs

864

0.95

0.16

1.1

1.2

53.93

45.60

mg/l

0.72

740

Squamous cell neoplasms and carcinomas of the skin

177

1.13

0.16

1.1

50.44

41.48

mg/l

0.25

155

Idiopathic urticaria

1.20

0.16

1.3

1.1

30.82

40.27

mg/l

0.52

Basal cell carcinoma, including Hilmo

138

898

1.04

0.15

1.1

60.37

42.86

mg/l

0.59

119

774

Type 2 diabetes, definitions combined

452

2683

0.98

0.15

1.1

1.2

44.96

42.73

mg/l

0.41

392

2288

Peripheral retinal degeneration

1.21

0.15

1.0

1.2

39.60

35.63

mg/l

—

Other chronic obstructive pulmonary disease, including avohilmo

165

1308

1.04

0.15

1.2

1.1

51.67

46.07

mg/l

0.16

127

1116

Other psoriatic arthropathies

351

1.08

0.15

1.1

1.2

39.97

41.26

mg/l

0.08

291

Coxarthrosis

168

1047

1.04

0.15

1.1

1.2

43.53

46.15

mg/l

0.20

136

880

Non-ischemic cardiomyopathy

683

0.95

0.15

1.1

37.62

47.30

mg/l

1.61

574

Otosclerosis

188

1.12

0.14

1.1

34.53

45.09

mg/l

0.81

161

Arthropod-borne viral fevers and viral haemorrhagic fevers

294

1.09

0.14

1.3

1.2

40.68

42.46

mg/l

0.09

242

Major anomalies of jaw size

1.18

0.14

1.3

1.2

36.00

34.33

mg/l

0.06

Gonarthrosis, primary, with knee surgery

168

1350

0.97

0.14

1.1

1.2

43.14

46.56

mg/l

0.35

133

1160

Psoriatic arthropathies, ICD10

362

1.08

0.14

1.1

39.97

41.30

mg/l

0.08

301

519

0.94

0.14

1.2

1.1

58.17

45.18

mg/l

1.11

443

Suppurative and necrotic conditions of lower respiratory tract

139

0.86

0.14

1.1

43.58

43.78

mg/l

0.01

114

Solid cancers

399

2291

1.02

0.14

1.2

47.46

41.55

mg/l

0.70

334

1945

Conductive hearing loss, unspecified

266

1.09

0.14

1.2

1.1

25.53

44.48

mg/l

4.07

226

LSIL lesion of the vulva

103

1.17

0.13

1.0

1.2

34.03

30.78

mg/l

—

Carbimazole or st.post thyroidectomy, condition for graves disease

832

1.05

0.13

1.2

40.16

39.74

mg/l

0.03

708

Malignant neoplasm of stomach

0.83

0.13

1.1

73.00

35.73

mg/l

—

Ulcerative enterocolitis

0.82

0.13

1.1

34.20

40.59

mg/l

—

Contact with other sharp object(s)

305

1.08

0.13

1.1

34.50

41.62

mg/l

1.05

247

Congenital ovarian cysts

201

0.89

0.13

1.1

28.29

33.49

mg/l

0.32

164

Malignant neoplasm, without specification of site, including Hilmo

1.17

0.13

1.2

1.1

50.98

35.83

mg/l

—

Pedal cyclist injured in transport accident

103

991

1.04

0.13

1.1

44.16

41.03

mg/l

0.17

849

Benign neoplasm of ovary

521

1.06

0.12

1.2

43.05

36.40

mg/l

0.36

451

Lichen ruber planus, wide definition including periferal and oral lichen planus

737

1.05

0.12

1.1

1.2

52.76

41.30

mg/l

0.61

623

Graves disease, strict definition

414

1.06

0.12

1.3

1.1

40.33

36.03

mg/l

0.24

358

Inguinal hernia

234

1591

0.98

0.12

1.2

1.1

47.09

46.76

mg/l

0.03

198

1362

Chronic periodontitis, complicated

223

2123

1.02

0.11

1.2

1.1

50.97

44.60

mg/l

0.55

187

1801

Other chronic obstructive pulmonary disease

120

950

1.03

0.11

1.2

1.1

59.10

47.06

mg/l

0.28

819

Fracture of femur

559

1.05

0.11

1.1

43.52

46.32

mg/l

0.17

473

Acute appendicitis, with complications

660

1.05

0.11

1.1

61.77

42.37

mg/l

0.98

554

Left ventricular outflow tract obstruction (LVOTO), broad definition

353

0.93

0.11

1.0

1.2

30.46

44.78

mg/l

2.87

289

Pedal cyclist injured in other and unspecified transport accidents

435

1.06

0.11

1.1

60.39

40.58

mg/l

0.63

360

Ulcerative colitis (strict definition, all Crohn cases excluded)

592

1.05

0.11

1.1

45.98

41.00

mg/l

0.33

498

Abrasion of teeth

153

1572

0.97

0.11

1.2

39.01

40.85

mg/l

0.23

120

1334

HSIL lesion of the cervix uteri

106

1025

1.03

0.11

1.1

1.2

33.39

35.81

mg/l

0.38

875

Maternal care for other known or suspected fetal problems

148

954

0.97

0.10

1.1

1.2

38.95

38.43

mg/l

0.05

120

795

COPD, hospital admissions 1, only main diagnosis

705

0.96

0.10

1.1

67.37

46.33

mg/l

0.36

601

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

700

1.04

0.10

1.1

35.79

40.78

mg/l

0.73

580

Fracture of forearm

248

2183

1.02

0.10

1.1

1.2

49.66

41.51

mg/l

0.91

195

1870

Embedded and impacted teeth

165

1372

0.98

0.10

1.1

1.2

30.41

40.35

mg/l

4.96

139

1157

Primary coxarthrosis, bilateral

722

1.04

0.10

1.2

1.1

55.77

44.41

mg/l

0.46

621

Benign neoplasm of male genital organs

1.14

0.10

1.0

1.2

34.00

50.15

mg/l

—

Other specified/unspecified spondylopathies

1.14

0.10

1.0

34.20

46.48

mg/l

—

Uterine polyps

111

668

0.97

0.09

1.1

39.79

42.71

mg/l

0.25

566

Adhesive middle ear disease

1.04

0.09

1.0

1.2

33.60

38.14

mg/l

—

Coxarthrosis, primary, with hip surgery

123

1171

0.97

0.09

1.1

42.03

45.97

mg/l

0.39

1005

Basal cell carcinoma

129

856

1.03

0.09

1.1

62.25

43.06

mg/l

0.62

112

740

Polyp of the female genital tract

123

715

0.97

0.08

1.1

38.81

42.31

mg/l

0.37

102

603

Postpartum hemorraghe, parous women as controls

151

1234

1.02

0.08

1.1

1.2

31.41

35.92

mg/l

1.14

129

1035

Injury of muscle and tendon at forearm level

1.05

0.08

1.0

1.1

36.33

44.97

mg/l

—

Long labour

136

1180

0.98

0.08

1.2

36.83

38.47

mg/l

0.20

117

986

Maternal care for known or suspected fetal abnormality and damage

828

0.97

0.08

1.2

30.63

37.28

mg/l

1.22

695

Renal cell carcinoma of kidney

0.83

0.08

1.0

1.1

40.60

36.09

mg/l

—

Type 2 diabetes, definitions combined, including avohilmo

464

2713

0.99

0.08

1.1

1.2

45.08

42.60

mg/l

0.47

403

2307

Use of levodopa decarbox-comt-inhibitor

1.09

0.08

2.1

1.1

68.57

48.98

mg/l

—

Haemangioma, any site

283

1.06

0.08

1.2

39.47

39.96

mg/l

0.02

240

Myocardial infarction, without ST-elevation

851

1.03

0.08

1.1

41.04

46.95

mg/l

0.98

733

Coronary atherosclerosis

209

1341

0.98

0.08

1.2

44.40

48.71

mg/l

0.53

168

1139

Malignant neoplasm of prostate

406

1.03

0.08

1.1

51.47

47.02

mg/l

0.32

358

Juvenile osteochondrosis

127

1.10

0.08

1.0

1.2

21.03

41.85

mg/l

—

101

Carcinoma in situ of colon

0.84

0.07

2.0

1.1

35.83

44.69

mg/l

—

Premenstrual syndrome

0.81

0.07

1.5

1.2

30.03

36.00

mg/l

—

Malignant neoplasm of endocrine gland, including Hilmo

264

1.06

0.07

1.2

39.77

35.53

mg/l

0.14

224

Valvular heart disease excluding rheumatic fever

159

1157

0.98

0.07

1.1

45.17

44.67

mg/l

0.04

129

991

Other renal tubulo-interstitial diseases

1.03

0.07

1.0

1.1

49.51

32.20

mg/l

—

Periodontal disease, other/unspecified

0.84

0.07

1.7

1.1

36.80

42.89

mg/l

—

Supervision of high-risk pregnancy

118

693

1.02

0.07

1.2

1.1

38.53

39.63

mg/l

0.05

103

562

Other disorders of amniotic fluid and membranes

789

1.03

0.07

1.1

1.2

38.53

36.74

mg/l

0.14

664

Other acute skin changes due to ultraviolet radiation

1.03

0.07

1.3

1.2

34.33

36.96

mg/l

—

Malignant neoplasm of skin

158

1049

1.02

0.07

1.1

60.29

42.56

mg/l

0.71

135

897

Maternal care for known or suspected abnormality of pelvic organs

150

993

1.02

0.07

1.2

33.38

38.97

mg/l

1.03

130

836

Childhood allergy (age < 16)

764

1.03

0.06

1.2

1.1

34.71

39.76

mg/l

0.66

637

Rubella [German measles]

100

0.90

0.06

1.2

1.1

39.60

48.52

mg/l

—

Cyst of Bartholin Gland

142

0.91

0.06

1.1

1.2

21.17

34.76

mg/l

3.32

115

Other (not insulin) diabetes medications

470

2782

0.99

0.06

1.2

45.42

42.91

mg/l

0.49

407

2366

Pyothorax

111

0.90

0.06

1.1

46.50

44.19

mg/l

—

Malignant neoplasm of thyroid gland

207

1.06

0.06

1.1

1.2

26.19

35.16

mg/l

0.95

175

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

414

1.04

0.06

1.2

1.1

49.33

43.44

mg/l

0.53

346

Lichen planus, including avohilmo

598

0.97

0.06

1.1

1.2

50.83

41.37

mg/l

0.52

504

Benign neoplasm of breast

385

1.04

0.05

1.3

1.1

41.40

34.97

mg/l

0.40

330

Ovarian hyperstimulation (induction)

1.11

0.05

1.0

1.1

31.09

34.72

mg/l

—

Benign mammary dysplasia

405

1.04

0.05

1.3

1.1

57.45

35.38

mg/l

0.91

349

Obstructed labour due to malposition and malpresentation of fetus

126

1187

0.98

0.05

1.1

1.2

42.05

38.21

mg/l

0.25

114

992

564

1.03

0.05

1.1

1.2

31.67

34.84

mg/l

0.49

480

Hypertensive Heart Disease

420

1.03

0.05

1.2

43.46

43.14

mg/l

0.02

354

Other menopausal disorders

111

607

1.02

0.05

1.2

37.88

43.26

mg/l

0.44

515

Gonarthrosis,primary

336

2006

1.01

0.05

1.2

42.70

46.44

mg/l

0.68

287

1688

Persistent delusional disorders

242

0.95

0.05

1.1

1.2

34.92

41.14

mg/l

0.49

200

Carcinoma in situ of cervix uteri

565

1.03

0.04

1.1

1.2

37.25

35.33

mg/l

0.16

479

Crohn's disease of large intestine

199

1.06

0.04

1.1

1.2

37.35

42.14

mg/l

0.18

164

Congenital malformations of heart and great arteries

510

1.03

0.04

1.1

1.2

31.63

41.13

mg/l

2.00

421

COPD, hospital admission 2, with asthma infections

666

1.02

0.04

1.2

1.1

73.45

47.22

mg/l

0.42

570

Diabetes medication

531

3119

0.99

0.04

1.2

44.88

42.84

mg/l

0.39

457

2645

malignant neoplasm of male genital organs

460

1.02

0.04

1.1

53.42

46.32

mg/l

0.59

397

Other secondary gonarthrosis

131

1.07

0.03

1.0

1.1

37.78

41.54

mg/l

—

111

Ventral hernia

753

0.98

0.03

1.1

41.11

41.32

mg/l

0.01

641

Malignant neoplasm of skin, including Hilmo

175

1160

1.01

0.03

1.1

1.2

57.91

41.87

mg/l

0.71

149

991

Congenital malformations of genital organs

468

0.98

0.03

1.1

33.95

37.09

mg/l

0.22

402

Major coronary heart disease event excluding revascularizations

194

1268

1.01

0.03

1.1

41.72

49.13

mg/l

1.63

165

1071

AV-block

375

1.02

0.03

1.1

41.20

45.99

mg/l

0.40

312

Varicose veins

209

1565

1.01

0.03

1.2

38.84

44.96

mg/l

1.23

175

1319

Extreme obesity with alveolar hypoventilation

118

0.93

0.02

1.0

1.2

24.40

37.99

mg/l

—

Congenital malformations of ovaries, fallopian tubes and broad ligaments

249

0.96

0.02

1.0

1.1

27.65

32.69

mg/l

0.41

211

Single delivery by forceps and vacuum extractor

562

0.99

0.02

1.2

34.75

38.24

mg/l

0.47

474

Dipeptidyl peptidase 4 (DPP-4) inhibitors

175

1382

0.99

0.02

1.1

48.46

46.16

mg/l

0.21

153

1171

Postpartum haemorrhage

151

1235

1.01

0.02

1.1

1.2

31.41

37.98

mg/l

1.84

129

1031

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

579

0.98

0.02

1.2

1.1

49.73

40.57

mg/l

0.74

480

365

1.02

0.02

1.1

55.58

44.56

mg/l

0.73

317

Impacted teeth

124

1073

0.99

0.02

1.2

31.77

38.74

mg/l

2.62

104

901

Schizoaffective disorder

302

1.03

0.02

1.1

1.2

31.05

40.90

mg/l

1.59

249

COPD, hospital admissions

118

1002

0.99

0.01

1.2

1.1

58.98

46.38

mg/l

0.30

859

Calcific aortic valvular stenosis, including rheumatic fever

575

0.99

0.01

1.1

41.47

47.17

mg/l

0.67

487

Seborrhoeic keratosis

722

1.01

0.01

1.1

1.2

46.27

41.77

mg/l

0.29

616

Glaucoma, exfoliation

184

1.03

0.00

1.1

63.32

41.89

mg/l

0.61

155

Gout, strict definition

424

1.01

0.00

1.1

53.71

47.06

mg/l

0.34

354

Umbilical hernia

104

1046

0.99

0.00

1.2

1.1

38.50

45.64

mg/l

1.07

894

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

125

1244

1.00

0.00

1.2

46.50

43.99

mg/l

0.21

112

1056

Glucagon-like peptide-1 (GLP-1) analogues

125

1244

1.00

0.00

1.2

46.50

43.99

mg/l

0.21

112

1056

Calcific aortic valvular stenosis, operated

572

0.99

0.00

1.1

41.47

47.13

mg/l

0.66

485

Calcific aortic valvular stenosis

572

0.99

0.00

1.1

41.47

47.13

mg/l

0.66

485

Pacemaker

794

1.01

0.00

1.2

1.1

39.24

46.90

mg/l

1.25

674

COPD, early/later onset

120

1007

1.00

0.00

1.2

1.1

59.10

46.28

mg/l

0.31

863

Non-rheumatic valve diseases

160

1139

1.00

0.00

1.1

45.09

44.84

mg/l

0.02

130

978

Operations 2 for CAVS

571

0.99

0.00

1.1

41.47

47.12

mg/l

0.66

484

Calcific aortic valvular stenosis, diagnosis (helper)

571

0.99

0.00

1.1

41.47

47.12

mg/l

0.66

484

Aortic valve malfunction, age under 60 years

322

0.99

0.00

1.0

1.2

30.02

45.81

mg/l

3.13

267

Type 1 diabetes, wide definition

101

1008

1.00

0.00

1.1

1.2

46.18

39.99

mg/l

0.54

862

Malignant neoplasm of endocrine gland

229

1.00

0.00

1.1

1.2

39.48

34.88

mg/l

0.12

192

Psoriasis vulgaris

685

1.01

0.00

1.1

1.2

45.94

40.26

mg/l

0.36

580

Malignant neoplasm of breast, ER-negative, including Hilmo

598

1.00

0.00

1.1

1.2

33.08

40.05

mg/l

0.91

510

Postpartum hemorraghe, all women as controls

151

1470

1.00

0.00

1.1

1.2

31.41

36.97

mg/l

1.58

129

1240

Carcinoma in situ of other and unspecified digestive organs

106

1.04

0.00

1.6

1.2

39.54

43.28

mg/l

0.16

Delivery, wide proxy

145

770

1.00

0.00

1.1

1.2

31.33

39.98

mg/l

2.47

114

644

Labour and delivery complicated by fetal stress [distress]

160

1043

1.00

0.00

1.2

31.62

37.26

mg/l

1.56

137

865

Complications associated with artificial fertilization

1.02

0.00

1.0

1.2

31.09

33.48

mg/l

—

Postpartum haemorrhage due to retained placenta

656

1.01

0.00

1.2

33.86

37.29

mg/l

0.40

556

Malignant neoplasm of prostate, including Hilmo

420

1.00

0.00

1.1

51.11

46.79

mg/l

0.31

369

Other or unspecified ileus, impaction or obstruction

501

1.00

0.00

1.1

38.31

45.41

mg/l

0.82

413

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

648

1.00

0.00

1.3

1.1

47.24

40.90

mg/l

0.50

543

Contact with machinery

349

1.00

0.00

1.2

1.1

50.33

47.36

mg/l

0.15

281

Crowding of teeth, including avohilmo

401

1.01

0.00

1.1

32.61

37.20

mg/l

0.47

325

Ectopic pregnancy

749

1.00

0.00

1.3

1.2

30.36

38.63

mg/l

1.96

643

Type 1 diabetes, wide definition, subgroup 1

972

1.00

0.00

1.1

1.2

47.16

40.21

mg/l

0.61

832

Other Crohn's disease

287

1.01

0.00

1.1

1.2

36.59

41.09

mg/l

0.26

238

Failed induction of labour

357

1.01

0.00

1.1

1.2

37.36

36.31

mg/l

0.07

292

Malignant neoplasm of breast, HER-negative

545

1.00

0.00

1.1

1.2

29.62

39.90

mg/l

2.51

465

Haemangioma and lymphangioma, any site

307

1.01

0.00

1.2

1.1

39.47

41.21

mg/l

0.07

259

malignant neoplasm of male genital organs, including Hilmo

469

1.00

0.00

1.1

53.10

46.63

mg/l

0.52

404

Mental and behavioural disorders of puerperium, not classified elsewhere

1.02

0.00

1.2

1.1

32.88

33.78

mg/l

—

Malignant neoplasm of other and unspecified urinary organs

0.00

0.0

1.0

—

44.83

—

Benign neoplasm: Lip

1.00

0.00

1.0

1.1

85.40

45.09

mg/l

—

Macular cyst

0.95

0.00

1.3

1.1

61.17

40.17

mg/l

—

Secondary sideroblastic anaemia

0.00

0.0

1.0

—

31.80

—

Other and unspecified acute skin changes due to ultraviolet radiation

0.91

0.00

1.0

1.1

43.00

41.32

mg/l

—

Malignant neoplasm of cervix uteri, including Hilmo

1.00

-0.00

1.3

1.1

26.50

30.12

mg/l

—

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

0.88

-0.00

1.0

1.1

35.80

39.88

mg/l

—

Cystic kidney disease

0.93

-0.00

1.1

1.2

45.92

40.62

mg/l

—

Hereditary lymphedema, including avohilmo

0.00

-0.00

0.0

1.0

—

39.47

—

Brain mixed glioma

0.00

-0.00

0.0

1.2

—

34.74

—

Epidermolysis bullosa

0.00

-0.00

0.0

1.0

—

28.74

—

Other and unspecified hereditary haemolytic anaemias

0.00

-0.00

0.0

1.4

—

24.40

—

Ankylosis of teeth

0.00

-0.00

0.0

1.3

—

34.50

—

Mental and behavioural disorders associated with the puerperium

1.00

-0.00

1.2

1.1

32.88

33.71

mg/l

—

Cleft lip, lip and palate or palate

0.93

-0.00

1.0

1.1

85.20

35.22

mg/l

—

Cystic kidney disease, including avohilmo

0.93

-0.00

1.1

1.2

61.38

39.08

mg/l

—

Lipoprotein deficiency

0.00

-0.00

0.0

1.2

—

40.34

—

Noonan syndrome

0.00

-0.00

0.0

1.2

—

24.94

—

Motor- or nonmotor-vehicle accident, type of vehicle unspecified - non-traffic accident

0.00

-0.00

0.0

1.2

—

38.40

—

Folliculitis decalvans

0.00

-0.00

0.0

1.1

—

44.24

—

Disorders of fructose metabolism

0.00

-0.00

0.0

1.2

—

38.54

—

Induced delusional disorder

0.00

-0.00

0.0

1.2

—

35.00

—

Injury of blood vessels of thorax

0.00

-0.00

0.0

1.2

—

39.67

—

Brain mixed glioma, helper endpoint

0.00

-0.00

0.0

1.2

—

44.34

—

Photocontact dermatitis [berloque dermatitis]

0.00

-0.00

0.0

1.1

—

41.50

—

Rubella [German measles], including avohilmo

100

1.00

-0.00

1.2

1.1

47.64

48.52

mg/l

—

Hereditary lymphedema

0.00

-0.00

0.0

1.0

—

39.47

—

Pterygium

0.92

-0.00

1.2

1.1

40.42

44.57

mg/l

—

Eccrine sweat disorders

0.00

-0.00

0.0

1.0

—

38.98

—

Haematosalpinx/Haematoma of broad ligament

0.00

-0.00

0.0

1.0

—

22.20

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

IgG [Mass/volume] in Cerebral spinal fluid

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS